<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">73557</article-id><article-id pub-id-type="doi">10.7554/eLife.73557</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Activation of the CaMKII-Sarm1-ASK1-p38 MAP kinase pathway protects against axon degeneration caused by loss of mitochondria</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-114370"><name><surname>Ding</surname><given-names>Chen</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1054-9668</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-253126"><name><surname>Wu</surname><given-names>Youjun</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-253127"><name><surname>Dabas</surname><given-names>Hadas</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6654-0873</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-6557"><name><surname>Hammarlund</surname><given-names>Marc</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3068-068X</contrib-id><email>marc.hammarlund@yale.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03v76x132</institution-id><institution>Department of Neuroscience, Yale University School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">New Haven</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03v76x132</institution-id><institution>Department of Genetics, Yale University School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">New Haven</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Shen</surname><given-names>Kang</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Howard Hughes Medical Institute, Stanford University</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Sengupta</surname><given-names>Piali</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05abbep66</institution-id><institution>Brandeis University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>14</day><month>03</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e73557</elocation-id><history><date date-type="received" iso-8601-date="2021-09-02"><day>02</day><month>09</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-01-25"><day>25</day><month>01</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2021-09-12"><day>12</day><month>09</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.09.12.459970"/></event></pub-history><permissions><copyright-statement>© 2022, Ding et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Ding et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-73557-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-73557-figures-v1.pdf"/><abstract><p>Mitochondrial defects are tightly linked to axon degeneration, yet the underlying cellular mechanisms remain poorly understood. In <italic>Caenorhabditis elegans,</italic> PVQ axons that lack mitochondria degenerate spontaneously with age. Using an unbiased genetic screen, we found that cell-specific activation of CaMKII/UNC-43 suppresses axon degeneration due to loss of mitochondria. Unexpectedly, CaMKII/UNC-43 activates the conserved Sarm1/TIR-1-ASK1/NSY-1-p38 MAPK pathway and eventually the transcription factor CEBP-1 to protect against degeneration. In addition, we show that disrupting a trafficking complex composed of calsyntenin/CASY-1, Mint/LIN-10, and kinesin suppresses axon degeneration. Further analysis indicates that disruption of this trafficking complex activates the CaMKII-Sarm1-MAPK pathway through L-type voltage-gated calcium channels. Our findings identify CaMKII as a pivot point between mitochondrial defects and axon degeneration, describe how it is regulated, and uncover a surprising neuroprotective role for the Sarm1-p38 MAPK pathway in this context.</p></abstract><abstract abstract-type="executive-summary"><title>eLife digest</title><p>Within the cell are various compartments that carry out specific roles. This includes the mitochondria, which are responsible for generating the chemical energy that powers the cell. Some of the most power-hungry cells are nerve cells, which have long, slender projections called axons that relay signals from one part of the nervous system to another. If the mitochondria do not work properly, the axons break down which can lead to neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease.</p><p>Previous studies showed that defects in how mitochondria are transported cause axons in the roundworm <italic>Caenorhabditis elegans</italic> to spontaneously deteriorate with age. These transparent worms are often used to study biological questions related to the nervous system. Here, Ding et al. have used this model organism to identify a molecular pathway that stops axons from degenerating.</p><p>Random mutations were introduced into the genome of <italic>C. elegans</italic> that are unable to transport mitochondria in to their axons. Ding et al. then searched for mutant strains that still had intact axons despite this mitochondrial defect. This revealed that mutations that activate a protein called CaMKII stop axons from breaking down. Further experiments showed that CAMKII does this by switching on a series of signals, including the protein Sarm1, that eventually turn on another protein that suppresses degeneration.</p><p>The protective role of Sarm1 is surprising given that this protein has been shown to promote axon degeneration after injury in flies and mammals. This suggests that the gene for Sarm1 as well as others likely play different roles depending on the context in which they are activated.</p><p>These findings could help researchers identify new drug targets and strategies for treating neurodegenerative diseases caused by mitochondrial defects. However, further work is needed to see if this newly discovered pathway works the same way in other model systems, such as flies and mammals.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>axon degeneration</kwd><kwd>mitochondria</kwd><kwd>CaMKII</kwd><kwd>Sarm1</kwd><kwd>MAPK signaling</kwd><kwd>calsyntenin</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>C. elegans</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100014989</institution-id><institution>Chan Zuckerberg Initiative</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Hammarlund</surname><given-names>Marc</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001201</institution-id><institution>Kavli Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Hammarlund</surname><given-names>Marc</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 NS098817</award-id><principal-award-recipient><name><surname>Hammarlund</surname><given-names>Marc</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 NS094219</award-id><principal-award-recipient><name><surname>Hammarlund</surname><given-names>Marc</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Axon degeneration due to loss of mitochondria is suppressed by CaMKII activity and MAP kinase signaling.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Mitochondria are abundant in axons and at most synapses. The critical importance of these distal mitochondria is highlighted by the close relationship between defects in mitochondria localization or function and multiple neurodegenerative diseases. For some forms of hereditary neurodegeneration, such as hereditary spastic paraplegias, dominant optic atrophy, and Charcot–Marie–Tooth hereditary neuropathy type 2A (CMT2A), mutations in genes encoding distinct mitochondrial proteins are thought to be causative (<xref ref-type="bibr" rid="bib3">Alavi and Fuhrmann, 2013</xref>; <xref ref-type="bibr" rid="bib12">Blackstone, 2018</xref>; <xref ref-type="bibr" rid="bib116">Züchner et al., 2004</xref>). Additionally, familial forms of Parkinson’s disease (PD) arise from defective mitochondria quality control associated with mutations in the PINK1 and Parkin genes (<xref ref-type="bibr" rid="bib78">Pickrell and Youle, 2015</xref>). Mitochondrial dysfunction has also been suggested to play roles in the more common, sporadic, forms of both PD and Alzheimer’s disease (AD) (<xref ref-type="bibr" rid="bib28">Grünewald et al., 2019</xref>; <xref ref-type="bibr" rid="bib35">Hauptmann et al., 2006</xref>). However, the cellular mechanisms that determine the neurodegenerative response to mitochondria mislocalization or dysfunction are not well understood.</p><p>One well-established prodegenerative pathway in neurons involves dysregulated calcium homeostasis. For example, in neurodegenerative diseases including AD, PD, Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS), elevated intracellular calcium levels have been observed. Proposed mechanisms resulting in elevated calcium include weakening of calcium buffering capacity, deregulation of calcium channel activities, and disruption of mitochondrial calcium homeostasis (<xref ref-type="bibr" rid="bib11">Bezprozvanny, 2009</xref>; <xref ref-type="bibr" rid="bib63">Marambaud et al., 2009</xref>; <xref ref-type="bibr" rid="bib117">Zündorf and Reiser, 2011</xref>). Excess cytosolic calcium activates the calpain family of Ca<sup>2+</sup>-dependent proteases, which cleave a variety of neuronal substrates and lead to degeneration (<xref ref-type="bibr" rid="bib14">Camins et al., 2006</xref>). Ca<sup>2+</sup>/calmodulin-dependent protein kinase II (CaMKII) has also been shown to mediate neurodegeneration in the context of elevated intracellular calcium levels (<xref ref-type="bibr" rid="bib46">Hou et al., 2009</xref>; <xref ref-type="bibr" rid="bib109">Woolums et al., 2020</xref>). In addition, elevated calcium causes mitochondrial malfunctions (<xref ref-type="bibr" rid="bib11">Bezprozvanny, 2009</xref>). Mitochondria can buffer cytosolic calcium through the mitochondrial Ca<sup>2+</sup> uniporter (MCU) and can release their calcium content through the mitochondrial permeability transition pore (mPTP) (<xref ref-type="bibr" rid="bib32">Halestrap, 2009</xref>; <xref ref-type="bibr" rid="bib44">Hoppe, 2010</xref>). Mitochondria calcium overload, together with mitochondrial depolarization and oxidative stress, can trigger the opening of mPTP, which also leads to the release of apoptotic factors and triggers cell death (<xref ref-type="bibr" rid="bib32">Halestrap, 2009</xref>). Thus, elevated calcium can promote neurodegeneration via various mechanisms.</p><p>More recently, a second major prodegenerative pathway in neurons was identified, centered on Sarm1. Sarm1 is essential for Wallerian degeneration in flies and mammals (<xref ref-type="bibr" rid="bib21">Gerdts et al., 2013</xref>; <xref ref-type="bibr" rid="bib72">Osterloh et al., 2012</xref>) and has a role in selected additional degeneration models such as traumatic brain injury (<xref ref-type="bibr" rid="bib40">Henninger et al., 2016</xref>) and peripheral neuropathy (<xref ref-type="bibr" rid="bib100">Turkiew et al., 2017</xref>). The Sarm1 TIR domains possess intrinsic NAD<sup>+</sup> hydrolase activity (<xref ref-type="bibr" rid="bib19">Essuman et al., 2017</xref>), and activation of Sarm1 rapidly depletes NAD<sup>+</sup> in axons, leading to metabolic catastrophe and eventually axon degeneration (<xref ref-type="bibr" rid="bib22">Gerdts et al., 2015</xref>). In addition to NAD<sup>+</sup> metabolism, Sarm1 has been shown to activate MAPK pathways (<xref ref-type="bibr" rid="bib17">Chuang and Bargmann, 2005</xref>; <xref ref-type="bibr" rid="bib47">Hsu et al., 2021</xref>; <xref ref-type="bibr" rid="bib112">Yang et al., 2015</xref>). The role of MAPK signaling was examined in Wallerian degeneration, but mixed results were reported. Two studies showed that the c-Jun N-terminal kinase (JNK) MAPK pathway promotes axon degeneration, although its epistatic relationship with Sarm1 remains controversial (<xref ref-type="bibr" rid="bib106">Walker et al., 2017</xref>; <xref ref-type="bibr" rid="bib112">Yang et al., 2015</xref>). However, an in vivo study in <italic>Drosophila</italic> argues against the requirement of JNK signaling in axon degeneration (<xref ref-type="bibr" rid="bib68">Neukomm et al., 2017</xref>). Sarm1 also contains a mitochondrial targeting sequence (MTS) for association with the outer mitochondrial membrane (<xref ref-type="bibr" rid="bib75">Panneerselvam et al., 2012</xref>). However, the importance of interactions between Sarm1 and mitochondria is still unclear as cytosolic Sarm1 protein lacking MTS is fully capable of activating degeneration and mitochondrial shape and motility is unaffected in Sarm1 KO neurons (<xref ref-type="bibr" rid="bib21">Gerdts et al., 2013</xref>; <xref ref-type="bibr" rid="bib92">Summers et al., 2014</xref>).</p><p>In this study, to identify cellular mechanisms that oppose or promote neurodegeneration in response to mitochondria dysfunction, we analyzed a <italic>Caenorhabditis elegans</italic> model of axon degeneration caused by complete absence of axonal mitochondria (<xref ref-type="bibr" rid="bib81">Rawson et al., 2014</xref>). Using an unbiased approach, we discovered that Ca<sup>2+</sup>/calmodulin-dependent protein kinase II (CaMKII/UNC-43) activity cell-autonomously protects against degeneration, even though mitochondria mislocalization persists. We found that CaMKII/UNC-43 abundance in axons is greatly reduced in the absence of mitochondria, suggesting that CaMKII/UNC-43 insufficiency is a key pivot point that links the loss of mitochondria to axon degeneration. Surprisingly, axon protection by CaMKII/UNC-43 requires Sarm1/TIR-1 and the downstream NSY-1-SEK-1-PMK-3-CEBP-1 mitogen-activated protein kinase (MAPK) pathway (<xref ref-type="bibr" rid="bib17">Chuang and Bargmann, 2005</xref>; <xref ref-type="bibr" rid="bib36">Hayakawa et al., 2006</xref>). Finally, we found that loss of the conserved axonal transport factors calsyntenin or Mint suppresses axon degeneration, and that this suppression is dependent on L-type voltage-gated calcium channel (VGCC) and CaMKII/UNC-43. Together, our data provide insight into the cellular mechanisms that control the neurodegenerative response to mitochondria mislocalization and reveal a novel anti-degenerative function for Sarm1, calcium, and CaMKII.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>An unbiased screen identifies suppressors of axon degeneration caused by lack of mitochondria</title><p>In <italic>C. elegans</italic>, anterograde traffic of mitochondria from neuronal cell bodies to axons is known to depend on a small number of factors: <italic>unc-116</italic>, which encodes the kinesin heavy chain (KHC) of the kinesin-1 motor complex (<xref ref-type="bibr" rid="bib86">Schwarz, 2013</xref>); the novel factor <italic>ric-7</italic>, which is specifically required for mitochondria localization in axons (<xref ref-type="bibr" rid="bib81">Rawson et al., 2014</xref>); and the combined activity of Miro, Milton, and metaxin, which couple mitochondria to kinesin-1-mediated traffic (<xref ref-type="bibr" rid="bib26">Glater et al., 2006</xref>; <xref ref-type="bibr" rid="bib30">Guo et al., 2005</xref>; <xref ref-type="bibr" rid="bib91">Stowers et al., 2002</xref>; <xref ref-type="bibr" rid="bib115">Zhao et al., 2021</xref>). The two PVQ neurons are a pair of unipolar neurons in the posterior of the animal that each extends a single long neurite to the nerve ring in the head (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). PVQ was previously shown to degenerate as a result of lack of axonal mitochondria in <italic>ric-7</italic> mutants (<xref ref-type="bibr" rid="bib81">Rawson et al., 2014</xref>). We labeled both PVQ neurons with the <italic>oyIs14[sra-6p::GFP]</italic> transgene (which additionally marks the ASI and ASH neurons in the head) (<xref ref-type="bibr" rid="bib70">Nolan et al., 2002</xref>; <xref ref-type="fig" rid="fig1">Figure 1C</xref>). We also labeled mitochondria in PVQ using a TagRFP marker targeted to the mitochondria matrix (mito::TagRFP) with the mitochondrial import signal from chicken aspartate aminotransferase (<xref ref-type="fig" rid="fig1">Figure 1E</xref>; <xref ref-type="bibr" rid="bib24">Ghose et al., 2013</xref>; <xref ref-type="bibr" rid="bib49">Jaussi et al., 1985</xref>). We quantified degeneration by determining the fraction of animals with no PVQ degeneration (two intact nontruncated PVQ axons) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Consistent with previous findings (<xref ref-type="bibr" rid="bib81">Rawson et al., 2014</xref>), loss of <italic>ric-7</italic> results in a complete absence of mitochondria in PVQ axons as early as the L1 stage, which continues into and past the L4 stage (<xref ref-type="fig" rid="fig1">Figure 1E–G</xref>). The loss of axonal mitochondria is accompanied by completely penetrant degeneration of PVQ axons in adults (<xref ref-type="fig" rid="fig1">Figure 1C and D</xref>). Most axons degenerate during the L4 to 1-day-old adult (1doa) transition (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Similarly, PVQ axons also degenerate in KHC/<italic>unc-116</italic> mutants and Miro-metaxin/<italic>miro-1; mtx-2</italic> double mutants (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>), in which mitochondria are completely absent in axons (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>; <xref ref-type="bibr" rid="bib81">Rawson et al., 2014</xref>; <xref ref-type="bibr" rid="bib115">Zhao et al., 2021</xref>). By contrast, PVQ axons do not degenerate in <italic>miro-1; miro-2</italic> double mutants or in Milton/<italic>trak-1</italic> single mutants (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>), likely because mitochondria are still present in axons in these mutants (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>; <xref ref-type="bibr" rid="bib95">Sure et al., 2018</xref>; <xref ref-type="bibr" rid="bib115">Zhao et al., 2021</xref>). Therefore, spontaneous PVQ axon degeneration is induced by the complete loss of axonal mitochondria. Because kinesin-1 is involved in the transport of multiple axonal cargoes in addition to mitochondria (<xref ref-type="bibr" rid="bib29">Guedes-Dias and Holzbaur, 2019</xref>), we used <italic>ric-7</italic> mutants for further analysis of the relationship between axonal mitochondria and degeneration.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>An unbiased screen identifies suppressors of spontaneous axon degeneration caused by loss of mitochondria.</title><p>(<bold>A</bold>) Diagrams of PVQ neurons in control, <italic>ric-7(n2657</italic>), and <italic>ric-7(n2657</italic>) + suppressor animals. Throughout this study, PVQ neurons are visualized with <italic>oyIs14[sra-6p::GFP]</italic>, and mitochondria in PVQ are visualized with <italic>sra-6p::mito::TagRFP</italic>. (<bold>B</bold>) Axon degeneration modifiers identified in unbiased forward genetic screen. Graph shows proportion of 3-day-old adult (3doa) animals without degeneration in either PVQ neuron. Leftmost bars show control (99% animals without degeneration) and <italic>ric-7(n2657</italic>) (0% animals without degeneration). Remaining bars show strains that are all <italic>ric-7(n2657</italic>) mutants and that also carry an independent mutation that suppresses degeneration. The top two suppressor mutants, <italic>ric-7(n2657); casy-1(wp60</italic>) and <italic>ric-7(n2657); unc-43(wp64</italic>), are highlighted. Bars show proportion and 95% confidence intervals (CIs), N &gt; 74 for all strains. ****p&lt;0.0001, compared to <italic>ric-7(n2657</italic>), Fisher’s exact test. (<bold>C</bold>) Suppression of axon degeneration by mutations in CaMKII/<italic>unc-43</italic> and calsyntenin/<italic>casy-1</italic>. Representative images of control, <italic>ric-7(n2657</italic>), <italic>ric-7(n2657); unc-43(wp64</italic>), and <italic>ric-7(n2657); casy-1(wp60</italic>) 2–3doa. Arrows indicate the tips of degenerated axons. Asterisks indicate the head neurons—these are co-labeled by the GFP reporter but are not the subject of this study. Scale bar, 50 μm. (<bold>D</bold>) Quantification of suppression of axon degeneration. PVQ degeneration is analyzed from the L3 stage to 5-day-old adult (5doa) in control and suppressor mutants. Graph shows proportion and 95% CI. N = 44–74 for each timepoint. ****p&lt;0.0001, ns, not significant, Chi-square test. (<bold>E</bold>) Suppressors of degeneration do not restore axonal mitochondria. Images of mitochondria in PVQ neurons in control, <italic>ric-7(n2657</italic>), and suppressor mutants at L4. Arrowheads indicate mitochondria in axons. Scale bar, 5 μm. (<bold>F, G</bold>) Quantification of mitochondria density in control, <italic>ric-7(n2657</italic>), and suppressor mutants at L1 and L4 stages. Bars show mean and SEM. N = 16, 26, 63, 53 for L1s and N = 54, 52, 50, 70 for L4s. ****p&lt;0.0001, ns, not significant, compared to control except where indicated, one-way ANOVA, Kruskal–Wallis test, followed by Dunn’s multiple comparisons. (<bold>H</bold>) Axon degeneration in the absence of mitochondria is progressive. Images of axon morphology in a single control and a single <italic>ric-7(n2657</italic>) animal at timepoints during the L4-1doa transition. Asterisk indicates the nerve ring. Scale bar, 10 μm.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Axon degeneration and mitochondria density in control and suppressor mutants.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73557-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73557-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Complete loss of axonal mitochondria leads to degeneration and key allele information.</title><p>(<bold>A</bold>) Axon degeneration in mutants of the mitochondria transport machinery. Quantification of axon degeneration in control (N = 28), <italic>ric-7(n2657</italic>) (N = 26), <italic>unc-116(rh24sb79</italic>) (N = 21), <italic>miro-1(wy50180); mtx-2(wy50266</italic>) (N = 45), <italic>trak-1(gk571211</italic>) (N = 39), and <italic>miro-1(tm1966); miro-2(tm2933</italic>) (N = 50) 3-day-old adult (3doa). Bars show proportion and 95% CI. ****p&lt;0.0001, ns, not significant, Fisher’s exact test. (<bold>B</bold>) Mitochondria density in control (N = 27), <italic>miro-1(wy50180); mtx-2(wy50266</italic>) (N = 22), and <italic>miro-1(tm1966); miro-2(tm2933</italic>) (N = 30) L4 animals. Mean ± SEM. ****p&lt;0.0001, ns, not significant, one-way ANOVA, Kruskal–Wallis test, followed by Dunn’s multiple comparisons. (<bold>C</bold>) Images of restored axonal mitochondria and suppressed degeneration in a <italic>ric-7(n2657</italic>) mutant that expresses the UNC-116::TOMM-7 chimera in PVQ. Scale bar, 5 µm for mitochondria and 50 µm for whole animal. (<bold>D</bold>) Axon degeneration in <italic>ric-7(n2657</italic>) is due to loss of axonal mitochondria. Quantification of axon degeneration in control (N = 27), <italic>ric-7(n2657</italic>) (N = 57), and <italic>ric-7(n2657</italic>) with the UNC-116::TOMM-7 chimera in PVQ (N = 56). Bars show proportion and 95% CI. ****p&lt;0.0001, ns, not significant, Fisher’s exact test. (<bold>E</bold>) Detailed molecular information of key <italic>unc-43</italic> and <italic>casy-1</italic> alleles.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Axon degeneration and mitochondria density in mutants that affect mitochondria transport.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73557-fig1-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73557-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title><italic>casy-1(wp60</italic>) and <italic>unc-43(wp64</italic>) do not suppress enhanced injury-induced axon degeneration (after laser axotomy) in <italic>ric-7(n2657</italic>).</title><p>(<bold>A</bold>) Representative images of laser axotomy-induced axon degeneration in PVQ in control and <italic>ric-7(n2657</italic>) animals. Asterisk indicates the remaining distal axon segment after axotomy. (<bold>B</bold>) Quantification of the presence of the distal axon segments 24 hr after axotomy in control (N = 19), <italic>ric-7(n2657</italic>) (N = 24), <italic>ric-7(n2657); casy-1(wp60</italic>) (N = 30), and <italic>ric-7(n2657); unc-43(wp64</italic>) (N = 21) animals. Bars show proportion and 95% CI. ****p&lt;0.0001, ns, not significant, compared to control except where indicated, Fisher’s exact test.</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>Axotomy-induced axon degeneration in <italic>ric-7</italic>, <italic>ric-7; casy-1</italic> and <italic>ric-7; unc-43 gof</italic> animals.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73557-fig1-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73557-fig1-figsupp2-v1.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title><italic>casy-1(wp78</italic>) and <italic>unc-43(n498sd</italic>) suppress axon degeneration in <italic>miro-1(wy50180); mtx-2(wy50266</italic>) mutants.</title><p>Quantification of axon degeneration in <italic>miro-1(wy50180); mtx-2(wy50266</italic>) (N = 35–45), <italic>miro-1(wy50180); mtx-2(wy50266); casy-1(wp78</italic>) (N = 22–37) and <italic>miro-1(wy50180); mtx-2(wy50266); unc-43(n498sd</italic>) (N = 35–43). Graph shows proportion and 95% CI. ****p&lt;0.0001, chi-square test.</p><p><supplementary-material id="fig1s3sdata1"><label>Figure 1—figure supplement 3—source data 1.</label><caption><title>Axon degeneration in <italic>miro-1; mtx-2</italic>, <italic>miro-1; mtx-2; casy-1</italic> and <italic>miro-1; mtx-2; unc-43 gof</italic> animals.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73557-fig1-figsupp3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73557-fig1-figsupp3-v1.tif"/></fig></fig-group><p>End-stage PVQ degeneration is visible in <italic>ric-7</italic> mutants as truncated axons that are disconnected from the nerve ring (<xref ref-type="fig" rid="fig1">Figure 1A–C</xref>). To determine the sequence of events that leads to degeneration, we performed longitudinal imaging of individual axons. We found that degeneration is a sequential process beginning with axon swelling, progressing through thinning and fragmentation, and ending with debris clearance (<xref ref-type="fig" rid="fig1">Figure 1H</xref>). To further confirm that PVQ axon degeneration in <italic>ric-7</italic> mutants is caused by the absence of mitochondria, we expressed a chimeric construct consisting of the UNC-116/kinesin-1 motor and the mitochondrial outer membrane protein TOMM-7, which restores axonal mitochondria localization, and we found that degeneration could be completely suppressed (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C and D</xref>; <xref ref-type="bibr" rid="bib69">Nichols et al., 2016</xref>; <xref ref-type="bibr" rid="bib81">Rawson et al., 2014</xref>). Thus, the PVQ axon in <italic>ric-7</italic> mutants is a completely penetrant system for analyzing axon degeneration caused by loss of axonal mitochondria.</p><p>To identify molecular mechanisms required for axon degeneration in the absence of mitochondria, we performed an unbiased suppressor screen in the <italic>ric-7(n2657</italic>) background (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). After standard EMS mutagenesis and screening of semi-clonal F2s (see Materials and methods), we recovered 11 strains with &gt;50% suppression of degeneration (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). We cloned the two strongest suppressors, <italic>wp64</italic> and <italic>wp60</italic>, using whole-genome sequencing (see Materials and methods). <italic>wp64</italic> is an allele of <italic>unc-43</italic>, the <italic>C. elegans</italic> homolog of CaMKII, and <italic>wp60</italic> is an allele of <italic>casy-1</italic>, the <italic>C. elegans</italic> homolog of calsyntenin (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>). In <italic>ric-7(n2657); unc-43(wp64</italic>) and <italic>ric-7(n2657); casy-1(wp60</italic>) animals, over 80% of 5-day-old adult (5doa) have no degeneration—both PVQ axons are intact (<xref ref-type="fig" rid="fig1">Figure 1C and D</xref>). However, despite the strong suppression of degeneration, mitochondria are still absent from axons in both suppressed strains at both the L1 and L4 stages (<xref ref-type="fig" rid="fig1">Figure 1E–G</xref>). Therefore, instead of restoring mitochondria localization in axons, the CaMKII/<italic>unc-43(wp64</italic>) and calsyntenin/<italic>casy-1(wp60</italic>) mutations maintain axon integrity in the absence of mitochondria.</p></sec><sec id="s2-2"><title>Constitutively active CaMKII/UNC-43 suppresses spontaneous axon degeneration cell-autonomously</title><p>The CaMKII/<italic>unc-43(wp64</italic>) allele is a G-to-A point mutation, which leads to a glycine to arginine substitution (G207R) in one of the two hydrophobic pockets of the catalytic domain (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>; <xref ref-type="bibr" rid="bib102">Umemura et al., 2005</xref>). This hydrophobic pocket interacts with T284 on the autoinhibitory domain and is critical for the autoinhibition of CaMKII in low calcium (<xref ref-type="bibr" rid="bib111">Yang and Schulman, 1999</xref>). Abolishing this interaction with a T284D mutation in the autoinhibitory domain, or with a V206E mutation in the hydrophobic pocket, causes CaMKII/UNC-43 to be constitutively active (CA) even in the absence of calcium (<xref ref-type="bibr" rid="bib102">Umemura et al., 2005</xref>; <xref ref-type="bibr" rid="bib111">Yang and Schulman, 1999</xref>). Since the G207R alteration in our <italic>wp64</italic> allele is next to the V206E change that results in constitutive activity, we hypothesized that the <italic>wp64</italic> mutation also makes CaMKII/UNC-43 CA. Indeed, the <italic>unc-43(wp64</italic>) worms display a dominant lethargic phenotype, similar to the canonical CA <italic>unc-43(n498sd</italic>) mutants (<xref ref-type="bibr" rid="bib82">Reiner et al., 1999</xref>). Further, we found that the <italic>unc-43(n498sd</italic>) mutation phenocopies <italic>unc-43(wp64</italic>) in terms of the anti-degeneration effect in <italic>ric-7(n2657</italic>) animals (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). By contrast, the loss-of-function (lof) allele <italic>unc-43(e408</italic>) does not suppress degeneration in <italic>ric-7(n2657</italic>) animals (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Interestingly, although PVQ axons rarely degenerate when CaMKII/UNC-43 is activated, aberrant axonal swellings are still observed (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), suggesting that degeneration is blocked at a step between initiation and severing. Mitochondria anterograde transport also requires kinesin-1/UNC-116 (<xref ref-type="bibr" rid="bib43">Hollenbeck and Saxton, 2005</xref>), and adaptor proteins including MIRO-1 and MTX-2 (<xref ref-type="bibr" rid="bib30">Guo et al., 2005</xref>; <xref ref-type="bibr" rid="bib115">Zhao et al., 2021</xref>). PVQ axons spontaneously degenerate in <italic>unc-116(rh24sb79</italic>) animals between L3 and L4 (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). We found that CA <italic>unc-43(n498sd</italic>) suppresses degeneration in <italic>unc-116(rh24sb79</italic>) (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Similarly, <italic>unc-43(n498sd</italic>) also suppresses degeneration in <italic>miro-1(wy50180); mtx-2(wy50266</italic>) double mutants (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). In conclusion, activated CaMKII/UNC-43 suppresses axon degeneration caused by the absence of mitochondria.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Active CaMKII/UNC-43 suppresses axon degeneration cell-autonomously through the conserved Sarm1/TIR-1-ASK1/NSY-1 MAPK pathway.</title><p>(<bold>A</bold>) Active CaMKII/UNC-43 functions cell-autonomously to suppress degeneration. Quantification of axon degeneration in 3-day-old adult (3doa) animals. Genotypes and number of animals: <italic>ric-7(n2657</italic>) (N = 36), <italic>ric-7(n2657); unc-43(wp64</italic>) (N = 35), <italic>ric-7(n2657); unc-43(n498sd</italic>) (N = 31), <italic>ric-7(n2657); unc-43(e408</italic>) (N = 35), <italic>ric-7(n2657</italic>) + P<sub>PVQ</sub>::WT UNC-43 (N = 43) and <italic>ric-7(n2657</italic>) + P<sub>PVQ</sub>::constitutively active (CA) UNC-43 (N = 39). Bars show proportion and 95% CI. ****p&lt;0.0001, **p&lt;0.01, ns, not significant, compared to ric-7(n2657) except where indicated, Fisher’s exact test. (<bold>B</bold>) Images of axon morphology in a single <italic>ric-7(n2657); unc-43(n498sd</italic>) animal at timepoints during the L4-1doa transition. Arrowheads indicate axon swellings. Scale bar, 10 µm. (<bold>C</bold>) Loss of kinesin-1/<italic>unc-116</italic> results in axon degeneration that is suppressed by active CaMKII/<italic>unc-43</italic>. Quantification of axon degeneration from the L3 stage to 1-day-old adults (1doa). Genotypes and number of animals: <italic>unc-116(rh24sb79</italic>) (N = 50–73), and <italic>unc-116(rh24sb79); unc-43(n498sd</italic>) (N = 38–55). Graph shows proportion and 95% CI. ****p&lt;0.0001, ns, not significant, compared to <italic>unc-116(rh24sb79</italic>), Fisher’s exact test. (<bold>D</bold>) Endogenous CaMKII/UNC-43 localization. Images of native and tissue-specific fluorescence (NATF)-tagged CaMKII/UNC-43 in PVQ cell bodies and distal axons adjacent to the nerve ring in control, <italic>ric-7(n2657</italic>), and <italic>ric-7(n2657</italic>) + P<sub>PVQ</sub>::UNC-116::TOMM-7 in L3 stage animals. Scale bar, 5 µm. (<bold>E</bold>) Normalized NATF-tagged CaMKII/UNC-43 intensities (arbitrary units) in PVQ cell bodies and distal axons in control, <italic>ric-7(n2657</italic>) and <italic>ric-7(n2657</italic>) + P<sub>PVQ</sub>::UNC-116::TOMM-7 in L3 stage animals. Violin plots with median and quantiles are shown. ****p&lt;0.0001, **p&lt;0.01, *p&lt;0.05, ns, not significant, compared to control except where indicated, one-way ANOVA, Kruskal–Wallis test, followed by Dunn’s multiple comparisons. (<bold>F</bold>) The UNC-43-TIR-1-MAPK pathway and conservation in mammals. (<bold>G</bold>) The TIR-1-NSY-1-SEK-1-PMK-3-CEBP-1 pathway is required to suppress axon degeneration in activated CaMKII/<italic>unc-43</italic> mutants. Quantification of axon degeneration in 1doa. Genotypes and number of animals: <italic>ric-7(n2657); unc-43(n498sd</italic>) (N = 35), <italic>ric-7(n2657); unc-43(n498sd); tir-1(qd4</italic>) (N = 37), <italic>ric-7(n2657); unc-43(n498sd); nsy-1(ok593</italic>) (N = 33), <italic>ric-7(n2657); unc-43(n498sd), pmk-1(km25</italic>) (N = 33), <italic>ric-7(n2657); unc-43(n498sd), pmk-3(ok169</italic>) (N = 27), and <italic>ric-7(n2657); unc-43(n498sd), cebp-1(tm2807</italic>) (N = 48). Bars show proportion and 95% CI. ****p&lt;0.0001, ns, not significant, compared to <italic>ric-7(n2657); unc-43(n498sd</italic>), Fisher’s exact test. (<bold>H</bold>) Sarm1/TIR-1 protects against degeneration in the context of lack of axonal mitochondria. Quantification of axon degeneration in 3doa. Genotypes and number of animals: <italic>ric-7(n2657</italic>) (N = 24), <italic>ric-7(n2657); tir-1(qd4</italic>) (N = 30), <italic>ric-7(n2657); tir-1(ok2859</italic>) (N = 25) and <italic>ric-7(n2657</italic>) + P<sub>PVQ</sub>::WT TIR-1 (N = 35). Bars show proportion and 95% CI. ****p&lt;0.0001, ns, not significant, compared to <italic>ric-7(n2657</italic>), Fisher’s exact test.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Axon degeneration in mutants in the CaMKII-Sarm1-MAPK pathway and endogenous CaMKII abundance.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73557-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73557-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>The GFP1-10 control and the <italic>casy-1::gfp11x7</italic> control for the native and tissue-specific fluorescence (NATF) approach.</title><p>(<bold>A</bold>) The P<sub>PVQ</sub>::GFP1-10 construct alone has no detectable fluorescence. Asterisk indicates the approximate location of PVQ cell bodies. (<bold>B</bold>) The NATF tag does not disrupt the function of calsyntenin/<italic>casy-1</italic> in axon degeneration. Quantification of axon degeneration in <italic>ric-7(n2657</italic>) (N = 36) and <italic>ric-7(n2657); casy-1(syb3311[casy-1::gfp11x7]</italic>) (N = 63) 3-day-old adult (3doa). Bars show proportion and 95% CI. ns, not significant, Fisher’s exact test.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>The <italic>gfp11x7</italic> insertion at the <italic>casy-1</italic> locus does not affect axon degeneration.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73557-fig2-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73557-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Overexpressing worm NMNATs does not suppress degeneration in <italic>ric-7(n2657</italic>).</title><p>Quantification of axon degeneration in <italic>ric-7(n2657</italic>) (N = 26), <italic>ric-7(n2657</italic>) + P<sub>PVQ</sub>::NMAT-1 (N = 30) and <italic>ric-7(n2657</italic>) + P<sub>PVQ</sub>::NMAT-2 (N = 33) 3-day-old adult (3doa). Bars show proportion and 95% CI. ns, not significant, Fisher’s exact test.</p><p><supplementary-material id="fig2s2sdata1"><label>Figure 2—figure supplement 2—source data 1.</label><caption><title>Axon degeneration in <italic>ric-7</italic> animals that overexpress NMATs in PVQ.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73557-fig2-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73557-fig2-figsupp2-v1.tif"/></fig></fig-group><p>To examine if CaMKII/UNC-43 functions in PVQ cell-autonomously, we overexpressed CaMKII/UNC-43 in PVQ in <italic>ric-7(n2657</italic>) animals. Expressing wildtype CaMKII/UNC-43 leads to mild but distinct protection against degeneration (20% of 3doa have no degeneration), while expressing a CA form of CaMKII/UNC-43 (T284D) results in much stronger protection (70% of 3doa have no degeneration) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). These data indicate that active CaMKII/UNC-43 functions cell-autonomously to suppress axon degeneration. Further, since overexpression of wildtype CaMKII/UNC-43 has less effect on degeneration than expression of the CA protein, our results suggest that WT UNC-43 cannot be adequately activated even when overexpressed in PVQ axons without mitochondria.</p><p>To explore potential mechanisms that might affect CaMKII/UNC-43 function in animals lacking axonal mitochondria, we examined the abundance and distribution of CaMKII/UNC-43 protein using the native and tissue-specific fluorescence (NATF) approach (<xref ref-type="bibr" rid="bib37">He et al., 2019</xref>). Briefly, seven copies of the GFP11 β-strand were knocked into the C terminus of the endogenous CaMKII/<italic>unc-43</italic> locus by CRISPR/Cas9. The complementary split-GFP fragment GFP1-10 was then expressed under the PVQ promoter, resulting in PVQ-specific labeling of CaMKII/UNC-43 at endogenous expression levels (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). The <italic>unc-43::gfp11x7</italic> knock-in (KI) animals displayed no apparent uncoordinated or lethargic phenotype related to <italic>unc-43</italic> mutants (data not shown), indicating that CaMKII/UNC-43 function is not impaired by the KI. As a negative control, expressing GFP1-10 alone in PVQ did not produce visible GFP fluorescence (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). We examined the distribution of labeled CaMKII/UNC-43 in control and <italic>ric-7</italic> animals at the L3 stage, which precedes spontaneous degeneration (<xref ref-type="fig" rid="fig1">Figure 1D</xref>; <xref ref-type="bibr" rid="bib81">Rawson et al., 2014</xref>). We found that in <italic>ric-7(n2657</italic>) animals CaMKII/UNC-43 abundance in distal axons (posterior to the nerve ring) is dramatically reduced (37% of the control levels), while CaMKII/UNC-43 abundance in cell bodies is not affected (<xref ref-type="fig" rid="fig2">Figure 2D and E</xref>). Further, axonal CaMKII/UNC-43 abundance in <italic>ric-7(n2657</italic>) animals was partially restored (to 69% of control levels) by expression of the UNC-116::TOMM-7 chimeric protein, a synthetic method of forcing mitochondria into the axon in the absence of <italic>ric-7</italic> (<xref ref-type="bibr" rid="bib81">Rawson et al., 2014</xref>; <xref ref-type="fig" rid="fig2">Figure 2D and E</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). Therefore, our data indicate that axonal mitochondria promote CaMKII/UNC-43 localization in axons.</p></sec><sec id="s2-3"><title>CaMKII/UNC-43 suppresses axon degeneration through the conserved Sarm1/TIR-1-ASK1/NSY-1-PMK-3-CEBP-1 MAPK pathway</title><p>We next sought to identify the downstream targets of CaMKII/UNC-43. In <italic>C. elegans</italic> nervous system, CaMKII/UNC-43 has been shown to regulate asymmetric neural development through the conserved Sarm1/TIR-1-ASK1/NSY-1-p38 MAPK pathway (<xref ref-type="bibr" rid="bib17">Chuang and Bargmann, 2005</xref>; <xref ref-type="bibr" rid="bib36">Hayakawa et al., 2006</xref>; <xref ref-type="fig" rid="fig2">Figure 2F</xref>). Specifically, in one of the two AWC sensory neurons, high calcium activates UNC-43, which then directly interacts with TIR-1 and releases the autoinhibition on the TIR domains. Active TIR-1 then recruits and activates the NSY-1 MAPKKK to inhibit the expression of specific odorant receptors. In addition, UNC-43, TIR-1, and NSY-1 colocalize at synaptic regions of AWC and physically interact with each other to form a signaling complex (<xref ref-type="bibr" rid="bib17">Chuang and Bargmann, 2005</xref>; <xref ref-type="bibr" rid="bib84">Sagasti et al., 2001</xref>). To test if this signaling complex functions in PVQ degeneration, we examined whether the individual components were required for the protection against degeneration conferred by <italic>unc-43(n498sd</italic>) in animals lacking axonal mitochondria. We found that lof mutations in <italic>tir-1(qd4</italic>) and <italic>nsy-1(ok593</italic>) completely abolish the protection against degeneration conferred by the CA <italic>unc-43(n498sd</italic>) allele (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). Thus, the UNC-43/TIR-1/NSY-1 complex functions to suppress axon degeneration in the absence of mitochondria. During development, this complex regulates asymmetric neuronal development via the MAPKK SEK-1 and two redundant p38 MAPKs, PMK-1 and PMK-2 (<xref ref-type="bibr" rid="bib6">Alqadah et al., 2016b</xref>; <xref ref-type="bibr" rid="bib74">Pagano et al., 2015</xref>). We could not assess SEK-1 function in axon degeneration, as we found that <italic>ric-7(n2657); sek-1(km4); unc-43(n498sd</italic>) animals are sick and arrest before adulthood, precluding analysis of degeneration. However, we found that loss of PMK-1 alone does not prevent activated CaMKII/UNC-43 from suppressing degeneration (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). By contrast, loss of another p38 MAPK, PMK-3, or loss of its downstream C/EBP bZIP transcription factor CEBP-1 (<xref ref-type="bibr" rid="bib110">Yan et al., 2009</xref>) largely blocks the protective effects of activated CaMKII (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). Therefore, active CaMKII protects against axon degeneration through CEBP-1-mediated transcription regulation.</p><p>Our data suggest that Sarm1/TIR-1 has an axon protective role: it is required for constitutively activated CaMKII to suppress degeneration due to mitochondria mislocalization (<xref ref-type="fig" rid="fig2">Figure 2I</xref>). By contrast, Sarm1/TIR-1 in other contexts—particularly Wallerian degeneration—promotes axon degeneration by depleting axonal NAD<sup>+</sup> (<xref ref-type="bibr" rid="bib21">Gerdts et al., 2013</xref>; <xref ref-type="bibr" rid="bib40">Henninger et al., 2016</xref>; <xref ref-type="bibr" rid="bib72">Osterloh et al., 2012</xref>; <xref ref-type="bibr" rid="bib100">Turkiew et al., 2017</xref>). We examined whether loss of Sarm1/TIR-1 might suppress degeneration in axons that lack mitochondria. We found that neither of the two lof mutations of <italic>tir-1, qd4</italic> and <italic>ok2859</italic>, suppresses PVQ degeneration (<xref ref-type="fig" rid="fig2">Figure 2J</xref>). Similarly, overexpressing the <italic>C. elegans</italic> NAD<sup>+</sup> synthase <italic>nmat-1</italic> or <italic>nmat-2</italic> does not suppress degeneration in <italic>ric-7(n2657</italic>) (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). By contrast, overexpression of WT TIR-1 in PVQ strongly suppresses degeneration (<xref ref-type="fig" rid="fig2">Figure 2J</xref>). Overall, our results indicate a surprising neuroprotective role for Sarm1/TIR-1 as part of the UNC-43/TIR-1/NSY-1 signaling complex.</p></sec><sec id="s2-4"><title>Loss of calsyntenin/CASY-1 suppresses axon degeneration</title><p>Our unbiased screen identified a mutation in the <italic>casy-1</italic> gene, <italic>wp60</italic>, that suppresses PVQ degeneration to a similar extent as activated CaMKII/UNC-43 (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). CASY-1 is the <italic>C. elegans</italic> homologue of calsyntenin, and comparison of CASY-1 to its <italic>Drosophila</italic> and mammalian homologues shows that these proteins share significant sequence similarity along their entire lengths (<xref ref-type="bibr" rid="bib41">Hill et al., 2001</xref>). Calsyntenins are type I transmembrane (TM) proteins and are members of the cadherin superfamily (<xref ref-type="bibr" rid="bib41">Hill et al., 2001</xref>). Their extracellular region contains two cadherin domains and an LG/LNS (laminin G-like) domain and has been shown to regulate synapse development through interactions with neurexin (<xref ref-type="bibr" rid="bib52">Kim et al., 2020a</xref>; <xref ref-type="bibr" rid="bib53">Kim et al., 2020b</xref>; <xref ref-type="bibr" rid="bib77">Pettem et al., 2013</xref>). Their intracellular region is characterized by two kinesin-binding sites (KBS), which are important for its anterograde trafficking (<xref ref-type="bibr" rid="bib8">Araki et al., 2003</xref>; <xref ref-type="bibr" rid="bib54">Konecna et al., 2006</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Calsyntenin/CASY-1 promotes axon degeneration cell-autonomously.</title><p>(<bold>A</bold>) The three <italic>C. elegans</italic> CASY-1 isoforms. SP, signal peptide; LG/LNS, laminin G-like; TM, transmembrane domain; KBS, kinesin-binding site. (<bold>B</bold>) Loss of calsyntenin/<italic>casy-1</italic> suppresses degeneration due to loss of axonal mitochondria. Quantification of axon degeneration in 3-day-old adult (3doa). Genotypes and number of animals: <italic>ric-7(n2657</italic>) (N = 25), <italic>ric-7(n2657); casy-1(wp60</italic>) (N = 22), <italic>ric-7(n2657); casy-1(wp78</italic>) (N = 30), <italic>ric-7(n2657); casy-1(wp60</italic>) + the <italic>casy-1</italic> fosmid WRM0622dH03 (N = 32), and <italic>ric-7(n2657); casy-1(tm718</italic>) (N = 49). Bars show proportion and 95% CI. ****p&lt;0.0001, ns, =not significant, compared to <italic>ric-7(n2657</italic>), Fisher’s exact test. (<bold>C</bold>) Loss of calsyntenin/<italic>casy-1</italic> arrests degeneration before axon severing. Images of axon morphology in a <italic>ric-7(n2657); casy-1(wp78</italic>) animal during the L4-1doa transition. Arrowheads indicate axon swellings. Scale bar, 10 µm. (<bold>D</bold>) Structure-function analysis of CASY-1. Left, six CASY-1 fragments expressed in PVQ in <italic>ric-7(n2657); casy-1(wp60</italic>) animals. Right, quantification of axon degeneration in 3doa. Number of animals in experiments, respectively: 23, 76, 97, 80, 30, 47, and 56. Bars show proportion and 95% CI. ****p&lt;0.0001, ns, not significant, compared to <italic>ric-7(n2657); casy-1(wp60</italic>) with no transgene, Fisher’s exact test. Transgenic fragments #1–4 restore degeneration to <italic>ric-7(n2657); casy-1(wp60</italic>) mutants. (<bold>E</bold>) Overexpression of calsyntenin/<italic>casy-1</italic> enhances axon degeneration due to loss of axonal mitochondria. Quantification of axon degeneration in L4 stage animals. Genotypes and number of animals: <italic>ric-7(n2657</italic>) (N = 51), <italic>ric-7(n2657); casy-1(wp60</italic>) (N = 44), <italic>ric-7(n2657); casy-1(wp60</italic>) + P<sub>PVQ</sub>::CASY-1C (N = 43), and <italic>casy-1(wp60</italic>) + P<sub>PVQ</sub>::CASY-1C (N = 34). Bars show proportion and 95% CI. ****p&lt;0.0001, ns, not significant, compared to <italic>ric-7(n2657</italic>), Fisher’s exact test.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Axon degeneration in <italic>casy-1</italic> loss-of-function and overexpression animals.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73557-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73557-fig3-v1.tif"/></fig><p>The <italic>C. elegans casy-1</italic> locus encodes three isoforms (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). The longest isoform, <italic>casy-1a,</italic> encodes a protein with all domains. The two shorter isoforms, <italic>casy-1b and casy-1c</italic>, share the TM domain and the intracellular region, but do not contain the extracellular cell adhesion domains. The <italic>wp60</italic> allele we identified in the screen is a G-to-A point mutation at the splice acceptor site in the intron before the first KBS, and it affects all three isoforms (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>). We used CRISPR/Cas9 to delete the entire coding region of <italic>casy-1</italic> (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>). This 11.5 kb deletion allele, <italic>wp78</italic>, phenocopies the <italic>wp60</italic> mutation from the screen and strongly suppresses PVQ degeneration in both <italic>ric-7(n2657</italic>) and <italic>miro-1(wy50180); mtx-2(wy50266</italic>) mutants (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). In the <italic>ric-7(n2657); casy-1(wp78</italic>) animals, PVQ axons rarely degenerate and only develop a few swellings during the L4-1doa transition (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). The phenotype is very similar to the protection conferred by activated CaMKII/UNC-43 (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Further, protection of <italic>casy-1(wp60</italic>) can be abolished by expressing a 34.6 kb fosmid that contains the endogenous <italic>casy-1</italic> locus (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Together, these data indicate that loss of calsyntenin/<italic>casy-1</italic> prevents degeneration of axons caused by lack of mitochondria.</p></sec><sec id="s2-5"><title>Calsyntenin/CASY-1 TM domain and ICD function together to promote axon degeneration cell-autonomously</title><p>To determine if CASY-1 acts cell-autonomously to promote axon degeneration, we performed PVQ-specific rescue experiments in <italic>ric-7(n2657); casy-1(wp60</italic>) animals, in which degeneration is suppressed due to loss of calsyntenin. Overexpression of full-length calsyntenin completely restored degeneration to <italic>ric-7(n2657); casy-1(wp60</italic>) animals, indicating that calsyntenin is required cell-autonomously for PVQ axon degeneration (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Next, we used this approach to define a minimal fragment of calsyntenin capable of supporting its pro-degeneration function. We examined six CASY-1 fragments (<xref ref-type="fig" rid="fig3">Figure 3D</xref>) for their abilities to promote axon degeneration in this context, including the three endogenous isoforms (#1–3, see also <xref ref-type="fig" rid="fig3">Figure 3A</xref>), a fragment containing the TM domain+ ICD (#4), CASY-1a without the C terminus starting from the first KBS (#5), and the ICD alone (#6). Expression of CASY-1 fragments #1–4, but not #5 or #6, caused strong PVQ degeneration in <italic>ric-7(n2657); casy-1(wp60</italic>) animals (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). This structure-function analysis indicated that both calsyntenin’s TM domain and the ICD are required for degeneration, while its extracellular region is dispensable. Consistent with these results, we did not observe suppression of degeneration in an existing <italic>casy-1</italic> allele, <italic>tm718,</italic> which is a deletion within the extracellular domain (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>).</p><p>We then examined if overexpressing <italic>casy-1</italic> promotes degeneration. Overexpressing CASY-1C in <italic>ric-7(n2657); casy-1(wp60</italic>) leads to near complete degeneration at L4, a timepoint at which only a few <italic>ric-7(n2657</italic>) control animals show degeneration (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). However, overexpressing CASY-1C in <italic>casy-1(wp60</italic>) single mutants does not induce degeneration (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). Therefore, overexpressing CASY-1 alone is not sufficient to cause degeneration, but is able to enhance degeneration in the absence of mitochondria.</p></sec><sec id="s2-6"><title>Anterograde traffic of calsyntenin/CASY-1 promotes axon degeneration</title><p>The calsyntenin ICD contains two conserved KBS, and in <italic>C. elegans</italic>, the CASY-1 intracellular region binds to kinesin light chain 2 (KLC-2) of the kinesin complex (<xref ref-type="bibr" rid="bib10">Araki et al., 2007</xref>; <xref ref-type="bibr" rid="bib71">Ohno et al., 2014</xref>). To test the importance of the KBS for degeneration, we mutated the conserved tryptophan residues in each KBS to alanine (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>; <xref ref-type="bibr" rid="bib54">Konecna et al., 2006</xref>). We found that this change completely eliminates the pro-degeneration function of calsyntenin (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). These data suggest that calsyntenin functions together with kinesin to mediate degeneration. Next, we tested whether loss of KLC-2 would suppress degeneration, similar to loss of calsyntenin. Indeed, the <italic>klc-2(km11</italic>) lof mutation strongly suppresses degeneration in axons that lack mitochondria (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). By contrast, loss of KLC-1 did not affect axon degeneration (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Together, these data suggest that a kinesin complex containing KLC-2 regulates calsyntenin traffic to promote degeneration.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Calsyntenin/CASY-1 functions as a kinesin adaptor for Mint/LIN-10 to promote axon degeneration.</title><p>(<bold>A</bold>) Kinesin binding is required for calsyntenin’s function in axon degeneration. Quantification of axon degeneration in 3-day-old adult (3doa). All animals have the <italic>ric-7(n2657); casy-1(wp60</italic>) background. Transgenes and number of animals: none (control) (N = 100); WT CASY-1C (N = 114); CASY-1C with mutated acidic residues (N = 88); CASY-1C with the WW/AA mutation (N = 118). Bars show proportion and 95% CI. ****p&lt;0.0001, ***p&lt;0.001, ns, not significant, compared to <italic>ric-7(n2657); casy-1(wp60</italic>) with no transgene except where indicated, Fisher’s exact test. Transgenic CASY-1C with the WW/AA mutation does not restore degeneration to <italic>ric-7(n2657); casy-1(wp60</italic>) mutants. (<bold>B</bold>) Loss of kinesin light chain <italic>klc-2</italic> suppresses axon degeneration. Quantification of axon degeneration in 3doa. Genotypes and number of animals: <italic>ric-7(n2657</italic>) (N = 22), <italic>ric-7(n2657), klc-2(km11</italic>) (N = 27), and <italic>ric-7(n2657); klc-1(ok2609</italic>) (N = 20). Bars show proportion and 95% CI. **** p&lt;0.0001, ns, not significant, compared to <italic>ric-7(n2657</italic>), Fisher’s exact test. (<bold>C</bold>) Loss of Mint/<italic>lin-10</italic> suppresses axon degeneration. Quantification of axon degeneration in 3doa. Genotypes and number of animals: <italic>ric-7(n2657</italic>) (N = 50), <italic>ric-7(n2657); lin-10(n1853</italic>) (N = 48), and <italic>ric-7(n2657); lin-10(e1439</italic>) (N = 38). Bars show proportion and 95% CI. ****p&lt;0.0001, compared to <italic>ric-7(n2657</italic>), Fisher’s exact test. (<bold>D</bold>) Images of native and tissue-specific fluorescence (NATF)-tagged calsyntenin/CASY-1 in PVQ cell bodies and distal axons in control, <italic>ric-7(n2657), and klc-2(km11</italic>) animals at early L4 stage. Scale bar, 5 µm. (<bold>E, F</bold>) Loss of kinesin light chain <italic>klc-2</italic> alters calsyntenin abundance. Normalized NATF-tagged CASY-1 intensities (arbitrary units) in PVQ cell bodies and distal axons. Violin plots with median and quantiles are shown. *** p&lt;0.001, ns, not significant, compared to control, one-way ANOVA, Kruskal–Wallis test, followed by Dunn’s multiple comparisons. (<bold>G</bold>) Calsyntenin accumulates in cell body puncta in animals that lack kinesin light chain <italic>klc-2</italic>. Images of NATF-tagged CASY-1 in PVQ cell bodies in control and <italic>klc-2(km11</italic>) at early L4 stage. Excitation and contrast are enhanced in <italic>klc-2(km11</italic>) animals. Scale bar, 5 µm. (<bold>H</bold>) Number of NATF-tagged CASY-1 puncta in PVQ cell bodies. Violin plots with median and quantiles are shown. ****p&lt;0.0001, compared to control, Mann–Whitney test. (<bold>I</bold>) Images of NATF-tagged Mint/LIN-10 in PVQ cell bodies and distal axons in control and <italic>casy-1(wp78</italic>) animals at L4 stage. Boxes highlight the distal axon region for quantifications in (<bold>K</bold>). Scale bar, 5 µm. (<bold>J, K</bold>) Mint/LIN-10 is depleted from distal axon in animals that lack calsyntenin. Normalized NATF-tagged LIN-10 intensities (arbitrary units) in PVQ cell bodies and distal axons. Violin plots with median and quantiles are shown. ****p&lt;0.0001, **p&lt;0.01, compared to control, Mann–Whitney test.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Axon degeneration in CASY-1/KLC/LIN-10 mutants and endogenous CASY-1 and LIN-10 localization.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73557-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73557-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Functional domains in the CASY-1 ICD and quantification of CASY-1C traffic.</title><p>(<bold>A</bold>) Sequence alignment of the transmembrane and intracellular portion of <italic>C. elegans</italic>, <italic>Drosophila,</italic> and human calsyntenins. The two tryptophan residues critical for kinesin light chain (KLC) binding are highlighted in red. (<bold>B</bold>) Model of how CASY-1 functions as a kinesin adaptor that transports cargoes such as Mint/LIN-10. KHC, kinesin heavy chain; TPR, tetratricopeptide repeat. (<bold>C</bold>) GFP-tagged CASY-1C functions in axon degeneration. Quantification of axon degeneration in <italic>ric-7(n2657</italic>) (N = 26), <italic>ric-7(n2657); casy-1(wp78</italic>) (N = 20), and <italic>ric-7(n2657); casy-1(wp78</italic>) + P<sub>PVQ</sub>::CASY-1C::GFP (N = 23) 3-day-old adult (3doa). Bars show proportion and 95% CI. ****p&lt;0.0001, ns, not significant, Fisher’s exact test. (<bold>D</bold>) Representative kymographs of trafficking of overexpressed CASY-1C::GFP in PVQ axons in <italic>casy-1(wp78</italic>) animals. (<bold>E</bold>) Percentage of anterograde events of overexpressed CASY-1C::GFP in distal axons in <italic>casy-1(wp78</italic>) (N = 1729) and <italic>ric-7(n2657); casy-1(wp78</italic>) (N = 957) animals at L4. Bars show proportion and 95% CI. ****p&lt;0.0001, Fisher’s exact test. (<bold>F</bold>) Speeds of CASY-1 vesicles in distal axons in <italic>casy-1(wp78</italic>) and <italic>ric-7(n2657); casy-1(wp78</italic>) (nontruncated axons) at L4. N = 1125 for <italic>casy-1(wp78</italic>) anterograde, 604 for <italic>ric-7(n2657); casy-1(wp78</italic>) anterograde, 262 for <italic>casy-1(wp78</italic>) retrograde, and 353 for <italic>ric-7(n2657); casy-1(wp78</italic>) retrograde. Box plots with whiskers are shown. ****p&lt;0.0001, unpaired <italic>t</italic>-test. (<bold>G</bold>) Run lengths of CASY-1 vesicles in distal axons in <italic>casy-1(wp78</italic>) and <italic>ric-7(n2657); casy-1(wp78</italic>) (nontruncated axons) at L4. N = 1125 for <italic>casy-1(wp78</italic>) anterograde, 604 for <italic>ric-7(n2657); casy-1(wp78</italic>) anterograde, 262 for <italic>casy-1(wp78</italic>) retrograde, and 353 for <italic>ric-7(n2657); casy-1(wp78</italic>) retrograde. Box plots with whiskers are shown. ****p&lt;0.0001, unpaired <italic>t</italic>-test.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Quantification of CASY-1 vesicle trafficking.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73557-fig4-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73557-fig4-figsupp1-v1.tif"/></fig></fig-group><p>To test this model, we first examined CASY-1’s localization in PVQ axons. We used the NATF approach to label endogenous CASY-1 proteins in PVQ. The <italic>gfp11x</italic>7 insertion at the C terminus of the endogenous <italic>casy-1</italic> locus does not interfere with CASY-1’s pro-degenerative function as these animals show complete axon degeneration when combined with the <italic>ric-7(n2657</italic>) mutation (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). Endogenous CASY-1 fluorescence is visible in the PVQ cell body and throughout the axon (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Loss of <italic>ric-7</italic> does not lead to a significant change in steady-state CASY-1 abundance in the cell body or the distal axon (<xref ref-type="fig" rid="fig4">Figure 4D–F</xref>). By contrast, loss of KLC-2 results in a dramatic redistribution of CASY-1 to punctate structures located in the cell body and proximal axon (<xref ref-type="fig" rid="fig4">Figure 4G and H</xref>). This redistribution was accompanied by a near-complete loss of CASY-1 from the distal axon, as well as a partial reduction of CASY-1 levels in the cell body (<xref ref-type="fig" rid="fig4">Figure 4D–F</xref>). The lack of calsyntenin in the distal axon is consistent with a transport defect, while the reduction in the cell body could result from degradation of accumulated CASY-1 in the soma. Together, these data suggest that CASY-1 localization in axons depends on a kinesin complex containing KLC-2.</p><p>To confirm and extend these results, we performed live imaging. The endogenous CASY-1 signals (<xref ref-type="fig" rid="fig4">Figure 4D</xref>) were too weak for live imaging of trafficking, so we overexpressed CASY-1C with a C terminal GFP tag. This construct preserves CASY-1’s pro-degenerative function as its expression in <italic>ric-7(n2657); casy-1(wp78</italic>) animals leads to strong axon degeneration (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). Live imaging of CASY-1C::GFP in <italic>casy-1(wp78</italic>) animals shows that CASY-1 vesicles undergo extensive trafficking in both the proximal and distal regions of the PVQ axon (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>). We focused on the distal axon region for analysis. Consistent with the previous finding that calsyntenin interacts with kinesin (<xref ref-type="bibr" rid="bib90">Steuble et al., 2012</xref>), CASY-1C trafficking is highly anterogradely biased (81% of trafficking events are anterograde, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>). For anterograde trafficking, the average speed is 1.07 μm/s, and the average run length is 5.79 μm; for retrograde trafficking, the average speed is 2.08 μm/s, and the average run length is 9.87 μm (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1F and G</xref>). Although we found no change in endogenous <italic>casy-1</italic> distribution in <italic>ric-7(n2657</italic>) animals (<xref ref-type="fig" rid="fig4">Figure 4D–F</xref>), we did find that CASY-1C trafficking is greatly affected by <italic>ric-7</italic>: the anterograde bias is largely lost (63% are anterograde), and speeds and run lengths in both directions are dramatically reduced (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1F and G</xref>). Because CASY-1 intensity in axon is too weak for trafficking analysis in the <italic>klc-2</italic> mutant, we were unable to directly compare it with the control. Nevertheless, the anterograde bias and speed of calsyntenin traffic (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D–F</xref>), together with the dependence of endogenous CASY-1 localization on KLC-2 (<xref ref-type="fig" rid="fig4">Figure 4D–H</xref>), suggest that trafficking of CASY-1 into distal axons likely depends on kinesin motors.</p></sec><sec id="s2-7"><title>Mint/LIN-10 is trafficked by calsyntenin/CASY-1 and is required for degeneration</title><p>Calsyntenin/CASY-1 has been shown to function as a kinesin adaptor that transports vesicular and protein cargoes from the neuronal cell body to the distal axon (<xref ref-type="bibr" rid="bib54">Konecna et al., 2006</xref>). For example, mammalian calsyntenin-1 can mediate the anterograde transport of APP (<xref ref-type="bibr" rid="bib61">Ludwig et al., 2009</xref>) and axon guidance receptors such as Robo1 and frizzled 3 (<xref ref-type="bibr" rid="bib7">Alther et al., 2016</xref>). In <italic>C. elegans</italic>, CASY-1 mediates the translocation of a specific insulin receptor isoform, DAF-2C, from the soma to the distal axon in ASE neurons during taste avoidance learning (<xref ref-type="bibr" rid="bib71">Ohno et al., 2014</xref>), and also modulates the transport of synaptic vesicles in GABAergic neurons (<xref ref-type="bibr" rid="bib98">Thapliyal et al., 2018</xref>). It has been proposed that the transport complex consists of four calsyntenin-1 molecules bound to one kinesin-1 motor (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>; <xref ref-type="bibr" rid="bib61">Ludwig et al., 2009</xref>). The intracellular region of calsyntenin, in addition to its kinesin interaction, also contains a conserved region that has been shown to bind Mint/LIN-10 in mammals (<xref ref-type="bibr" rid="bib8">Araki et al., 2003</xref>) and an acidic region that has been proposed to buffer calcium (<xref ref-type="bibr" rid="bib105">Vogt et al., 2001</xref>). To test the importance of the acidic region, we expressed CASY-1C with all the acidic residues in the acidic region mutated to neutral residues (E to Q and D to N). We found that this CASY-1C (mutated acidic) restored strong degeneration to <italic>ric-7(n2657); casy-1(wp60</italic>) animals, but to a lesser extent than the wildtype <italic>casy-1c</italic> transgene (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). We conclude that the acidic domain is not essential for calsyntenin’s pro-degeneration function; the minor reduction in function may be due to a secondary effect on a different function of this region.</p><p>To examine the importance of the Mint/LIN-10 interaction, we tested whether Mint/LIN-10 functions similarly to calsyntenin and KLC-2. We found that two independent lof alleles of <italic>lin-10</italic>, <italic>n1853</italic> and <italic>e1439</italic>, suppress axon degeneration (<xref ref-type="fig" rid="fig4">Figure 4C</xref>), similar to loss of <italic>casy-1</italic> (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). If LIN-10 is a cargo of CASY-1 vesicles, then LIN-10 localization would be affected in <italic>casy-1</italic> KO animals. We labeled endogenous LIN-10 with the NATF approach. In <italic>casy-1(wp78</italic>) single mutants, LIN-10 abundance in the distal axon is dramatically reduced to 56% of the control level, while its abundance in the soma is increased by 27% (<xref ref-type="fig" rid="fig4">Figure 4I–K</xref>). In conclusion, our data suggest a model in which CASY-1 transports LIN-10 from the cell body to the distal axon to mediate axon degeneration in the absence of mitochondria. Since CASY-1C has both a TM sequence and KBS, we reasoned that CASY-1C functions as a TM kinesin adaptor that transports Mint/LIN-10 as well as a potential organelle cargo to the distal axon to mediate degeneration (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>).</p></sec><sec id="s2-8"><title>Loss of calsyntenin/CASY-1 and Mint/LIN-10 suppresses axon degeneration through the CaMKII/UNC-43-Sarm1/TIR-1-ASK1/NSY-1-p38 MAPK pathway</title><p>We hypothesized that knocking out calsyntenin/CASY-1 or Mint/LIN-10 protects against degeneration through a specific signaling pathway in axons. It has been shown that calsyntenin, Mint, and APP can form a tripartite complex in mammals (<xref ref-type="bibr" rid="bib8">Araki et al., 2003</xref>), we thus examined the role of the <italic>C. elegans</italic> APP homologue, APL-1, in spontaneous degeneration in <italic>ric-7(n2657</italic>). We used the Cre-loxP system to knock out the entire <italic>apl-1</italic> locus in PVQ (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A and B</xref>), but did not observe significant protection against degeneration compared to the P<sub>PVQ</sub>::Cre control (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>). We also tested an allele (<italic>wp22</italic>) that deletes most of the APL-1 intracellular region at the C terminus, which has been shown to interact with Mint/LIN-10 (<xref ref-type="bibr" rid="bib99">Tomita et al., 1999</xref>). <italic>ric-7(n2657); apl-1(wp22</italic>) double mutants still show a complete degeneration phenotype (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>). Therefore, APL-1 is not involved in the spontaneous degeneration in the absence of mitochondria. LIN-10 has also been shown to form a complex with LIN-2 and LIN-7 to localize EGF receptors in vulval epithelial cells (<xref ref-type="bibr" rid="bib50">Kaech et al., 1998</xref>). However, the <italic>lin-2</italic> lof allele <italic>e1309</italic> does not suppress axon degeneration in <italic>ric-7(n2657</italic>) (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>), indicating that the LIN-2/7/10 complex (or EGF receptors) is not involved.</p><p>Since we identified the <italic>casy-1</italic> and <italic>unc-43</italic> mutations in the same unbiased screen, we next examined the possibility that CaMKII/UNC-43 acts downstream of CASY-1. In <italic>ric-7(n2657); casy-1(wp78</italic>) animals, degeneration is strongly delayed. However, the <italic>unc-43</italic> lof allele <italic>e408</italic> largely abolishes the protection: there is some residual protection in 1doa but degeneration is almost complete in 2doa (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). <italic>unc-43(e408</italic>) also suppresses <italic>lin-10(n1853</italic>) and <italic>klc-2(km11</italic>) with a similar trend (<xref ref-type="fig" rid="fig5">Figure 5B and C</xref>). Therefore, the protection against degeneration in <italic>casy-1, lin-10,</italic> and <italic>klc-2</italic> mutants requires the shared downstream factor CaMKII/UNC-43. We could rescue UNC-43 in <italic>ric-7(n2657); casy-1(wp78); unc-43(e408</italic>) triple mutants by expressing WT or CA UNC-43 in PVQ (<xref ref-type="fig" rid="fig5">Figure 5D</xref>), consistent with the cell-autonomous role of UNC-43 and CASY-1. We next examined if the TIR-1-NSY-1-SEK-1 signaling also functions downstream of CASY-1. Indeed, the lof mutations <italic>tir-1(qd4), nsy-1(ok593), sek-1(km4), pmk-3(ok169),</italic> and <italic>cebp-1(tm2807</italic>) all suppress <italic>casy-1(wp78</italic>) (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). By contrast, the <italic>pmk-1(km25</italic>) single lof mutation and the <italic>pmk-1(km25); pmk-2(qd279qd171</italic>) double mutation do not suppress <italic>casy-1(wp78</italic>). Therefore, loss of CASY-1 and LIN-10 acts via the UNC-43-TIR-1-NSY-1-SEK-1-PMK-3-CEBP-1 pathway to protect against axon degeneration in the absence of mitochondria (<xref ref-type="fig" rid="fig5">Figure 5F</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Loss of calsyntenin/CASY-1 or Mint/LIN-10 suppresses axon degeneration by activating the CaMKII-Sarm1-ASK1 MAPK pathway.</title><p>(<bold>A–C</bold>) Axon protection conferred by loss of calsyntenin/<italic>casy-1</italic> requires CaMKII (<bold>A</bold>), Mint (<bold>B</bold>), and kinesin (<bold>C</bold>). Quantification of axon degeneration from L4 to 5-day-old adult (5doa). Number of animals: 45–77 (<bold>A</bold>), 33–75 (<bold>B</bold>), and 42–60 (<bold>C</bold>) animals. Graphs show proportion and 95% CI. **** p&lt;0.0001, **p&lt;0.01, *p&lt;0.05, ns, not significant, compared to the triple mutant (blue curve) at each timepoint, Fisher’s exact test. (<bold>D</bold>) CaMKII/<italic>unc-43</italic> is required cell-autonomously to suppress axon degeneration in calsyntenin/<italic>casy-1</italic> mutants. Quantification of axon degeneration in 3-day-old adult (3doa). Genotypes and number of animals: <italic>ric-7(n2657); casy-1(wp78</italic>) (N = 53), <italic>ric-7(n2657); casy-1(wp78); unc-43(e408</italic>) (N = 61), and <italic>ric-7(n2657); casy-1(wp78); unc-43(e408</italic>) + P<sub>PVQ</sub>::WT UNC-43 (N = 46) or constitutively active (CA) UNC-43 (N = 55). Bars show proportion and 95% CI. ****p&lt;0.0001, *p&lt;0.05, ns, not significant, compared to <italic>ric-7(n2657); casy-1(wp78</italic>) except where indicated, Fisher’s exact test. (<bold>E</bold>) The TIR-1-NSY-1-MAPK pathway is required to suppress axon degeneration in calsyntenin/<italic>casy-1</italic> mutants. Suppression of protection against axon degeneration in <italic>ric-7(n2657); casy-1(wp78</italic>) (N = 61) by <italic>tir-1(qd4</italic>) (N = 36), <italic>nsy-1(ok593</italic>) (N = 44), <italic>sek-1(km4</italic>) (N = 29), <italic>pmk-1(km25</italic>) (N = 39), <italic>pmk-1(km25); pmk-2(qd279qd171</italic>) (N = 40), <italic>pmk-3(ok169</italic>) (N = 33), and <italic>cebp-1(tm2807</italic>) (N = 37). Bars show proportion and 95% CI. ****p&lt;0.0001, ns, not significant, compared to <italic>ric-7(n2657); casy-1(wp78</italic>), Fisher’s exact test. (<bold>F</bold>) Diagram of regulation of axon degeneration by the calsyntenin-Mint-CaMKII-Sarm1-ASK1 p38 MAPK pathway.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Epistatic analysis of mutants in the CASY-1-CaMKII-Sarm1-p38 MAPK pathway.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73557-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73557-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>APL-1 mutations do not suppress spontaneous degeneration in <italic>ric-7(n2657</italic>).</title><p>(<bold>A</bold>) Schematic of the Cre-loxP method to knock out the entire <italic>apl-1</italic> gene in PVQ. (<bold>B</bold>) Gel image showing the KO bands in three individual animals that express Cre in PVQ. The loxP control without Cre expression only shows the WT band. (<bold>C</bold>) Quantification of axon degeneration in <italic>ric-7(n2657</italic>) (N = 50), <italic>ric-7(n2657); apl-1(wp19</italic>)+ P<sub>PVQ</sub>::Cre (N = 91), <italic>ric-7(n2657</italic>) + P<sub>PVQ</sub>::Cre (N = 119), and <italic>ric-7(n2657); apl-1(wp22</italic>) (N = 33) 3-day-old adult (3doa). Mean and 95% CI are plotted. Bars show proportion and 95% CI. *p&lt;0.05, ns, not significant, compared to <italic>ric-7(n2657</italic>) except where indicated, Fisher’s exact test.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Gel images of APL-1 genotyping. Three extrachromosomal array lines (<italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; apl-1(wp19) X + sra-6p::nCre</italic>) were generated from one microinjection and genotyped for APL KO in PVQ. 15 worms from line 1, 8 worms from line 2, and 8 worms from line 3 were genotyped. The KO band (583 bp) can be seen in most worms from line 1 but not in worms from line 2 or line 3, probably due to expression levels and mosaicism. Line 1 was then integrated to generate <italic>XE2634(oyIs14[sra-6p::GFP], ric-7(n2657) V; apl-1(wp19) X; wpIs146[sra-6p::nCre + odr-1p::RFP])</italic>, which was used for analysis of axon degeneration. Control is <italic>XE2415(oyIs14[sra-6p::GFP], ric-7(n2657) V; apl-1(wp19) X)</italic>. Blank is no worm input. The cropped image of control and last three worms from line 1 is shown in Figure 5—figure supplement 1B, with enhanced contrast.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-73557-fig5-figsupp1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5s1sdata2"><label>Figure 5—figure supplement 1—source data 2.</label><caption><title>Axon degeneration in <italic>apl-1</italic> mutants.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73557-fig5-figsupp1-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73557-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>The <italic>lin-2</italic> lof allele <italic>e1309</italic> does not suppress PVQ degeneration in <italic>ric-7(n2657</italic>).</title><p>Quantification of suppression of axon degeneration. N = 25 for <italic>ric-7(n2657</italic>) and N = 32 for <italic>ric-7(n2657); lin-2(e1309</italic>). Bars show proportion and 95% CI. ns, not significant, Fisher’s exact test.</p><p><supplementary-material id="fig5s2sdata1"><label>Figure 5—figure supplement 2—source data 1.</label><caption><title>Axon degeneration in the <italic>ric-7; lin-2</italic> mutant.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73557-fig5-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73557-fig5-figsupp2-v1.tif"/></fig></fig-group></sec><sec id="s2-9"><title>The L-type voltage-gated calcium channel subunits EGL-19 and UNC-36 mediate axon protection in <italic>casy-1</italic> and <italic>lin-10</italic> mutants</title><p>Our data suggest that loss of CASY-1 and LIN-10 protect axons by activating CaMKII/UNC-43 and its downstream MAP kinase pathway (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). How might loss of CASY-1 and LIN-10 increase CaMKII/UNC-43 activity? One possibility is that loss of these factors upregulates CaMKII/UNC-43 abundance in axons in <italic>ric-7(n2657</italic>) mutants. However, endogenous CaMKII/UNC-43 levels in distal PVQ axons are not restored in <italic>ric-7(n2657); casy-1(wp78</italic>) or <italic>ric-7(n2657); lin-10(e1439</italic>) animals compared to the <italic>ric-7(n2657</italic>) control (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). Therefore, CASY-1 and LIN-10 do not regulate CaMKII/UNC-43 protein levels in axons. We next tested the hypothesis that loss of CASY-1 or LIN-10 may alter CaMKII/UNC-43 activity by regulating calcium homeostasis. We focused on the VGCCs for two reasons: first, calcium influx through VGCCs can activate CaMKII/UNC-43 (<xref ref-type="bibr" rid="bib84">Sagasti et al., 2001</xref>; <xref ref-type="bibr" rid="bib108">West et al., 2001</xref>); second, Mint/LIN-10 has been shown to directly interact with VGCCs in mammals (<xref ref-type="bibr" rid="bib65">Maximov and Bezprozvanny, 2002</xref>; <xref ref-type="bibr" rid="bib64">Maximov et al., 1999</xref>).</p><p>In <italic>C. elegans</italic>, the L-type VGCC α<sub>1</sub> subunit, EGL-19, the non-L-type α<sub>1</sub> subunit, UNC-2, and the regulatory α<sub>2</sub>δ subunit, UNC-36, have been shown to function upstream of CaMKII/UNC-43 (<xref ref-type="bibr" rid="bib5">Alqadah et al., 2016a</xref>; <xref ref-type="bibr" rid="bib6">Alqadah et al., 2016b</xref>; <xref ref-type="bibr" rid="bib16">Caylor et al., 2013</xref>; <xref ref-type="bibr" rid="bib84">Sagasti et al., 2001</xref>). We thus examined if these subunits are required for protection against axon degeneration in <italic>casy-1</italic> and <italic>lin-10</italic> mutants. We found that the lof mutations <italic>egl-19(n582</italic>) and <italic>unc-36(e251</italic>) completely abolish the delayed degeneration in adult <italic>ric-7(n2657); casy-1(wp78</italic>) animals (<xref ref-type="fig" rid="fig6">Figure 6A and B</xref>). They also suppress the protection in <italic>ric-7(n2657); lin-10(n1853</italic>) animals, with <italic>ric-7(n2657); lin-10(n1853); egl-19(n582</italic>) triple mutants also displaying enhanced degeneration at L4 (<xref ref-type="fig" rid="fig6">Figure 6C and D</xref>). By contrast, the lof mutation <italic>unc-2(e55</italic>) does not suppress <italic>casy-1(wp78</italic>) and partially suppresses <italic>lin-10(n1853</italic>) (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A and B</xref>). We conclude that the L-type VGCC composed of EGL-19 and UNC-36 is required for axon protection in <italic>casy-1</italic> and <italic>lin-10</italic> mutants.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Loss of calsyntenin/CASY-1 or Mint/LIN-10 activates CaMKII/UNC-43 through the L-type voltage-gated calcium channel (VGCC) to suppress axon degeneration.</title><p>(<bold>A–D</bold>) Axon protection conferred by loss of calsyntenin/<italic>casy-1</italic> or Mint/<italic>lin-10</italic> requires VGCC subunit <italic>egl-19</italic> (<bold>A, C</bold>) and VGCC subunit <italic>unc-36</italic> (<bold>B, D</bold>). Quantification of axon degeneration from L4 to 3-day-old adult (3doa). Number of animals = 23–58. Graphs show proportion and 95% CI. ****p&lt;0.0001 at each timepoint, ns, not significant, Fisher’s exact test. (<bold>E</bold>) Axon protection conferred by activation of CaMKII does not requires VGCC subunit <italic>unc-36</italic>. Quantification of axon degeneration in 2-day-old adult (2doa). Genotypes and number of animals: <italic>ric-7(n2657); unc-43(n498sd</italic>) (N = 34) and <italic>ric-7(n2657); unc-43(n498sd); unc-36(e251</italic>) (N = 22). Bars show proportion and 95% CI. ns, not significant, Fisher’s exact test. (<bold>F</bold>) Integrated model of how loss of calsyntenin/<italic>casy-1</italic> and Mint/<italic>lin-10</italic> suppresses axon degeneration caused by the absence of mitochondria.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Epistatic analysis between <italic>egl-19/unc-36</italic> and <italic>casy-1/lin-10</italic>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73557-fig6-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73557-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>CaMKII/UNC-43 abundance in distal axons is not restored in <italic>ric-7(n2657); casy-1(wp78</italic>) and <italic>ric-7(n2657); lin-10(e1439</italic>) animals.</title><p>(<bold>A</bold>) Images of native and tissue-specific fluorescence (NATF)-tagged CaMKII/UNC-43 in PVQ cell bodies and distal axons in L4 stage animals. Genotypes: control, <italic>ric-7(n2657</italic>), <italic>ric-7(n2657); casy-1(wp78</italic>), and <italic>ric-7(n2657); lin-10(e1439</italic>). Scale bar, 5 µm. (<bold>B</bold>) Normalized NATF-tagged CaMKII/UNC-43 intensity (arbitrary units) in PVQ distal axons in control, <italic>ric-7(n2657</italic>), <italic>ric-7(n2657); casy-1(wp78</italic>), and <italic>ric-7(n2657); lin-10(e1439</italic>) animals at L4. Violin plots with median and quantiles are shown. ****p&lt;0.0001, ns, not significant, compared to control except where indicated, one-way ANOVA, Kruskal–Wallis test, followed by Dunn’s multiple comparisons.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Endogenous CaMKII abundance in distal axon in control and suppressor mutants.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73557-fig6-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73557-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>Voltage-gated calcium channel (VGCC) subunit <italic>unc-2</italic> does not mediate axon protection, and loss of CaMKII/<italic>unc-43</italic>, VGCC subunit <italic>egl-19</italic> or VGCC subunit <italic>unc-36</italic> does not result in axon degeneration.</title><p>(<bold>A, B</bold>) Effect of the loss-of-function (lof) mutation, <italic>unc-2(e55</italic>), on the protection against degeneration in <italic>ric-7(n2657); casy-1(wp78</italic>) (N = 13–41) and <italic>ric-7(n2657); lin-10(n1853</italic>) (N = 21–51) animals. Graphs show proportion and 95% CI. ****p&lt;0.0001, ns, not significant, Fisher’s exact test. (<bold>C</bold>) Quantification of axon degeneration in control (N = 52), <italic>unc-43(e408</italic>) (N = 69), <italic>egl-19(n582</italic>) (N = 49), <italic>unc-36(e251</italic>) (N = 52) 3-day-old adult (3doa). Bars show proportion and 95% CI. ns, not significant, compared to control, Fisher’s exact test.</p><p><supplementary-material id="fig6s2sdata1"><label>Figure 6—figure supplement 2—source data 1.</label><caption><title>Epistatic analysis between <italic>unc-2</italic> and <italic>cays-1/lin-10</italic> and degeneration in <italic>unc-43</italic>, <italic>egl-19</italic> and <italic>unc-36</italic> single mutants.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-73557-fig6-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73557-fig6-figsupp2-v1.tif"/></fig></fig-group><p>Next, we determined the relationship of the EGL-19/UNC-36 calcium channel to CaMKII/UNC-43 in axon protection. We found that the EGL-19/UNC-36 calcium channel is not required for protection conferred by gain of function in CaMKII/UNC-43: <italic>unc-36(e251</italic>); <italic>ric-7(n2657); unc-43(n498sd</italic>) animals protected from axon degeneration similar to <italic>ric-7(n2657); unc-43(n498sd</italic>) alone (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). These data indicate that CaMKII/UNC-43 activity acts downstream of EGL-19/UNC-36 calcium channel, consistent with the model that VGCCs act to activate CaMKII/UNC-43 (<xref ref-type="bibr" rid="bib5">Alqadah et al., 2016a</xref>). Importantly, we found that while EGL-19, UNC-36, and CaMKII/UNC-43 are required to suppress degeneration triggered by loss of mitochondria, loss of any of these factors is not sufficient to trigger axon degeneration in otherwise wild-type animals (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2C</xref>). Thus<italic>,</italic> the VGCC-CaMKII/UNC-43 pathway is required specifically for axon protection conferred by loss of <italic>casy-1</italic> or <italic>lin-10</italic> in the context of mitochondria mislocalization. Overall, our data suggest a model in which loss of CASY-1 or LIN-10 results in increased neuronal calcium via L-type VGCC. Increased calcium leads to activation of CaMKII/UNC-43. In turn, CaMKII/UNC-43 activity suppresses axon degeneration through the TIR-1-NSY-1-SEK-1 MAPK pathway (<xref ref-type="fig" rid="fig6">Figure 6F</xref>).</p></sec><sec id="s2-10"><title>The calsyntenin-CaMKII-MAPK pathway protects against early-stage degeneration, before axon breakage</title><p>Axon degeneration is a sequence of events beginning with axon thinning/beading, followed by axon breakage, fragmentation, and ending with debris clearance (<xref ref-type="fig" rid="fig1">Figure 1H</xref>). At what step does the calsyntenin-CaMKII-MAPK pathway prevent degeneration? To test whether the calsyntenin-CaMKII-MAPK pathway can prevent the late steps of degeneration that occur after axon breakage, we used laser axotomy to experimentally induce an axon break in one PVQ axon and examined the degeneration of the distal axon segment 24 hr later. Consistent with previous findings (<xref ref-type="bibr" rid="bib18">Ding and Hammarlund, 2018</xref>; <xref ref-type="bibr" rid="bib69">Nichols et al., 2016</xref>; <xref ref-type="bibr" rid="bib81">Rawson et al., 2014</xref>), injury-induced degeneration of distal PVQ axon segments is slow as nearly all axons are still present 24 hr later (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A and B</xref>). By contrast, in <italic>ric-7(n2657</italic>) mutants, degeneration after injury is greatly enhanced due to the lack of axonal mitochondria (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A and B</xref>; <xref ref-type="bibr" rid="bib18">Ding and Hammarlund, 2018</xref>; <xref ref-type="bibr" rid="bib69">Nichols et al., 2016</xref>; <xref ref-type="bibr" rid="bib81">Rawson et al., 2014</xref>). However, loss of calsyntenin or activation of CaMKII did not significantly suppress degeneration in <italic>ric-7(n2657</italic>) after axon transection (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B</xref>). These data indicate that the calsyntenin-CaMKII-MAPK pathway protects against degeneration by acting before axon breakage and cannot stop degeneration after axon breaks occur. Consistent with this model, protected axons in <italic>ric-7(n2657); casy-1(wp78</italic>) and <italic>ric-7(n2657); unc-43(n498sd</italic>) animals mostly stop at the beading stage and rarely enter the breaking stage (<xref ref-type="fig" rid="fig2">Figures 2B</xref> and <xref ref-type="fig" rid="fig3">3C</xref>). Therefore, we conclude that the calsyntenin-CaMKII-MAPK pathway specifically prevents the transition from axon thinning and beading towards axon breakage.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Axon degeneration is a critical step in neurodegenerative disease. We used an unbiased approach to identify mechanisms that regulate axon degeneration triggered by loss of axonal mitochondria. We discovered a novel anti-degenerative pathway involving CaMKII/UNC-43, Sarm1/TIR-1, and MAP kinase signaling. In particular, CA CaMKII/UNC-43 activates Sarm1/TIR-1 and the downstream NSY-1-SEK-1-PMK-3-CEBP-1 MAPK pathway to protect against degeneration in a cell-specific manner. Furthermore, we found that the loss of the conserved calsyntenin/Mint/KLC-2 trafficking complex activates the CaMKII-TIR-1-MAPK pathway through the L-type VGCC and suppresses degeneration.</p><sec id="s3-1"><title>A key anti-degenerative role for CaMKII</title><p>We discovered that CaMKII/UNC-43 is a key factor in regulating axon degeneration when mitochondria are absent. CaMKII is an abundant kinase that is well studied in neurons. Calcium sensitivity is conferred by the interaction with Ca<sup>2+</sup>/calmodulin. Binding of Ca<sup>2+</sup>/calmodulin releases the autoinhibition of CaMKII and activates the enzyme (<xref ref-type="bibr" rid="bib59">Lisman et al., 2002</xref>). CaMKII can also undergo autophosphorylation, leading to persistent activation even after dissociation of calmodulin (<xref ref-type="bibr" rid="bib59">Lisman et al., 2002</xref>). CaMKII in neurons is well studied for its role in long-term potentiation (LTP), which is one of the major mechanisms underlying learning and memory (<xref ref-type="bibr" rid="bib59">Lisman et al., 2002</xref>). Ca<sup>2+</sup> entry into postsynaptic sites activates CaMKII, which then initiates the signaling cascades that potentiate synaptic transmission (<xref ref-type="bibr" rid="bib59">Lisman et al., 2002</xref>). CaMKII is enriched at postsynaptic density (PSD) and interacts with numerous PSD proteins, including NMDA receptor, AMPA receptor, F-actin, and calcium channels to regulate synaptic function (<xref ref-type="bibr" rid="bib39">Hell, 2014</xref>; <xref ref-type="bibr" rid="bib59">Lisman et al., 2002</xref>; <xref ref-type="bibr" rid="bib113">Zalcman et al., 2018</xref>). Besides its role in learning and memory, neuronal CaMKII has been proposed to function in neurodegeneration, although its role has been unclear. On the one hand, CaMKII has a pro-degenerative function in the context of calcium overload. For example, CaMKII promotes axon degeneration downstream of a mutant TRPV4 channel, where it acts to increase intracellular Ca<sup>2+</sup> (<xref ref-type="bibr" rid="bib109">Woolums et al., 2020</xref>). On the other hand, in the <italic>Drosophila</italic> retina, failure to activate CaMKII leads to photoreceptor cell death (<xref ref-type="bibr" rid="bib4">Alloway et al., 2000</xref>; <xref ref-type="bibr" rid="bib55">Kristaponyte et al., 2012</xref>). Consistent with a function in opposing cell death, it was recently shown that activation of CaMKII in mouse retinal ganglion cells protects them against cell death induced by excitotoxicity, optic nerve injury, and glaucoma models (<xref ref-type="bibr" rid="bib31">Guo et al., 2021</xref>). Here, we show that in axon degeneration caused by the absence of mitochondria, CaMKII/UNC-43 acts to oppose axon degeneration: its activation strongly suppresses axon degeneration cell-autonomously.</p><p>Our data indicate that CaMKII’s effect on axon degeneration is context dependent. Loss of CaMKII/UNC-43 alone does not affect axon stability as the <italic>unc-43(e408</italic>) single mutants do not show spontaneous axon degeneration (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). However, in the context of axonal mitochondria depletion, loss of CaMKII accelerates degeneration, while CaMKII activation is neuroprotective. Loss of axonal mitochondria also reduces axonal levels of CaMKII (<xref ref-type="fig" rid="fig2">Figure 2D and E</xref>). Together, these observations suggest that reduced axonal CaMKII activity contributes to degeneration. However, since even complete loss of CAMKII does not trigger degeneration when axonal mitochondria are normal, loss of axonal mitochondria must trigger parallel pro-degenerative signals besides having effects on CaMKII. This is not surprising since mitochondria perform multifaceted activities to regulate neuronal metabolism. Nonetheless, our work reveals that active CaMKII/UNC-43 can protect against axon degeneration in the absence of mitochondria, which may serve as an entry point for therapeutical interventions.</p></sec><sec id="s3-2"><title>CaMKII localization and activation depend on mitochondria</title><p>We observed that loss of axonal mitochondria results in reduced axonal CaMKII/UNC-43, suggesting that axonal CaMKII localization or stabilization depends on mitochondria. Precise control of CaMKII localization in neurons is critical for its function. For example, although CaMKII is highly abundant throughout neuronal processes, anchoring at dendritic spines refines its substrate selectivity and is important for LTP (<xref ref-type="bibr" rid="bib39">Hell, 2014</xref>). It has been well studied that CaMKII can translocate to PSD upon stimulation (<xref ref-type="bibr" rid="bib73">Otmakhov et al., 2004</xref>; <xref ref-type="bibr" rid="bib87">Shen and Meyer, 1999</xref>), and the translocation involves interactions with PSD proteins such as NMDA receptors (<xref ref-type="bibr" rid="bib33">Halt et al., 2012</xref>; <xref ref-type="bibr" rid="bib67">Merrill et al., 2005</xref>). However, the mechanisms governing CaMKII transport and abundance in axons are unclear. In <italic>C. elegans</italic>, translocation of CaMKII/UNC-43 to neurites has been shown to be regulated by the interactions between the catalytic and autoinhibitory domain (<xref ref-type="bibr" rid="bib102">Umemura et al., 2005</xref>). Multiple mutations that mimic autophosphorylation result in an increased neurite pool of CaMKII/UNC-43. It has been proposed that unknown transport factors facilitate the trafficking of CaMKII/UNC-43 by binding to its catalytic domain, and conformational changes of CaMKII/UNC-43 affect the interactions with the transport factors (<xref ref-type="bibr" rid="bib102">Umemura et al., 2005</xref>). In this study, we show that axonal mitochondria are important for endogenous CaMKII/UNC-43 localization in axons. It is possible that some CaMKII/UNC-43 transport factors are present on mitochondria, thus facilitating co-trafficking into axons.</p><p>In addition to reduced levels of axonal CaMKII/UNC-43, our data indicate that loss of axonal mitochondria also results in deficient CaMKII/UNC-43 activation. Overexpression of WT CaMKII/UNC-43 in <italic>ric-7</italic> animals has only a small protective effect on degeneration (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). By contrast, mutations that activate endogenous CaMKII, or overexpression of the activated form, strongly suppress degeneration (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Thus, CaMKII activation is a key choke point in the ability of axons to withstand degeneration. One possibility is that mitochondria can act as activators of CaMKII/UNC-43 through modulating local calcium homeostasis in axons. Overexpression of calcium-independent CA CaMKII/UNC-43 can thus strongly suppress degeneration, even though axonal mitochondria are absent.</p></sec><sec id="s3-3"><title>Kinesin-dependent localization of calsyntenin and Mint controls CaMKII activity and degeneration</title><p>We also found that PVQ neurons lacking calsyntenin/CASY-1 are highly resistant to degeneration. Calsyntenins are a family of neuronally enriched TM proteins characterized by the presence of two cadherin-like repeats, an LG/LNS domain in the extracellular region and an intracellular domain (ICD) that carries two KBS (<xref ref-type="bibr" rid="bib8">Araki et al., 2003</xref>; <xref ref-type="bibr" rid="bib54">Konecna et al., 2006</xref>). The three human calsyntenin proteins (CLSTN1–3) regulate diverse neuronal functions. For example, CLSTN1 mediates trafficking of NMDA receptors (<xref ref-type="bibr" rid="bib89">Ster et al., 2014</xref>) and axon guidance receptors (<xref ref-type="bibr" rid="bib7">Alther et al., 2016</xref>), and regulates axon branching (<xref ref-type="bibr" rid="bib79">Ponomareva et al., 2014</xref>) and microtubule polarity (<xref ref-type="bibr" rid="bib57">Lee et al., 2017</xref>). CLSTN2 is involved in learning and memory (<xref ref-type="bibr" rid="bib58">Lipina et al., 2016</xref>; <xref ref-type="bibr" rid="bib80">Preuschhof et al., 2010</xref>). CLSTN3 has been shown to mediate synapse development (<xref ref-type="bibr" rid="bib77">Pettem et al., 2013</xref>). Previous studies have also associated calsyntenins with neurodegeneration, specifically AD pathogenesis (<xref ref-type="bibr" rid="bib27">Gotoh et al., 2020</xref>; <xref ref-type="bibr" rid="bib101">Uchida and Gomi, 2016</xref>; <xref ref-type="bibr" rid="bib103">Vagnoni et al., 2012</xref>). There is also evidence for functional mammalian calsyntenins without the extracellular domain. For example, mammalian calsyntenins undergo proteolytic cleavage by α-secretase to produce the membrane-bound C-terminal fragment (CTF), which can be further cleaved by γ-secretase to produce the cytosolic ICD (<xref ref-type="bibr" rid="bib9">Araki et al., 2004</xref>; <xref ref-type="bibr" rid="bib34">Hata et al., 2009</xref>; <xref ref-type="bibr" rid="bib105">Vogt et al., 2001</xref>). Calsyntenin CTF and ICD have been shown to regulate the trafficking, metabolism, and signaling of amyloid precursor protein (APP) (<xref ref-type="bibr" rid="bib10">Araki et al., 2007</xref>; <xref ref-type="bibr" rid="bib9">Araki et al., 2004</xref>; <xref ref-type="bibr" rid="bib8">Araki et al., 2003</xref>; <xref ref-type="bibr" rid="bib90">Steuble et al., 2012</xref>; <xref ref-type="bibr" rid="bib96">Takei et al., 2015</xref>). In addition, a recent study shows that mouse calsyntenin 3β, which lacks the extracellular region for cell adhesion, promotes the secretion of S100b from brown adipocytes and stimulates sympathetic innervation (<xref ref-type="bibr" rid="bib114">Zeng et al., 2019</xref>).</p><p>We show that in the absence of mitochondria the CASY-1 TM domain and ICD promote degeneration. Specifically, CASY-1’s kinesin-binding sites are critical for its pro-degenerative function (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Further, loss of <italic>klc-2,</italic> like loss of calsyntenin, suppresses degeneration (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). The <italic>C. elegans</italic> genome encodes two kinesin light chain genes, <italic>klc-1</italic> and <italic>klc-2</italic>. However, loss of <italic>klc-1</italic> did not phenocopy the <italic>casy-1</italic> or <italic>klc-2</italic> mutant (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Consistent with these data, <italic>klc-1</italic> does not appear to be expressed in PVQ (<xref ref-type="bibr" rid="bib97">Taylor et al., 2020</xref>). Further, KLC-1 is a divergent kinesin and its function in axonal transport is unclear (<xref ref-type="bibr" rid="bib85">Sakamoto et al., 2005</xref>), thus, calsyntenin may specifically acts with the kinesin light chain KLC-2 to mediate axon degeneration. We also found that loss of the calsyntenin/CASY-1 cargo, Mint/LIN-10, suppresses degeneration (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Therefore, our data support a model in which disruption of a calsyntenin/Mint/KLC-2 trafficking complex prevents axon degeneration in the absence of mitochondria.</p></sec><sec id="s3-4"><title>L-type calcium channels link the calsyntenin/Mint/KLC-2 trafficking complex to CaMKII activity and axon protection</title><p>We found that axon protection by loss of calsyntenin or Mint requires L-type VGCC. VGCCs are composed of a pore-forming α<sub>1</sub> subunit and are usually associated with auxiliary β subunits and α2δ subunits (<xref ref-type="bibr" rid="bib15">Catterall, 2011</xref>). In <italic>C. elegans,</italic> EGL-19 is the L-type α<sub>1</sub> subunit, and UNC-36 is the α<sub>2</sub>δ subunit (<xref ref-type="bibr" rid="bib42">Hobert, 2013</xref>). L-type VGCCs composed of EGL-19 and UNC-36 have critical roles in neurons in calcium influx (<xref ref-type="bibr" rid="bib20">Frøkjaer-Jensen et al., 2006</xref>). However, L-type VGCCs have not been previously shown to mediate neurodegeneration. We found that loss of <italic>egl-19</italic> or <italic>unc-36</italic> completely blocks the protective effect of disrupting the calsyntenin/Mint/KLC-2 trafficking complex (<xref ref-type="fig" rid="fig6">Figure 6A–D</xref>). As L-type channels are known to bind Mint, these data suggest that disrupting the calsyntenin/Mint/KLC-2 trafficking complex changes the localization or organization of L-type calcium channels (<xref ref-type="fig" rid="fig6">Figure 6F</xref>). In turn, reorganized calcium channels protect axons.</p><p>What is the target of reorganized calcium channels? In <italic>C. elegans</italic>, EGL-19 and UNC-36 have been shown to activate CaMKII/UNC-43 (<xref ref-type="bibr" rid="bib5">Alqadah et al., 2016a</xref>; <xref ref-type="bibr" rid="bib6">Alqadah et al., 2016b</xref>; <xref ref-type="bibr" rid="bib16">Caylor et al., 2013</xref>; <xref ref-type="bibr" rid="bib84">Sagasti et al., 2001</xref>). In mammals, L-type channels can act as CaMKII anchor proteins at postsynaptic sites and allow efficient CaMKII stimulation upon Ca<sup>2+</sup> influx (<xref ref-type="bibr" rid="bib1">Abiria and Colbran, 2010</xref>; <xref ref-type="bibr" rid="bib48">Hudmon et al., 2005</xref>; <xref ref-type="bibr" rid="bib83">Rose et al., 2009</xref>). We found that L-type calcium channels are not required for axon protection by activated CaMKII (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). These data suggest that a key result of reorganized calcium channels is the activation of CaMKII. If CaMKII is activated by a gain-of-function mutation, its activity is not dependent on calcium and does not require reorganized L-type channels.</p><p>How and where does CASY-1 and LIN-10 activate the CaMKII-TIR-1-MAPK pathway through the L-type VGCC? We speculate that CASY-1/LIN-10 can regulate VGCC localization or activity. For example, CASY-1 and LIN-10 may mediate the export of VGCCs from the soma and its delivery into the distal axon. Therefore, in CASY-1, LIN-10, or KLC-2 KO, VGCCs may accumulate in the soma, leading to more Ca<sup>2+</sup> entry and hyperactivation of CaMKII. Eventually, active CEBP-1 enters the nucleus to regulate transcription, which in turn suppresses degeneration. Alternatively, CASY-1 and LIN-10 that are transported into distal axons may inhibit VGCC activity, leading to less Ca<sup>2+</sup> entry and reduced CaMKII activity. Therefore, in <italic>casy-1</italic> or <italic>lin-10</italic> mutants, axonal CaMKII is hyperactive and activates the TIR-1-MAPK pathway. Active PMK-3 or CEBP-1 may then be retrogradely transported back to the soma to instruct transcriptional changes. In favor of the second model, LIN-10, CaMKII, TIR-1, and NSY-1 have been shown to colocalize at synaptic regions in distal axons (<xref ref-type="bibr" rid="bib17">Chuang and Bargmann, 2005</xref>), and L-type VGCCs are enriched at postsynaptic sites (<xref ref-type="bibr" rid="bib38">Hell et al., 1996</xref>). Further experiments that examine CaMKII/UNC-43 and MAPK activity in distinct compartments will help disentangle these two models.</p></sec><sec id="s3-5"><title>The surprising neuroprotective role of the Sarm1/TIR-1-ASK1/NSY-1-p38 MAPK pathway</title><p>We discovered a surprising axon-protective role of the <italic>C. elegans</italic> Sarm1 homologue, TIR-1 (CeTIR-1). Sarm1 was initially identified as an essential activator of injury-induced axon degeneration in flies and mammals (<xref ref-type="bibr" rid="bib21">Gerdts et al., 2013</xref>; <xref ref-type="bibr" rid="bib72">Osterloh et al., 2012</xref>). Sarm1 promotes axon degeneration by regulating NAD<sup>+</sup> metabolism (<xref ref-type="bibr" rid="bib19">Essuman et al., 2017</xref>; <xref ref-type="bibr" rid="bib22">Gerdts et al., 2015</xref>). Specifically, Sarm1 proteins form octamers through the sterile alpha motifs (SAM) domains (<xref ref-type="bibr" rid="bib45">Horsefield et al., 2019</xref>; <xref ref-type="bibr" rid="bib88">Sporny et al., 2019</xref>). The Toll/interleukin-1 receptor homology (TIR) domain possesses intrinsic capabilities to hydrolyze NAD<sup>+</sup>, but its activity is normally autoinhibited by the Armadillo/HEAT (ARM) repeat domain in healthy axons (<xref ref-type="bibr" rid="bib19">Essuman et al., 2017</xref>). Upon axon injury, the autoinhibition is released, causing rapid NAD<sup>+</sup> collapse, which eventually leads to axon degeneration. Sarm1 was later shown to mediate other types of axon degeneration such as in traumatic brain injury (<xref ref-type="bibr" rid="bib40">Henninger et al., 2016</xref>) and peripheral neuropathy (<xref ref-type="bibr" rid="bib100">Turkiew et al., 2017</xref>). Interestingly, there is evidence for Sarm1 involvement in neurodegeneration downstream of drug-induced mitochondria dysfunction (<xref ref-type="bibr" rid="bib60">Loreto et al., 2020</xref>; <xref ref-type="bibr" rid="bib92">Summers et al., 2014</xref>; <xref ref-type="bibr" rid="bib94">Summers et al., 2019</xref>). However, other forms of neurodegeneration, such as SOD1-ALS, do not require Sarm1 (<xref ref-type="bibr" rid="bib76">Peters et al., 2018</xref>), indicating that multiple pro-degeneration mechanisms may exist. <italic>C. elegans</italic> Sarm1 is well conserved with its counterparts in other species, containing the ARM domains, two SAM domains, and a TIR domain. Further, activated <italic>C. elegans</italic> TIR domains have been shown to cause NAD<sup>+</sup> depletion (<xref ref-type="bibr" rid="bib45">Horsefield et al., 2019</xref>) and trigger cell death in cultured mouse neurons (<xref ref-type="bibr" rid="bib93">Summers et al., 2016</xref>). Therefore, CeTIR-1 likely possesses the capacity to deplete NAD<sup>+</sup> and promote degeneration, albeit less efficiently than its human and fly counterparts (<xref ref-type="bibr" rid="bib45">Horsefield et al., 2019</xref>; <xref ref-type="bibr" rid="bib93">Summers et al., 2016</xref>). However, so far, there is little evidence that the NAD<sup>+</sup> hydrolase activity of CeTIR-1 is essential to axon degeneration in <italic>C. elegans</italic> in vivo. Loss of CeTIR-1 does not protect against axon degeneration induced by laser axotomy in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="bib69">Nichols et al., 2016</xref>). Overexpressing the murine <italic>Wld<sup>S</sup></italic> or the <italic>C. elegans</italic> Nmnats, which promote NAD<sup>+</sup> synthesis, does not delay axon degeneration (<xref ref-type="bibr" rid="bib69">Nichols et al., 2016</xref>). Our data show that loss of CeTIR-1 or overexpressing Nmnats does not suppress spontaneous axon degeneration caused by the loss of mitochondria. Together, these data suggest that NAD<sup>+</sup> consumption by CeTIR-1 does not play an essential role in promoting axon degeneration in <italic>C. elegans</italic>. However, given its intimate relationship with degeneration, CeTIR-1 may regulate degeneration through different or additional signaling in <italic>C. elegans</italic>.</p><p>Quite unexpectedly, we found that Sarm/TIR-1 is required for the protection against axon degeneration by active UNC-43/CaMKII, and this protection is mediated by the conserved NSY-1-SEK-1 MAPK pathway. In general, Sarm/TIR-1 family members have a complex relationship with MAP kinase signaling. Sarm1 has been shown to coordinate with different MAP kinase components to promote axon degeneration in mammals. Specifically, the MAPKKKs MEKK4, MLK2, and DLK, the MAPKKs MKK4 and MKK7, and the MAPKs JNK1-3 are required for axon degeneration after injury (<xref ref-type="bibr" rid="bib106">Walker et al., 2017</xref>; <xref ref-type="bibr" rid="bib112">Yang et al., 2015</xref>). However, an in vivo study in <italic>Drosophila</italic> did not observe the involvement of JNK in injury-induced axon degeneration (<xref ref-type="bibr" rid="bib68">Neukomm et al., 2017</xref>). The NSY-1-SEK-1 pathway is a different MAPK cascade: NSY-1(MAPKKK) is the homologue of human ASK1(or MEKK5), SEK-1(MAPKK) is the homologue of human MKK3/6, and the downstream MAPKs are PMKs, which fall in the p38 rather than the JNK family (<xref ref-type="bibr" rid="bib36">Hayakawa et al., 2006</xref>). The discrepancy between the neuroprotective role that we observed here and the previously identified pro-degenerative role of the TIR-1-MAPK pathways may be due to the specificity of the MAPK pathways that are activated in these different contexts. It is possible that distinct MAPK pathways are activated during different types of degeneration and function through distinct downstream factors. It has been well established that the TIR-1-NSY-1-SEK-1-PMK-1 signaling acts in innate immunity to resist bacterial pathogens (<xref ref-type="bibr" rid="bib51">Kim et al., 2002</xref>). The pathway also functions in the nervous system to regulate asymmetric neural development, with PMK-1 and PMK-2 acting redundantly (<xref ref-type="bibr" rid="bib6">Alqadah et al., 2016b</xref>; <xref ref-type="bibr" rid="bib74">Pagano et al., 2015</xref>). Interestingly, a previous study has shown that this pathway promotes motor neuron degeneration in a <italic>C. elegans</italic> model of ALS (<xref ref-type="bibr" rid="bib104">Vérièpe et al., 2015</xref>). In these animals, secreted molecules from neurons that overexpress human TDP-43 or FUS activate the transcription factor ATF-7 through the TIR-1-MAPK pathway and lead to neurodegeneration. Here, PMK-1 and ATF-7 form a linear pathway downstream of SEK-1 to mediate degeneration. By contrast, in our <italic>ric-7(n2657</italic>) model where degeneration is caused by the lack of mitochondria, PMK-3 and the transcription factor CEBP-1 confer protection downstream of TIR-1, NSY-1 ,and SEK-1, which highlights that the role of MAPK signaling is highly context dependent in neurodegeneration. Whether the protective role of the CaMKII-TIR-1-p38 MAPK axis is conserved in other species and other degeneration models awaits further investigation.</p></sec><sec id="s3-6"><title>An active mechanism that overrides neurodegeneration</title><p>Mitochondria defects are tightly associated with neurodegeneration. Because lack of axonal mitochondria results in completely penetrant PVQ axon degeneration, this model offers an opportunity to discover cellular mechanisms that control degeneration. This work identifies a linear CaMKII/UNC-43-Sarm1/TIR-1-ASK1/NSY-1 MAPK pathway as an active neuroprotective program that suppresses axon degeneration due to loss of axonal mitochondria. The surprising protective role of these molecules in this context highlights the complex nature of axon degeneration. In contexts where axon degeneration is associated with defects in mitochondria location or function, the calsyntenin-CaMKII-MAPK pathway may provide intervention points for suppressing degeneration.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Levamisole hydrochloride</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat# sc-205730</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Proteinase K</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat# 3115879001</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Polybead Microspheres 0.05 μm</td><td align="left" valign="bottom">Polysciences</td><td align="left" valign="bottom">Cat# 08691</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Gateway LR Clonase II Enzyme mix</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat# 11791020</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">1 kb DNA Ladder</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Cat# G571A</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Alt-R S.p. Cas9 Nuclease V3</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom">Cat# 1081058</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">RNA</td><td align="left" valign="bottom">tracrRNA</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom">Cat# 1072532</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Ethyl methanesulfonate</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat# M0880</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">QIAprep Spin Miniprep Kit</td><td align="left" valign="bottom">QIAGEN</td><td align="left" valign="bottom">Cat# 27106</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Phusion High-Fidelity DNA Polymerase</td><td align="left" valign="bottom">NEB</td><td align="left" valign="bottom">Cat# M0530L</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Nonidet P-40</td><td align="left" valign="bottom">americanBIO</td><td align="left" valign="bottom">Cat# AB01425</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">TWEEN 20</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat# P5927</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Gelatin</td><td align="left" valign="bottom">MP Biomedicals</td><td align="left" valign="bottom">Cat# 901771</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">β-Mercaptoethanol</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat# M3148-25ML</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">UltraPure phenol:chloroform:isoamyl alcohol</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat# 15593031</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Sodium acetate, 3 M solution, pH5.2</td><td align="left" valign="bottom">americanBIO</td><td align="left" valign="bottom">Cat# AB13168-01000</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Nuclease-free water</td><td align="left" valign="bottom">americanBIO</td><td align="left" valign="bottom">Cat# AB02123-00500</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Caenorhabditis elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP] V</italic></td><td align="left" valign="bottom">CGC</td><td align="left" valign="bottom">XE2047</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2046</td><td align="left" valign="bottom">Control; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP] V; wpEx369[sra-6p::mito::TagRFP+ odr-1p::RFP]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2263</td><td align="left" valign="bottom">Mito marker; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; wpEx369[sra-6p::mito::TagRFP+ odr-1p::RFP]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2264</td><td align="left" valign="bottom">Mito marker: Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; casy-1(wp60) II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2209</td><td align="left" valign="bottom"><italic>casy-1 lof</italic> suppressor; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; unc-43(wp64) II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2210</td><td align="left" valign="bottom"><italic>unc-43 gof</italic> suppressor; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>ric-7(n2657) V; casy-1(wp78) II; wpEx370[sra-6p::casy-1c::GFP+ sra-6p::TagRFP+ odr-1p::RFP]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2265</td><td align="left" valign="bottom"><italic>casy-1</italic> OE; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>casy-1(wp78) II; wpEx370[sra-6p::casy-1c::GFP+ sra-6p::TagRFP+ odr-1p::RFP]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2266</td><td align="left" valign="bottom"><italic>casy-1</italic> OE; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; unc-43(wp64) IV; wpEx369[sra-6p::mito::TagRFP+ odr-1p::RFP]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2618</td><td align="left" valign="bottom">Mito marker; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; casy-1(wp60) II; wpEx371[sra-6p::mito::TagRFP+ odr-1p::RFP]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2269</td><td align="left" valign="bottom">Mito marker; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; casy-1(wp60) II; wpEx374[sra-6p::casy-1a::SL2::mcherry+ myo-2p::mcherry]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2274</td><td align="left" valign="bottom"><italic>casy-1</italic> OE; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; casy-1(wp60) II; wpEx375[sra-6p::casy-1b::SL2::mcherry+ myo-2p::mcherry]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2275</td><td align="left" valign="bottom"><italic>casy-1</italic> OE; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; casy-1(wp60) II; wpEx376[sra-6p::casy-1c::SL2::mcherry+ myo-2p::mcherry]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2276</td><td align="left" valign="bottom"><italic>casy-1</italic> OE; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; casy-1(wp60) II; wpEx379[sra-6p::casy-1a no KBS::SL2::mcherry+ myo-2p::mcherry]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2277</td><td align="left" valign="bottom"><italic>casy-1</italic> OE; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra::gfp], ric-7(n2657) V; casy-1(wp60) II; wpEx407[sra-6p::casy-1c_delta_extracellular::SL2::mCherry+ myo-2p::mCherry];</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2355</td><td align="left" valign="bottom"><italic>casy-1</italic> OE; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; casy-1(wp60) II; wpEx380[sra-6p::casy-1 cytoplasmic domain::SL2::mcherry+ myo-2p::mcherry]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2278</td><td align="left" valign="bottom"><italic>casy-1</italic> OE; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP] V; casy-1(wp60) II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2374</td><td align="left" valign="bottom"><italic>casy-1(wp60)</italic> suppressor; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP] V; casy-1(wp60) II; wpEx376[sra-6p::casy-1c::SL2::mcherry+ myo-2p::mcherry]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2544</td><td align="left" valign="bottom"><italic>casy-1</italic> OE; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; wpEx438[sra-6p::casy-1c mutated acidic region::SL2::mcherry+ myo-2p::mcherry]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2547</td><td align="left" valign="bottom"><italic>casy-1</italic> OE; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra::gfp], ric-7(n2657) V; casy-1(wp60) II; wpEx431[sra-6p::casy-1(WW-AA)::SL2::mCherry+ myo-2p::mCherry]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2504</td><td align="left" valign="bottom"><italic>casy-1</italic> OE; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; wpEx381[sra-6p::unc-116::GFP::tomm-7+ sra-6p::mito::TagRFP+ odr-1p::RFP]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2279</td><td align="left" valign="bottom">Kinesin-mito chimera; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657), klc-2(km11) V</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2350</td><td align="left" valign="bottom"><italic>klc-2</italic> suppressor; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; klc-1(ok2609) IV</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2290</td><td align="left" valign="bottom"><italic>klc-1</italic> mutant; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; tir-1(qd4) III</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2308</td><td align="left" valign="bottom"><italic>tir-1 lof</italic>; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; tir-1(ok2859) III</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2309</td><td align="left" valign="bottom"><italic>tir-1 lof</italic>; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; casy-1(tm718) II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2294</td><td align="left" valign="bottom"><italic>casy-1(tm718)</italic>; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; casy-1(wp78) II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2262</td><td align="left" valign="bottom"><italic>casy-1(wp78)</italic> suppressor; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>casy-1(wp78) II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2260</td><td align="left" valign="bottom"><italic>casy-1</italic> KO; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; casy-1(wp60); wpEx397[WRM0622dH03+ myo-2p::mCherry]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2313</td><td align="left" valign="bottom"><italic>casy-1</italic> fosmid rescue; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; unc-43(n498sd) IV</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2419</td><td align="left" valign="bottom"><italic>unc-43(n498sd)</italic> suppressor; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; unc-43(e408) IV</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2423</td><td align="left" valign="bottom"><italic>unc-43 lof</italic>; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>ric-7(n2657) V; casy-1(wp78) II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2244</td><td align="left" valign="bottom"><italic>casy-1</italic> KO; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; lin-10(n1853) I</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2428</td><td align="left" valign="bottom"><italic>lin-10</italic> suppressor; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; unc-43(e408) IV; casy-1(wp78) II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2429</td><td align="left" valign="bottom"><italic>unc-43 lof; casy-1</italic>; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>wpIs141[sra-6p::GFP1−10+ myo-2p::mcherry]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2441</td><td align="left" valign="bottom">PVQ::GFP1-10; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; lin-10(n1853) I; unc-43(e408) IV</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2508</td><td align="left" valign="bottom"><italic>unc-43 lof; lin-10</italic>; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; lin-10(e1439) I</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2490</td><td align="left" valign="bottom"><italic>lin-10</italic> suppressor; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP] V; unc-43(e408) IV</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2580</td><td align="left" valign="bottom"><italic>unc-43 lof</italic>; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; unc-43(e408) IV; casy-1(wp78) II + wpEx430[sra-6p::unc-43g + myo-2p::mcherry]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2496</td><td align="left" valign="bottom">WT <italic>unc-43</italic> OE; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; unc-43(e408) IV; casy-1(wp78) II + wpEx432[sra-6p::unc-43g T284D::SL2::mcherry+ myo-2p::mcherry]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2506</td><td align="left" valign="bottom">Constitutively active <italic>unc-43</italic> OE; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; lin-10(e1439) I; unc-43(e408) IV</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2530</td><td align="left" valign="bottom"><italic>unc-43 lof; lin-10</italic>; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; unc-2(e55) X; casy-1(wp78) II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2546</td><td align="left" valign="bottom"><italic>unc-2; casy-1</italic>; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>ric-7(n2657) V; unc-43(wp106[unc-43::gfp11x7]) IV; wpIs141[sra-6p::GFP1−10+ myo-2p::mcherry] II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2564</td><td align="left" valign="bottom">Endogenous UNC-43; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>ric-7(n2657) V; unc-43(wp106[unc-43::gfp11x7]) IV; wpIs141[sra-6p::GFP1−10+ myo-2p::mcherry], casy-1(wp78) II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2565</td><td align="left" valign="bottom">Endogenous UNC-43; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>unc-43(wp106[unc-43::gfp11x7]) IV; wpIs141[sra-6p::GFP1−10+ myo-2p::mcherry] II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2567</td><td align="left" valign="bottom">Endogenous UNC-43; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>ric-7(n2657) V; lin-10(e1439) I; unc-43(wp106[unc-43::gfp11x7]) IV; wpIs141[sra-6p::GFP1−10+ myo-2p::mcherry] II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2605</td><td align="left" valign="bottom">Endogenous UNC-43; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>ric-7(n2657) V; unc-43(wp106[unc-43::gfp11x7]) IV; wpIs141[sra-6p::GFP1−10+ myo-2p::mcherry] II; wpEx450[sra-6p::unc-116::tomm-7+ odr-1p::RFP]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2649</td><td align="left" valign="bottom">Endogenous UNC-43 with forced transport of mito; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>casy-1(syb3311[casy-1::gfp11x7]) II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">PHX3311</td><td align="left" valign="bottom"><italic>casy-1::gfp11x7</italic> KI; Generated by SunyBiotech</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657), klc-2(km11) V; unc-43(e408</italic>)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2575</td><td align="left" valign="bottom"><italic>unc-43 lof; klc-2</italic>; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>casy-1(syb3311[casy-1::gfp11x7]), wpIs141[sra-6p::GFP1−10+ myo-2p::mcherry] II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2593</td><td align="left" valign="bottom">Endogenous <italic>casy-1</italic>; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>casy-1(syb3311[casy-1::gfp11x7]), wpIs141[sra-6p::GFP1−10+ myo-2p::mcherry] II; ric-7(n2657) V</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2594</td><td align="left" valign="bottom">Endogenous CASY-1; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>casy-1(syb3311[casy-1::gfp11x7]), wpIs141[sra-6p::GFP1−10+ myo-2p::mcherry] II; klc-2(km11) V</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2595</td><td align="left" valign="bottom">Endogenous CASY-1; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; unc-2(e55) X; lin-10(n1853) I</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2585</td><td align="left" valign="bottom"><italic>unc-2 lof; lin-10</italic>; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>lin-10(wp109[lin-10::gfp11x7]) I; wpIs141[sra-6p::GFP1−10+ myo-2p::mcherry] II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2586</td><td align="left" valign="bottom">Endogenous LIN-10; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>lin-10(wp109[lin-10::gfp11x7]) I; wpIs141[sra-6p::GFP1−10+ myo-2p::mcherry] casy-1(wp78) II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2587</td><td align="left" valign="bottom">Endogenous LIN-10; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; egl-19(n582) IV; casy-1(wp78) II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2606</td><td align="left" valign="bottom"><italic>egl-19 lof; casy-1</italic>; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; egl-19(n582) IV; lin-10(n1853) I</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2607</td><td align="left" valign="bottom"><italic>egl-19 lof; lin-10</italic>; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; unc-36(e251) III; casy-1(wp78) II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2608</td><td align="left" valign="bottom"><italic>unc-36 lof; casy-1</italic>; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; unc-36(e251) III; lin-10(n1853) I</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2609</td><td align="left" valign="bottom"><italic>unc-36 lof; lin-10</italic>; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; casy-1(syb3311[casy-1::gfp11x7]) II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2610</td><td align="left" valign="bottom"><italic>casy-1 gfp11x7</italic> KI; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; apl-1(wp19) X</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2415</td><td align="left" valign="bottom"><italic>apl-1(wp19)</italic>; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; apl-1(wp19) X; wpIs146[sra-6p::nCre+ odr-1p::RFP]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2634</td><td align="left" valign="bottom"><italic>apl-1</italic> KO; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; wpIs146[sra-6p::nCre+ odr-1p::RFP]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2698</td><td align="left" valign="bottom">Cre control; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; apl-1(wp22) X</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2489</td><td align="left" valign="bottom"><italic>apl-1(wp22)</italic>; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP] V; egl-19(n582) IV</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2640</td><td align="left" valign="bottom"><italic>egl-19 lof</italic>; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP] V; unc-36(e251) III</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2641</td><td align="left" valign="bottom"><italic>unc-36 lof</italic>; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; unc-43(n498sd) IV; unc-36(e251) III</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2648</td><td align="left" valign="bottom"><italic>unc-36 lof; unc-43 gof</italic>; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; unc-43(n498sd) IV; tir-1(qd4) III</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2652</td><td align="left" valign="bottom"><italic>tir-1 lof; unc-43 gof</italic>; Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; unc-43(n498sd) IV; nsy-1(ok593) II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2653</td><td align="left" valign="bottom"><italic>nsy-1 lof; unc-43 gof</italic>; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; unc-43(n498sd), pmk1(km25) IV</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2655</td><td align="left" valign="bottom"><italic>pmk-1 lof; unc-43 gof</italic>; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; casy-1(wp78) II; tir-1(qd4) III</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2656</td><td align="left" valign="bottom"><italic>tir-1 lof; casy-1</italic> KO; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; casy-1(wp78), nsy-1(ok593) II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2657</td><td align="left" valign="bottom"><italic>nsy-1 lof; casy-1</italic> KO; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; casy-1(wp78) II; sek-1(km4) X</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2658</td><td align="left" valign="bottom"><italic>sek-1 lof; casy-1</italic> KO; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; casy-1(wp78) II; pmk-1(km25) IV</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2659</td><td align="left" valign="bottom"><italic>pmk-3 lof; casy-1</italic> KO; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; wpEx453[sra-6p::unc-43g T284D::SL2::mcherry+ myo-2p::mcherry]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2661</td><td align="left" valign="bottom">Constitutively active <italic>unc-43</italic> OE; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; wpEx452[sra-6p::unc-43g + myo-2p::mcherry]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2662</td><td align="left" valign="bottom">Constitutively active <italic>unc-43</italic> OE; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP] V; unc-116(rh24sb79) III</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2411</td><td align="left" valign="bottom"><italic>unc-116 lof</italic>; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP] V; unc-116(rh24sb79) III; unc-43(n498sd) IV</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2717</td><td align="left" valign="bottom"><italic>unc-116 lof; unc-43 gof</italic>; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>ric-7(n2657) V; unc-43(wp106[unc-43::gfp11x7]) IV; wpEx475[sra-6p::unc-116::GFP1−10+ myo-2p::mCherry]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2752</td><td align="left" valign="bottom">Endogenous UNC-43 with forced transport of mitochondria; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; unc-43(wp106[unc-43::gfp11x7]) IV; wpEx475[sra-6p::unc-116::GFP1−10+ myo-2p::mCherry]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2753</td><td align="left" valign="bottom">Endogenous UNC-43 with forced transport of mitochondria; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP] V; miro-1(wy50180) IV; mtx-2(wy50266) III</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2839</td><td align="left" valign="bottom"><italic>miro-1 lof; mtx-2 lof</italic>; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP] V; trak-1(gk571211) I</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2840</td><td align="left" valign="bottom"><italic>trak-1 lof</italic>; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP] V; miro-1(tm1966) IV; miro-2(tm2933) X</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2349</td><td align="left" valign="bottom"><italic>miro-1 lof; miro-2 lof</italic>; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP] V; mtx-2(wy50266) III; miro-1(wy50180) IV; casy-1(wp78) II</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2840</td><td align="left" valign="bottom"><italic>miro-1 lof; mtx-2 lof; casy-1</italic> KO; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP] V; mtx-2(wy50266) III; miro-1(wy50180), unc-43(n498sd) IV;</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2878</td><td align="left" valign="bottom"><italic>miro-1 lof; mtx-2 lof; unc-43 gof</italic>; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; wpEx499[sra-6p::nmat-1::SL2::mCherry+ myo-2p::mCherry]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2910</td><td align="left" valign="bottom"><italic>nmat-1</italic> OE; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP], ric-7(n2657) V; wpEx500[sra-6p::nmat-2::SL2::mCherry+ myo-2p::mCherry]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2911</td><td align="left" valign="bottom"><italic>nmat-2</italic> OE; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP] V; mtx-2(wy50266) III; miro-1(wy50180) IV; wpEx369[sra-6p::mito::TagRFP+ odr-1p::RFP]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2883</td><td align="left" valign="bottom"><italic>miro-1 lof; mtx-2 lof</italic> with mito marker; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>C. elegans</italic> N2 hermaphrodite)</td><td align="left" valign="bottom"><italic>oyIs14[sra-6p::GFP] V; miro-1(tm1966) IV; miro-2(tm2933) X; wpEx501[sra-6p::mito::TagRFP+ myo-2p::mCherry]</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">XE2912</td><td align="left" valign="bottom"><italic>miro-1 lof; miro-2 lof</italic> with mito marker; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">sra-6p::casy-1a CDS::SL2::mCherry</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">pCD1</td><td align="left" valign="bottom">PVQ::casy-1a;  Generated in the Hammarlund lab</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">sra-6p::casy-1b CDS::SL2::mCherry</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">pCD2</td><td align="left" valign="bottom">PVQ::casy-1b;  Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">sra-6p::casy-1c CDS::SL2::mCherry</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">pCD3</td><td align="left" valign="bottom">PVQ::casy-1c;  Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">sra-6p::casy-1a no KBS CDS::SL2::mCherry</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">pCD4</td><td align="left" valign="bottom">PVQ::casy-1a no KBS;  Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">sra-6p::casy-1 cytoplasmic CDS::SL2::mCherry</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">pCD5</td><td align="left" valign="bottom">PVQ::casy-1 cytoplasmic domain;  Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">sra-6p::casy-1 CDS no ECD::SL2::mCherry</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">pYW135</td><td align="left" valign="bottom">PVQ::casy-1 with out ECD;  Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">sra-6p::mito::tagRFP</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">pCD6</td><td align="left" valign="bottom">PVQ::mito marker; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">sra-6p::unc-116::gfp::tomm7</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">pCD7</td><td align="left" valign="bottom">PVQ::mito-gfp-chimera; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">sra-6p::unc-43g WT</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">pCD8</td><td align="left" valign="bottom">PVQ::WT unc-43 isoform g; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">sra-6p::unc-43g T286D::SL2::mCherry</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">pCD9</td><td align="left" valign="bottom">PVQ::CA unc-43; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">sra-6p::GFP1-10</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">pCD10</td><td align="left" valign="bottom">PVQ::GFP1-10; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">sra-6p::unc-116::tomm-7</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">pCD11</td><td align="left" valign="bottom">PVQ::mito-chimera; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">sra-6p::casy-1c CDS-WWAA::SL2::mCherry</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">pCD12</td><td align="left" valign="bottom">PVQ::casy-1c with the WW/AA mutation; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">sra-6p::casy-1c CDS::mutated acidic region::SL2::mCherry</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">pYW184</td><td align="left" valign="bottom">PVQ::casy-1c with mutated acidic residues; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">sra-6p::casy-1c::GFP</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">pYW86</td><td align="left" valign="bottom">PVQ::casy-1c::GFP; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">sra-6p::Cre</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">pCD13</td><td align="left" valign="bottom">PVQ::Cre; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pRF4::rol-6(su1006)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib66">Mello et al., 1991</xref></td><td align="left" valign="bottom">pRF4</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">sra-6p::wt tir-1a::SL2::mCherry</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">pCD14</td><td align="left" valign="bottom">PVQ::WT tir-1 isoform a; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">sra-6p::unc-116::gfp1-10</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">pCD15</td><td align="left" valign="bottom">PVQ::kinesin-gfp1-10; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">sra-6p::nmat-1::SL2::mCherry</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">pCD27</td><td align="left" valign="bottom">PVQ::nmat-1; Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">sra-6p::nmat-2::SL2::mCherry</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">pCD28</td><td align="left" valign="bottom">PVQ::nmat-2: Generated in the Hammarlund lab </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Fiji 1.53c</td><td align="left" valign="bottom">NIH</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/download.html">https://imagej.nih.gov/ij/download.html</ext-link></td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MetaMorph, version 7.10.2.240</td><td align="left" valign="bottom">Molecular Devices</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://mdc.custhelp.com/app/products/detail/p/13">https://mdc.custhelp.com/app/products/detail/p/13</ext-link></td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Prism, version 8</td><td align="left" valign="bottom">GraphPad</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/scientific-software/prism/">https://www.graphpad.com/scientific-software/prism/</ext-link></td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Galaxy</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib2">Afgan et al., 2016</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://usegalaxy.org/">https://usegalaxy.org/</ext-link></td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MiModD</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib62">Maier and Baumeiste, 2016</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://mimodd.readthedocs.io/en/latest/index.html">http://mimodd.readthedocs.io/en/latest/index.html</ext-link></td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Bowtie2-2.3.4.2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib56">Langmead and Salzberg, 2012</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://bowtie-bio.sourceforge.net/bowtie2/index.shtml">http://bowtie-bio.sourceforge.net/bowtie2/index.shtml</ext-link></td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ApE</td><td align="left" valign="bottom">M.Wayne Davis</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://jorgensen.biology.utah.edu/wayned/ape/">https://jorgensen.biology.utah.edu/wayned/ape/</ext-link></td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Jalview, version 2.11.1.2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib107">Waterhouse et al., 2009</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://www.jalview.org/getdown/release/">http://www.jalview.org/getdown/release/</ext-link></td><td align="left" valign="bottom"> </td></tr></tbody></table></table-wrap><sec id="s4-1"><title><italic>C. elegans</italic></title><p>Worms were maintained at 20°C on NGM plates seeded with OP50 <italic>Escherichia coli</italic>. Hermaphrodites were used for all the assays in this study. Worm strains in this study are listed in the Key resources table.</p></sec><sec id="s4-2"><title>Generation of transgenic worms and CRISPR</title><p>Transgenic animals were generated by microinjection with Promega 1 kb DNA ladder as a filler in the injection mix. Plasmids for injection were assembled using Gateway recombination (Invitrogen). Entry clones for Gateway reactions were generated by Gibson Assembly (<xref ref-type="bibr" rid="bib25">Gibson et al., 2009</xref>).</p><p>CRISPR/Cas9 was used to generate deletions and knock-ins according to a recent improved protocol (<xref ref-type="bibr" rid="bib23">Ghanta and Mello, 2020</xref>). Briefly, 0.5 µl of 10 µg/ul Cas9 protein was mixed with 5 µl of 0.4 µg/ul tracrRNA and 2.8 µl of 0.4 µg/µl crRNA from IDT and was incubated @ 37°C for 15 min. Then 25 ng/µl double-stranded DNA donor with 40–50 bp homology arms was added to the mixture. 1.6 µl of 500 ng/µl PRF4::<italic>rol-6(su1006</italic>) plasmid was also added as a selection marker (<xref ref-type="bibr" rid="bib66">Mello et al., 1991</xref>). Nuclease-free water was added to bring the final volume to 20 µl. The mixture was then centrifuged @ 15,000 rpm for 2 min. 16 µl of the mixture was transferred to a fresh tube and was kept on ice before injection. To increase the frequency of homology-directed repair, the dsDNA donor amplified by PCR was melted and cooled before use according to the protocol (<xref ref-type="bibr" rid="bib23">Ghanta and Mello, 2020</xref>). F1 non-rollers were then selected for genotyping to find heterozygous mutants. Homozygotes were sequenced to confirm the edits. crRNAs, genotyping primers, and repair templates can be found in <xref ref-type="table" rid="table1">Table 1</xref>.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>List of key oligonucleotides for CRISPR.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Name</th><th align="left" valign="bottom">Sequence</th><th align="left" valign="bottom">Source</th></tr></thead><tbody><tr><td align="left" colspan="3" valign="bottom"><bold>crRNA(20 bp immediately 5' to the PAM sequence)</bold></td></tr><tr><td align="left" valign="bottom"><italic>casy-1(wp78) 5'</italic></td><td align="left" valign="bottom">gtgagggtggaaaatgattg</td><td align="left" valign="bottom">IDT</td></tr><tr><td align="left" valign="bottom"><italic>casy-1(wp78) 3'</italic></td><td align="left" valign="bottom">tgtgatgtaatcaacagggt</td><td align="left" valign="bottom">IDT</td></tr><tr><td align="left" valign="bottom"><italic>unc-43-gfp11x7</italic></td><td align="left" valign="bottom">gagaaaaataggcataaaga</td><td align="left" valign="bottom">IDT</td></tr><tr><td align="left" valign="bottom"><italic>casy-1-gfp11x7#1</italic></td><td align="left" valign="bottom">agaacgagcgttcgttgaga</td><td align="left" valign="bottom">SunyBiotech</td></tr><tr><td align="left" valign="bottom"><italic>casy-1-gfp11x7#2</italic></td><td align="left" valign="bottom">tgtcgttggaggtcttgagt</td><td align="left" valign="bottom">SunyBiotech</td></tr><tr><td align="left" valign="bottom"><italic>lin-10-gfp11x7</italic></td><td align="left" valign="bottom">ataaacaatcaaatgtattg</td><td align="left" valign="bottom">IDT</td></tr><tr><td align="left" colspan="3" valign="bottom"><bold>Genotyping primers</bold></td></tr><tr><td align="left" valign="bottom"><italic>casy-1(wp78</italic>)</td><td align="left" valign="bottom">f: gaataagaatgagaagacccgctgc; r1: ctccttgcagattgattattggcgc; r2: aaggagtgaaaaggacagtatgaagacg</td><td align="left" valign="bottom">IDT</td></tr><tr><td align="left" valign="bottom"><italic>unc-43-gfp11x7</italic></td><td align="left" valign="bottom">f: tcagaaacggagaagctcatacccg; r1: tcatgtagtaccatatggtcgcgtcc; r2: ccatatatctgagagaatgggacaag</td><td align="left" valign="bottom">IDT</td></tr><tr><td align="left" valign="bottom"><italic>casy-1-gfp11x7</italic></td><td align="left" valign="bottom">f: aaattccttcaggcatgttg; r: gaaggagtgaaaaggacagt</td><td align="left" valign="bottom">IDT</td></tr><tr><td align="left" valign="bottom"><italic>lin-10-gfp11x7</italic></td><td align="left" valign="bottom">f: tcgcagttgcacatgacaggtgag; r: attcacattagggcgcactttctgg</td><td align="left" valign="bottom">IDT</td></tr><tr><td align="left" colspan="3" valign="bottom"><bold>Others</bold></td></tr><tr><td align="left" valign="bottom"><italic>7XGFP11</italic> template</td><td align="left" valign="bottom">tcaggaggccgtgaccacatggtccttcatgagtatgtaaa<break/>tgctgctgggattacaggtggctctggaggtagagatcatat<break/>ggttctccacgaatacgttaacgccgcaggcatcactggcgg<break/>tagtggaggacgcgaccatatggtactacatgaatatgtcaatg<break/>cagccggaataaccggagggtccggaggccgggatcacat<break/>ggtgctgcatgagtatgtgaacgcggcgggtataactggtggg<break/>tcgggcggacgagaccatatggtgcttcacgaatacgtaaacg<break/>cagctggcattactggcggatcaggtggcagggatcacatggt<break/>actccatgagtacgtgaacgctgctggaatcacaggcggtagcgg<break/>cggtcgggaccatatggtcctgcacgaatatgtcaatgctg<break/>ccggtatcaccggcggcaag</td><td align="left" valign="bottom">IDT</td></tr><tr><td align="left" valign="bottom"><italic>GFP1-10</italic> template</td><td align="left" valign="bottom">atgtccaaaggagaagaactgtttacgggtgttgtgccaatttt<break/>ggttgaactcgatggtgatgtcaacggacataagttctcagtg<break/>agaggcgaaggagaaggtgacgccaccattggaaaattg<break/>actcttaaattcatctgtactactggtaaacttcctgtaccatgg<break/>ccgactctcgtaacaacgcttacgtacggagttcagtgcttttc<break/>gagatacccagaccatatgaaaagacatgacttttttaagtc<break/>ggctatgcctgaaggttacgtgcaagaaagaacaatttcgttc<break/>aaagatgatggaaaatataaaactagagcagttgttaaattt<break/>gaaggagatactttggttaaccgcattgaactgaaaggaacag<break/>attttaaagaagatggtaatattcttggacacaaactcgaatacaa<break/>ttttaatagtcataacgtatacatcactgctgataagcaaaagaac<break/>ggaattaaagcgaatttcacagtacgccataatgtagaagatgg<break/>cagtgttcaacttgccgaccattaccaacaaaacacccctattgg<break/>agacggtccggtacttcttcctgataatcactacctctcaacacaaa<break/>cagtcctgagcaaagatccaaatgaaaaataa</td><td align="left" valign="bottom">IDT</td></tr></tbody></table></table-wrap><p>The <italic>casy-1::gfp11x7</italic> KI strain PHX3311 was generated by SunyBiotech using CRISPR/Cas9 with two guide RNAs simultaneously (see <xref ref-type="table" rid="table1">Table 1</xref>).</p></sec><sec id="s4-3"><title>Fosmid preparation</title><p>The bacteria clone that contains the WRM0622dH03 fosmid was grown overnight in 3 ml LB with 1.1 µl chloramphenicol. 6 µl 500X CopyControl Fosmid Autoinduction Solution was also added to induce the fosmid to high copy according to the CopyControl Fosmid Library Production Kits (Epicentre). The fosmid was then prepared using the standard QIAGEN miniprep kit.</p></sec><sec id="s4-4"><title>Quantification of axon degeneration</title><p>Worms at the desired age were immobilized with 10 mM levamisole in M9 and mounted on a 3% agarose pad on a glass slide. Worms were then examined under a Zeiss Axioplan 2 microscope equipped with a Zeiss Plan-APOCHROMAT 63×/1.4 oil objective and a pE-300 LED from CoolLED. Fractions of worms with two nontruncated (intact) PVQ axons were quantified.</p></sec><sec id="s4-5"><title><italic>ric-7</italic> suppressor screen and mapping</title><p><italic>XE2046(oyIs14[sra-6p::GFP], ric-7(n2657) V</italic>) worms were mutated with 47 mM EMS. Three F1s were placed on each plate. We screened around 50 F2 adults from each plate using a Zeiss Axioplan 2 microscope with a Zeiss 63×/1.4 oil objective. A total of 340 plates were screened. Animals with strong suppression of PVQ truncation were recovered. The suppression phenotype was further confirmed in the following generations.</p><p>Mutants from the screen were backcrossed with the parent strain <italic>XE2046(oyIs14[sra-6p::GFP], ric-7(n2657) V</italic>) 3–4 times. Genomic DNA were extracted using phenol/CHCl<sub>3</sub> extraction from the backcrossed worms. Briefly, 10 plates of freshly starved worms were collected with M9, washed, and centrifuged to obtain ~100 µl pellet. The pellet was then lysed with 350 µl lysis buffer (50 mM KCl, 10 mM Tris pH 8.3, 25 mM MgCl<sub>2</sub>, 0.45% Nonidet P-40, 0.45% Tween-20%, and 0.01% gelatin), 12 µl 20% SDS, 2 µl 20 mg/ml proteinase K, and 1 µl β-mercaptoethanol at 65°C (water bath) for 2 hr. Next, 235 µl lysis buffer was added to bring the final volume to 700 µl. 700 µl of phenol/CHCl<sub>3</sub> was then added and mixed with the lysate. The solution was left resting for 1 min until both phases were defined. The tube was centrifuged for 5 min at 15,000 rpm at room temperature. 500 µl supernatant was transferred to a new tube and another round of phenol/CHCl3 was performed to get 400 µl supernatant. Ethanol/NaOAc precipitation was then performed by adding 50 µl 3 M NaOAc (1:10) and 1250 µl 100% ice-cold ethanol (2.5 volumes) and incubating on ice for 10 min. Precipitated nucleic acids and salts were spun down at 4°C, and the supernatant was removed. 400 µl EB buffer was added, and the tube was incubated at 37°C (water bath) for 10 min to dissolve the DNA. 2.3 µl P1 buffer from the QIAGEN miniprep kit that contains RNAse was then added, and the tube was incubated at 37°C (water bath) for 30 min to remove RNA. Another round of phenol/CHCl<sub>3</sub> extraction was performed to get 400 µl supernatant. Then ethanol/NaOAc precipitation was done to obtain the DNA pellet. The pellet was washed with 70% ice-cold ethanol three times to remove salts. The pellet was then air dried for 10 min and dissolved in 50 µl nuclease-free water at 37°C overnight. The DNA concentration was then measured and examined by electrophoresis the next day. The final genomic DNA were sent for whole-genome sequencing at the Yale Center for Genome Analysis. The parent strain was also sequenced as the control. Sequencing was performed using NovaSeq S4 paired-end 150 bp with each sample taking up 1.5% of a lane. The final coverage was around 70–150×.</p><p>Sequencing results were analyzed using MiModD (<xref ref-type="bibr" rid="bib62">Maier and Baumeiste, 2016</xref>) on the galaxy server (<xref ref-type="bibr" rid="bib2">Afgan et al., 2016</xref>). Briefly, reads were aligned to the reference genome (the WS220/ce10 assembly) using Bowtie2 (<xref ref-type="bibr" rid="bib56">Langmead and Salzberg, 2012</xref>). Homozygous variants in each mutant strain were then extracted based on the same reference genome using mimodd_varcall and mimodd_varextract. Variants were filtered using mimodd_vcf_filter so that only those that are present in one mutant strain but not in other mutant strains or the parent strain were kept. The filtered variants were then rebased to the ce11 assembly using mimodd_rebase and annotated with the SnpEff4.3 WBcel235.86 file. The annotated variants were finally exported using the MiModD Report Variants tool.</p><p>Usually, the variants in a certain mutant strain are enriched on one chromosome since backcrosses removed most unlinked variants. The mutations predicted to have the most severe effect on protein coding (stop gain, splicing mutations) on that chromosome were then further tested by fosmid rescue or mutants.</p></sec><sec id="s4-6"><title>Imaging</title><p>Worms were immobilized with 10 mM levamisole and mounted on a 3% agarose pad on a glass slide. To image the entire PVQ neuron including the nerve ring, we used a spinning disc confocal microscope (Nikon Ti-E Eclipse inverted scope equipped with 488 and 561 laser lines, a Prior NZ250 Piezo stage, a PerkinElmer UltraVIEW VoX, a Hamamatsu C9100-50 camera, and a CFI Plan Fluor 40× oil objective [1.3 NA]). Volocity software (PerkinElmer) was used to acquire images and automatically stitch them. Images that only cover a part of PVQ (no stitching) were performed on a Leica DMi8 microscope equipped with a Visitech i-SIM super-resolution confocal system, 488, 561, and 637 laser lines, an ASI-XYpZ Piezo stage and a Hamamatsu ORCA-Flash4.0 CMOS camera. MetaMorph Imaging software (Molecular Devices) was used to acquire these images.</p><p>Imaging analysis was performed with ImageJ. Image z-stacks were first projected using maximum projection. To quantify mitochondria density, mitochondria puncta in axons were identified based on manual thresholding. Both the proximal axon region and the distal axon region in each worm were included. For endogenous protein labeling, GFP intensity was background-subtracted, measured, and normalized to the control. In the distal axon, we focused on the region before the axon joins the nerve ring and becomes undistinguishable from the head neurons. PVQ axons shown in figures are often straightened in ImageJ.</p><p>Time-course images of PVQ degeneration from L4 to 1doa were acquired on the i-SIM microscope. Individual worms were first imaged at early L4 stage (0 hr) as described above. Worms were then transferred to OP50 seeded plates and allowed to recover before they were imaged again. Each worm was imaged five times in total (0 hr, 4 hr, 8 hr, 12 hr, and 24 hr).</p></sec><sec id="s4-7"><title>Laser axotomy</title><p>Laser axotomy was performed as described previously (<xref ref-type="bibr" rid="bib13">Byrne et al., 2011</xref>). L4 animals were immobilized with M9 containing 0.05 µm diameter polystyrene beads (Polysciences) and mounted on a 3% agarose pad on a glass slide. Animals were visualized with a Nikon Eclipse 80i microscope using a 100× Plan Apo VC lens (1.4 NA). One of the two PVQ axons in each worm was cut at the vulval region with 10 pulses of a 435 nm Micropoint laser at 20 Hz. Animals were then recovered to OP50-seeded NGM plates and analyzed 24 hr later for axon degeneration.</p></sec><sec id="s4-8"><title>Calsyntenins sequence alignment</title><p>Alignment of calsyntenin protein sequences was performed in Jalview (<xref ref-type="bibr" rid="bib107">Waterhouse et al., 2009</xref>) using the ClustalO algorithm with default settings.</p></sec><sec id="s4-9"><title>Quantification and statistical analysis</title><p>For axon degeneration analyses, fraction of worms with two intact (nontruncated) axons was quantified, and the data were expressed as proportion ± 95% confidence of interval. Two-sided Fisher’s exact tests were performed on these binary data in GraphPad Prism. For nonbinary data, multiple conditions were compared by Kruskal–Wallis nonparametric ANOVA test, followed by Dunn’s multiple comparisons test. Other statistical tests are also described in the figure legends.</p></sec><sec id="s4-10"><title>Materials availability</title><p>Plasmids and strains utilized in this study are listed in the Key resources table and will be made available to the scientific community upon request directed to Dr. Hammarlund. Strains generated in this study will be deposited at the Caenorhabditis Genetics Center (CGC).</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Investigation, Methodology, Visualization, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Funding acquisition, Resources, Supervision, Visualization, Writing - original draft, Writing - review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-73557-transrepform1-v1.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Figure 5-figure supplement 1-source data 1 contains the original gel image used to generate Figure 5-figure supplement 1B. All other data generated or analysed during this study are included in the manuscript.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Daniel Colon-Ramos’s lab for sharing fosmids. We thank Shaul Yogev’s lab for sharing strains, discussion of the project, and guidance on whole-genome sequencing. We thank the Yale Center for Genome Analysis for performing the whole-genome sequencing. We thank the Cellular Neuroscience, Neurodegeneration and Repair (CNNR) imaging core for microscopy. We thank the international Caenorhabditis Genetics Center for strains. We are grateful to members of the Hammarlund lab for valuable comments.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abiria</surname><given-names>SA</given-names></name><name><surname>Colbran</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>CaMKII associates with CaV1.2 L-type calcium channels via selected beta subunits to enhance regulatory phosphorylation</article-title><source>Journal of Neurochemistry</source><volume>112</volume><fpage>150</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06436.x</pub-id><pub-id pub-id-type="pmid">19840220</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afgan</surname><given-names>E</given-names></name><name><surname>Baker</surname><given-names>D</given-names></name><name><surname>van den Beek</surname><given-names>M</given-names></name><name><surname>Blankenberg</surname><given-names>D</given-names></name><name><surname>Bouvier</surname><given-names>D</given-names></name><name><surname>Čech</surname><given-names>M</given-names></name><name><surname>Chilton</surname><given-names>J</given-names></name><name><surname>Clements</surname><given-names>D</given-names></name><name><surname>Coraor</surname><given-names>N</given-names></name><name><surname>Eberhard</surname><given-names>C</given-names></name><name><surname>Grüning</surname><given-names>B</given-names></name><name><surname>Guerler</surname><given-names>A</given-names></name><name><surname>Hillman-Jackson</surname><given-names>J</given-names></name><name><surname>Von Kuster</surname><given-names>G</given-names></name><name><surname>Rasche</surname><given-names>E</given-names></name><name><surname>Soranzo</surname><given-names>N</given-names></name><name><surname>Turaga</surname><given-names>N</given-names></name><name><surname>Taylor</surname><given-names>J</given-names></name><name><surname>Nekrutenko</surname><given-names>A</given-names></name><name><surname>Goecks</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>W3</fpage><lpage>W10</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw343</pub-id><pub-id pub-id-type="pmid">27137889</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alavi</surname><given-names>MV</given-names></name><name><surname>Fuhrmann</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Dominant optic atrophy, OPA1, and mitochondrial quality control: understanding mitochondrial network dynamics</article-title><source>Molecular Neurodegeneration</source><volume>8</volume><elocation-id>32</elocation-id><pub-id pub-id-type="doi">10.1186/1750-1326-8-32</pub-id><pub-id pub-id-type="pmid">24067127</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alloway</surname><given-names>PG</given-names></name><name><surname>Howard</surname><given-names>L</given-names></name><name><surname>Dolph</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The formation of stable rhodopsin-arrestin complexes induces apoptosis and photoreceptor cell degeneration</article-title><source>Neuron</source><volume>28</volume><fpage>129</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)00091-x</pub-id><pub-id pub-id-type="pmid">11086989</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alqadah</surname><given-names>A</given-names></name><name><surname>Hsieh</surname><given-names>YW</given-names></name><name><surname>Schumacher</surname><given-names>JA</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Merrill</surname><given-names>SA</given-names></name><name><surname>Millington</surname><given-names>G</given-names></name><name><surname>Bayne</surname><given-names>B</given-names></name><name><surname>Jorgensen</surname><given-names>EM</given-names></name><name><surname>Chuang</surname><given-names>CF</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>SLO BK Potassium Channels Couple Gap Junctions to Inhibition of Calcium Signaling in Olfactory Neuron Diversification</article-title><source>PLOS Genetics</source><volume>12</volume><elocation-id>e1005654</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1005654</pub-id><pub-id pub-id-type="pmid">26771544</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alqadah</surname><given-names>A</given-names></name><name><surname>Hsieh</surname><given-names>YW</given-names></name><name><surname>Xiong</surname><given-names>R</given-names></name><name><surname>Chuang</surname><given-names>CF</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>Stochastic left-right neuronal asymmetry in <italic>Caenorhabditis elegans</italic></article-title><source>Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences</source><volume>371</volume><elocation-id>20150407</elocation-id><pub-id pub-id-type="doi">10.1098/rstb.2015.0407</pub-id><pub-id pub-id-type="pmid">27821536</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alther</surname><given-names>TA</given-names></name><name><surname>Domanitskaya</surname><given-names>E</given-names></name><name><surname>Stoeckli</surname><given-names>ET</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Calsyntenin 1-mediated trafficking of axon guidance receptors regulates the switch in axonal responsiveness at a choice point</article-title><source>Development (Cambridge, England)</source><volume>143</volume><fpage>994</fpage><lpage>1004</lpage><pub-id pub-id-type="doi">10.1242/dev.127449</pub-id><pub-id pub-id-type="pmid">26839361</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araki</surname><given-names>Y</given-names></name><name><surname>Tomita</surname><given-names>S</given-names></name><name><surname>Yamaguchi</surname><given-names>H</given-names></name><name><surname>Miyagi</surname><given-names>N</given-names></name><name><surname>Sumioka</surname><given-names>A</given-names></name><name><surname>Kirino</surname><given-names>Y</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Novel cadherin-related membrane proteins, Alcadeins, enhance the X11-like protein-mediated stabilization of amyloid beta-protein precursor metabolism</article-title><source>The Journal of Biological Chemistry</source><volume>278</volume><fpage>49448</fpage><lpage>49458</lpage><pub-id pub-id-type="doi">10.1074/jbc.M306024200</pub-id><pub-id pub-id-type="pmid">12972431</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araki</surname><given-names>Y</given-names></name><name><surname>Miyagi</surname><given-names>N</given-names></name><name><surname>Kato</surname><given-names>N</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name><name><surname>Wada</surname><given-names>S</given-names></name><name><surname>Nishimura</surname><given-names>M</given-names></name><name><surname>Komano</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>De Strooper</surname><given-names>B</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Coordinated metabolism of Alcadein and amyloid beta-protein precursor regulates FE65-dependent gene transactivation</article-title><source>The Journal of Biological Chemistry</source><volume>279</volume><fpage>24343</fpage><lpage>24354</lpage><pub-id pub-id-type="doi">10.1074/jbc.M401925200</pub-id><pub-id pub-id-type="pmid">15037614</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araki</surname><given-names>Y</given-names></name><name><surname>Kawano</surname><given-names>T</given-names></name><name><surname>Taru</surname><given-names>H</given-names></name><name><surname>Saito</surname><given-names>Y</given-names></name><name><surname>Wada</surname><given-names>S</given-names></name><name><surname>Miyamoto</surname><given-names>K</given-names></name><name><surname>Kobayashi</surname><given-names>H</given-names></name><name><surname>Ishikawa</surname><given-names>HO</given-names></name><name><surname>Ohsugi</surname><given-names>Y</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Matsuno</surname><given-names>K</given-names></name><name><surname>Kinjo</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The novel cargo Alcadein induces vesicle association of kinesin-1 motor components and activates axonal transport</article-title><source>The EMBO Journal</source><volume>26</volume><fpage>1475</fpage><lpage>1486</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601609</pub-id><pub-id pub-id-type="pmid">17332754</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bezprozvanny</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Calcium signaling and neurodegenerative diseases</article-title><source>Trends in Molecular Medicine</source><volume>15</volume><fpage>89</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.molmed.2009.01.001</pub-id><pub-id pub-id-type="pmid">19230774</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blackstone</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Converging cellular themes for the hereditary spastic paraplegias</article-title><source>Current Opinion in Neurobiology</source><volume>51</volume><fpage>139</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2018.04.025</pub-id><pub-id pub-id-type="pmid">29753924</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byrne</surname><given-names>AB</given-names></name><name><surname>Edwards</surname><given-names>TJ</given-names></name><name><surname>Hammarlund</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>In vivo Laser Axotomy in <italic>C. elegans</italic></article-title><source>Journal of Visualized Experiments: JoVE</source><volume>19</volume><elocation-id>2707</elocation-id><pub-id pub-id-type="doi">10.3791/2707</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camins</surname><given-names>A</given-names></name><name><surname>Verdaguer</surname><given-names>E</given-names></name><name><surname>Folch</surname><given-names>J</given-names></name><name><surname>Pallàs</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Involvement of calpain activation in neurodegenerative processes</article-title><source>CNS Drug Reviews</source><volume>12</volume><fpage>135</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1111/j.1527-3458.2006.00135.x</pub-id><pub-id pub-id-type="pmid">16958987</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catterall</surname><given-names>WA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Voltage-gated calcium channels</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>3</volume><elocation-id>a003947</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a003947</pub-id><pub-id pub-id-type="pmid">21746798</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caylor</surname><given-names>RC</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Ackley</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The <italic>Caenorhabditis elegans</italic> voltage-gated calcium channel subunits UNC-2 and UNC-36 and the calcium-dependent kinase UNC-43/CaMKII regulate neuromuscular junction morphology</article-title><source>Neural Development</source><volume>8</volume><elocation-id>10</elocation-id><pub-id pub-id-type="doi">10.1186/1749-8104-8-10</pub-id><pub-id pub-id-type="pmid">23663262</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuang</surname><given-names>CF</given-names></name><name><surname>Bargmann</surname><given-names>CI</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A Toll-interleukin 1 repeat protein at the synapse specifies asymmetric odorant receptor expression via ASK1 MAPKKK signaling</article-title><source>Genes &amp; Development</source><volume>19</volume><fpage>270</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1101/gad.1276505</pub-id><pub-id pub-id-type="pmid">15625192</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>C</given-names></name><name><surname>Hammarlund</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Aberrant information transfer interferes with functional axon regeneration</article-title><source>eLife</source><volume>7</volume><elocation-id>e38829</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.38829</pub-id><pub-id pub-id-type="pmid">30371349</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Essuman</surname><given-names>K</given-names></name><name><surname>Summers</surname><given-names>DW</given-names></name><name><surname>Sasaki</surname><given-names>Y</given-names></name><name><surname>Mao</surname><given-names>X</given-names></name><name><surname>DiAntonio</surname><given-names>A</given-names></name><name><surname>Milbrandt</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD<sup>+</sup> Cleavage Activity that Promotes Pathological Axonal Degeneration</article-title><source>Neuron</source><volume>93</volume><fpage>1334</fpage><lpage>1343</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.02.022</pub-id><pub-id pub-id-type="pmid">28334607</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frøkjaer-Jensen</surname><given-names>C</given-names></name><name><surname>Kindt</surname><given-names>KS</given-names></name><name><surname>Kerr</surname><given-names>RA</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Melnik-Martinez</surname><given-names>K</given-names></name><name><surname>Gerstbreih</surname><given-names>B</given-names></name><name><surname>Driscol</surname><given-names>M</given-names></name><name><surname>Schafer</surname><given-names>WR</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Effects of voltage-gated calcium channel subunit genes on calcium influx in cultured <italic>C. elegans</italic> mechanosensory neurons</article-title><source>Journal of Neurobiology</source><volume>66</volume><fpage>1125</fpage><lpage>1139</lpage><pub-id pub-id-type="doi">10.1002/neu.20261</pub-id><pub-id pub-id-type="pmid">16838374</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerdts</surname><given-names>J</given-names></name><name><surname>Summers</surname><given-names>DW</given-names></name><name><surname>Sasaki</surname><given-names>Y</given-names></name><name><surname>DiAntonio</surname><given-names>A</given-names></name><name><surname>Milbrandt</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Sarm1-mediated axon degeneration requires both SAM and TIR interactions</article-title><source>The Journal of Neuroscience</source><volume>33</volume><fpage>13569</fpage><lpage>13580</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1197-13.2013</pub-id><pub-id pub-id-type="pmid">23946415</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerdts</surname><given-names>J</given-names></name><name><surname>Brace</surname><given-names>EJ</given-names></name><name><surname>Sasaki</surname><given-names>Y</given-names></name><name><surname>DiAntonio</surname><given-names>A</given-names></name><name><surname>Milbrandt</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>SARM1 activation triggers axon degeneration locally via NAD+ destruction</article-title><source>Science (New York, N.Y.)</source><volume>348</volume><fpage>453</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1126/science.1258366</pub-id><pub-id pub-id-type="pmid">25908823</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghanta</surname><given-names>KS</given-names></name><name><surname>Mello</surname><given-names>CC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Melting dsDNA Donor Molecules Greatly Improves Precision Genome Editing in <italic>Caenorhabditis elegans</italic></article-title><source>Genetics</source><volume>216</volume><fpage>643</fpage><lpage>650</lpage><pub-id pub-id-type="doi">10.1534/genetics.120.303564</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghose</surname><given-names>P</given-names></name><name><surname>Park</surname><given-names>EC</given-names></name><name><surname>Tabakin</surname><given-names>A</given-names></name><name><surname>Salazar-Vasquez</surname><given-names>N</given-names></name><name><surname>Rongo</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Anoxia-reoxygenation regulates mitochondrial dynamics through the hypoxia response pathway, SKN-1/Nrf, and stomatin-like protein STL-1/SLP-2</article-title><source>PLOS Genetics</source><volume>9</volume><elocation-id>e1004063</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004063</pub-id><pub-id pub-id-type="pmid">24385935</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>DG</given-names></name><name><surname>Young</surname><given-names>L</given-names></name><name><surname>Chuang</surname><given-names>R-Y</given-names></name><name><surname>Venter</surname><given-names>JC</given-names></name><name><surname>Hutchison</surname><given-names>CA</given-names></name><name><surname>Smith</surname><given-names>HO</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Enzymatic assembly of DNA molecules up to several hundred kilobases</article-title><source>Nature Methods</source><volume>6</volume><fpage>343</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1318</pub-id><pub-id pub-id-type="pmid">19363495</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glater</surname><given-names>EE</given-names></name><name><surname>Megeath</surname><given-names>LJ</given-names></name><name><surname>Stowers</surname><given-names>RS</given-names></name><name><surname>Schwarz</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Axonal transport of mitochondria requires milton to recruit kinesin heavy chain and is light chain independent</article-title><source>The Journal of Cell Biology</source><volume>173</volume><fpage>545</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1083/jcb.200601067</pub-id><pub-id pub-id-type="pmid">16717129</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotoh</surname><given-names>N</given-names></name><name><surname>Saito</surname><given-names>Y</given-names></name><name><surname>Hata</surname><given-names>S</given-names></name><name><surname>Saito</surname><given-names>H</given-names></name><name><surname>Ojima</surname><given-names>D</given-names></name><name><surname>Murayama</surname><given-names>C</given-names></name><name><surname>Shigeta</surname><given-names>M</given-names></name><name><surname>Abe</surname><given-names>T</given-names></name><name><surname>Konno</surname><given-names>D</given-names></name><name><surname>Matsuzaki</surname><given-names>F</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Amyloidogenic processing of amyloid β protein precursor (APP) is enhanced in the brains of alcadein α-deficient mice</article-title><source>The Journal of Biological Chemistry</source><volume>295</volume><fpage>9650</fpage><lpage>9662</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA119.012386</pub-id><pub-id pub-id-type="pmid">32467230</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grünewald</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>KR</given-names></name><name><surname>Sue</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>New insights into the complex role of mitochondria in Parkinson’s disease</article-title><source>Progress in Neurobiology</source><volume>177</volume><fpage>73</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.pneurobio.2018.09.003</pub-id><pub-id pub-id-type="pmid">30219247</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guedes-Dias</surname><given-names>P</given-names></name><name><surname>Holzbaur</surname><given-names>ELF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Axonal transport: Driving synaptic function</article-title><source>Science (New York, N.Y.)</source><volume>366</volume><elocation-id>eaaw9997</elocation-id><pub-id pub-id-type="doi">10.1126/science.aaw9997</pub-id><pub-id pub-id-type="pmid">31601744</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Macleod</surname><given-names>GT</given-names></name><name><surname>Wellington</surname><given-names>A</given-names></name><name><surname>Hu</surname><given-names>F</given-names></name><name><surname>Panchumarthi</surname><given-names>S</given-names></name><name><surname>Schoenfield</surname><given-names>M</given-names></name><name><surname>Marin</surname><given-names>L</given-names></name><name><surname>Charlton</surname><given-names>MP</given-names></name><name><surname>Atwood</surname><given-names>HL</given-names></name><name><surname>Zinsmaier</surname><given-names>KE</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The GTPase dMiro is required for axonal transport of mitochondria to <italic>Drosophila</italic> synapses</article-title><source>Neuron</source><volume>47</volume><fpage>379</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2005.06.027</pub-id><pub-id pub-id-type="pmid">16055062</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Starr</surname><given-names>C</given-names></name><name><surname>Mohns</surname><given-names>EJ</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>EP</given-names></name><name><surname>Yoon</surname><given-names>Y</given-names></name><name><surname>Kellner</surname><given-names>CP</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Pasquale</surname><given-names>LR</given-names></name><name><surname>Demb</surname><given-names>JB</given-names></name><name><surname>Crair</surname><given-names>MC</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Preservation of vision after CaMKII-mediated protection of retinal ganglion cells</article-title><source>Cell</source><volume>184</volume><fpage>4299</fpage><lpage>4314</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.06.031</pub-id><pub-id pub-id-type="pmid">34297923</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halestrap</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>What is the mitochondrial permeability transition pore?</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>46</volume><fpage>821</fpage><lpage>831</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2009.02.021</pub-id><pub-id pub-id-type="pmid">19265700</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halt</surname><given-names>AR</given-names></name><name><surname>Dallapiazza</surname><given-names>RF</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Stein</surname><given-names>IS</given-names></name><name><surname>Qian</surname><given-names>H</given-names></name><name><surname>Juntti</surname><given-names>S</given-names></name><name><surname>Wojcik</surname><given-names>S</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Silva</surname><given-names>AJ</given-names></name><name><surname>Hell</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>CaMKII binding to GluN2B is critical during memory consolidation</article-title><source>The EMBO Journal</source><volume>31</volume><fpage>1203</fpage><lpage>1216</lpage><pub-id pub-id-type="doi">10.1038/emboj.2011.482</pub-id><pub-id pub-id-type="pmid">22234183</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hata</surname><given-names>S</given-names></name><name><surname>Fujishige</surname><given-names>S</given-names></name><name><surname>Araki</surname><given-names>Y</given-names></name><name><surname>Kato</surname><given-names>N</given-names></name><name><surname>Araseki</surname><given-names>M</given-names></name><name><surname>Nishimura</surname><given-names>M</given-names></name><name><surname>Hartmann</surname><given-names>D</given-names></name><name><surname>Saftig</surname><given-names>P</given-names></name><name><surname>Fahrenholz</surname><given-names>F</given-names></name><name><surname>Taniguchi</surname><given-names>M</given-names></name><name><surname>Urakami</surname><given-names>K</given-names></name><name><surname>Akatsu</surname><given-names>H</given-names></name><name><surname>Martins</surname><given-names>RN</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Maeda</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Nakaya</surname><given-names>T</given-names></name><name><surname>Gandy</surname><given-names>S</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Alcadein cleavages by amyloid beta-precursor protein (APP) alpha- and gamma-secretases generate small peptides, p3-Alcs, indicating Alzheimer disease-related gamma-secretase dysfunction</article-title><source>The Journal of Biological Chemistry</source><volume>284</volume><fpage>36024</fpage><lpage>36033</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.057497</pub-id><pub-id pub-id-type="pmid">19864413</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hauptmann</surname><given-names>S</given-names></name><name><surname>Keil</surname><given-names>U</given-names></name><name><surname>Scherping</surname><given-names>I</given-names></name><name><surname>Bonert</surname><given-names>A</given-names></name><name><surname>Eckert</surname><given-names>A</given-names></name><name><surname>Müller</surname><given-names>WE</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Mitochondrial dysfunction in sporadic and genetic Alzheimer’s disease</article-title><source>Experimental Gerontology</source><volume>41</volume><fpage>668</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1016/j.exger.2006.03.012</pub-id><pub-id pub-id-type="pmid">16677790</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayakawa</surname><given-names>T</given-names></name><name><surname>Matsuzawa</surname><given-names>A</given-names></name><name><surname>Noguchi</surname><given-names>T</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name><name><surname>Ichijo</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The ASK1-MAP kinase pathways in immune and stress responses</article-title><source>Microbes and Infection</source><volume>8</volume><fpage>1098</fpage><lpage>1107</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2005.12.001</pub-id><pub-id pub-id-type="pmid">16517200</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>S</given-names></name><name><surname>Cuentas-Condori</surname><given-names>A</given-names></name><name><surname>Miller</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>NATF (Native and Tissue-Specific Fluorescence): A Strategy for Bright, Tissue-Specific GFP Labeling of Native Proteins in <italic>Caenorhabditis elegans</italic></article-title><source>Genetics</source><volume>212</volume><fpage>387</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1534/genetics.119.302063</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hell</surname><given-names>JW</given-names></name><name><surname>Westenbroek</surname><given-names>RE</given-names></name><name><surname>Breeze</surname><given-names>LJ</given-names></name><name><surname>Wang</surname><given-names>KK</given-names></name><name><surname>Chavkin</surname><given-names>C</given-names></name><name><surname>Catterall</surname><given-names>WA</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>N-methyl-D-aspartate receptor-induced proteolytic conversion of postsynaptic class C L-type calcium channels in hippocampal neurons</article-title><source>PNAS</source><volume>93</volume><fpage>3362</fpage><lpage>3367</lpage><pub-id pub-id-type="doi">10.1073/pnas.93.8.3362</pub-id><pub-id pub-id-type="pmid">8622942</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hell</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>CaMKII: claiming center stage in postsynaptic function and organization</article-title><source>Neuron</source><volume>81</volume><fpage>249</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.12.024</pub-id><pub-id pub-id-type="pmid">24462093</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henninger</surname><given-names>N</given-names></name><name><surname>Bouley</surname><given-names>J</given-names></name><name><surname>Sikoglu</surname><given-names>EM</given-names></name><name><surname>An</surname><given-names>J</given-names></name><name><surname>Moore</surname><given-names>CM</given-names></name><name><surname>King</surname><given-names>JA</given-names></name><name><surname>Bowser</surname><given-names>R</given-names></name><name><surname>Freeman</surname><given-names>MR</given-names></name><name><surname>Brown</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Attenuated traumatic axonal injury and improved functional outcome after traumatic brain injury in mice lacking Sarm1</article-title><source>Brain</source><volume>139</volume><fpage>1094</fpage><lpage>1105</lpage><pub-id pub-id-type="doi">10.1093/brain/aww001</pub-id><pub-id pub-id-type="pmid">26912636</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>E</given-names></name><name><surname>Broadbent</surname><given-names>ID</given-names></name><name><surname>Chothia</surname><given-names>C</given-names></name><name><surname>Pettitt</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Cadherin superfamily proteins in <italic>Caenorhabditis elegans</italic> and <italic>Drosophila melanogaster</italic></article-title><source>Journal of Molecular Biology</source><volume>305</volume><fpage>1011</fpage><lpage>1024</lpage><pub-id pub-id-type="doi">10.1006/jmbi.2000.4361</pub-id><pub-id pub-id-type="pmid">11162110</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hobert</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The neuronal genome of <italic>Caenorhabditis elegans</italic></article-title><source>WormBook: The Online Review of C. elegans Biology</source><volume>10</volume><fpage>1</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1895/wormbook.1.161.1</pub-id><pub-id pub-id-type="pmid">24081909</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollenbeck</surname><given-names>PJ</given-names></name><name><surname>Saxton</surname><given-names>WM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The axonal transport of mitochondria</article-title><source>Journal of Cell Science</source><volume>118</volume><fpage>5411</fpage><lpage>5419</lpage><pub-id pub-id-type="doi">10.1242/jcs.02745</pub-id><pub-id pub-id-type="pmid">16306220</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoppe</surname><given-names>UC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mitochondrial calcium channels</article-title><source>FEBS Letters</source><volume>584</volume><fpage>1975</fpage><lpage>1981</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2010.04.017</pub-id><pub-id pub-id-type="pmid">20388514</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horsefield</surname><given-names>S</given-names></name><name><surname>Burdett</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Manik</surname><given-names>MK</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Qi</surname><given-names>T</given-names></name><name><surname>Gilley</surname><given-names>J</given-names></name><name><surname>Lai</surname><given-names>JS</given-names></name><name><surname>Rank</surname><given-names>MX</given-names></name><name><surname>Casey</surname><given-names>LW</given-names></name><name><surname>Gu</surname><given-names>W</given-names></name><name><surname>Ericsson</surname><given-names>DJ</given-names></name><name><surname>Foley</surname><given-names>G</given-names></name><name><surname>Hughes</surname><given-names>RO</given-names></name><name><surname>Bosanac</surname><given-names>T</given-names></name><name><surname>von Itzstein</surname><given-names>M</given-names></name><name><surname>Rathjen</surname><given-names>JP</given-names></name><name><surname>Nanson</surname><given-names>JD</given-names></name><name><surname>Boden</surname><given-names>M</given-names></name><name><surname>Dry</surname><given-names>IB</given-names></name><name><surname>Williams</surname><given-names>SJ</given-names></name><name><surname>Staskawicz</surname><given-names>BJ</given-names></name><name><surname>Coleman</surname><given-names>MP</given-names></name><name><surname>Ve</surname><given-names>T</given-names></name><name><surname>Dodds</surname><given-names>PN</given-names></name><name><surname>Kobe</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>NAD<sup>+</sup> cleavage activity by animal and plant TIR domains in cell death pathways</article-title><source>Science (New York, N.Y.)</source><volume>365</volume><fpage>793</fpage><lpage>799</lpage><pub-id pub-id-type="doi">10.1126/science.aax1911</pub-id><pub-id pub-id-type="pmid">31439792</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>ST</given-names></name><name><surname>Jiang</surname><given-names>SX</given-names></name><name><surname>Aylsworth</surname><given-names>A</given-names></name><name><surname>Ferguson</surname><given-names>G</given-names></name><name><surname>Slinn</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Leung</surname><given-names>T</given-names></name><name><surname>Kappler</surname><given-names>J</given-names></name><name><surname>Kaibuchi</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>CaMKII phosphorylates collapsin response mediator protein 2 and modulates axonal damage during glutamate excitotoxicity</article-title><source>Journal of Neurochemistry</source><volume>111</volume><fpage>870</fpage><lpage>881</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06375.x</pub-id><pub-id pub-id-type="pmid">19735446</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>JM</given-names></name><name><surname>Kang</surname><given-names>Y</given-names></name><name><surname>Corty</surname><given-names>MM</given-names></name><name><surname>Mathieson</surname><given-names>D</given-names></name><name><surname>Peters</surname><given-names>OM</given-names></name><name><surname>Freeman</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Injury-Induced Inhibition of Bystander Neurons Requires dSarm and Signaling from Glia</article-title><source>Neuron</source><volume>109</volume><fpage>473</fpage><lpage>487</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2020.11.012</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudmon</surname><given-names>A</given-names></name><name><surname>Schulman</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Maltez</surname><given-names>JM</given-names></name><name><surname>Tsien</surname><given-names>RW</given-names></name><name><surname>Pitt</surname><given-names>GS</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>CaMKII tethers to L-type Ca2+ channels, establishing a local and dedicated integrator of Ca2+ signals for facilitation</article-title><source>The Journal of Cell Biology</source><volume>171</volume><fpage>537</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1083/jcb.200505155</pub-id><pub-id pub-id-type="pmid">16275756</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaussi</surname><given-names>R</given-names></name><name><surname>Cotton</surname><given-names>B</given-names></name><name><surname>Juretić</surname><given-names>N</given-names></name><name><surname>Christen</surname><given-names>P</given-names></name><name><surname>Schümperli</surname><given-names>D</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>The primary structure of the precursor of chicken mitochondrial aspartate aminotransferase Cloning and sequence analysis of cDNA</article-title><source>The Journal of Biological Chemistry</source><volume>260</volume><fpage>16060</fpage><lpage>16063</lpage><pub-id pub-id-type="pmid">3840803</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaech</surname><given-names>SM</given-names></name><name><surname>Whitfield</surname><given-names>CW</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>The LIN-2/LIN-7/LIN-10 complex mediates basolateral membrane localization of the <italic>C. elegans</italic> EGF receptor LET-23 in vulval epithelial cells</article-title><source>Cell</source><volume>94</volume><fpage>761</fpage><lpage>771</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)81735-3</pub-id><pub-id pub-id-type="pmid">9753323</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Feinbaum</surname><given-names>R</given-names></name><name><surname>Alloing</surname><given-names>G</given-names></name><name><surname>Emerson</surname><given-names>FE</given-names></name><name><surname>Garsin</surname><given-names>DA</given-names></name><name><surname>Inoue</surname><given-names>H</given-names></name><name><surname>Tanaka-Hino</surname><given-names>M</given-names></name><name><surname>Hisamoto</surname><given-names>N</given-names></name><name><surname>Matsumoto</surname><given-names>K</given-names></name><name><surname>Tan</surname><given-names>M-W</given-names></name><name><surname>Ausubel</surname><given-names>FM</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>A conserved p38 MAP kinase pathway in <italic>Caenorhabditis elegans</italic> innate immunity</article-title><source>Science (New York, N.Y.)</source><volume>297</volume><fpage>623</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.1126/science.1073759</pub-id><pub-id pub-id-type="pmid">12142542</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>HY</given-names></name><name><surname>Park</surname><given-names>D</given-names></name><name><surname>Kang</surname><given-names>H</given-names></name><name><surname>Matsuda</surname><given-names>K</given-names></name><name><surname>Sterky</surname><given-names>FH</given-names></name><name><surname>Yuzaki</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Calsyntenin-3 Directly Interacts with Neurexins to Orchestrate Excitatory Synapse Development in the Hippocampus</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.01.24.918722</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>HY</given-names></name><name><surname>Park</surname><given-names>D</given-names></name><name><surname>Kang</surname><given-names>H</given-names></name><name><surname>Matsuda</surname><given-names>K</given-names></name><name><surname>Sterky</surname><given-names>FH</given-names></name><name><surname>Yuzaki</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Choi</surname><given-names>SY</given-names></name><name><surname>Ko</surname><given-names>J</given-names></name><name><surname>Um</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Calsyntenin-3 interacts with both α- and β-neurexins in the regulation of excitatory synaptic innervation in specific Schaffer collateral pathways</article-title><source>The Journal of Biological Chemistry</source><volume>295</volume><fpage>9244</fpage><lpage>9262</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA120.013077</pub-id><pub-id pub-id-type="pmid">32434929</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konecna</surname><given-names>A</given-names></name><name><surname>Frischknecht</surname><given-names>R</given-names></name><name><surname>Kinter</surname><given-names>J</given-names></name><name><surname>Ludwig</surname><given-names>A</given-names></name><name><surname>Steuble</surname><given-names>M</given-names></name><name><surname>Meskenaite</surname><given-names>V</given-names></name><name><surname>Indermühle</surname><given-names>M</given-names></name><name><surname>Engel</surname><given-names>M</given-names></name><name><surname>Cen</surname><given-names>C</given-names></name><name><surname>Mateos</surname><given-names>J-M</given-names></name><name><surname>Streit</surname><given-names>P</given-names></name><name><surname>Sonderegger</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Calsyntenin-1 docks vesicular cargo to kinesin-1</article-title><source>Molecular Biology of the Cell</source><volume>17</volume><fpage>3651</fpage><lpage>3663</lpage><pub-id pub-id-type="doi">10.1091/mbc.e06-02-0112</pub-id><pub-id pub-id-type="pmid">16760430</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kristaponyte</surname><given-names>I</given-names></name><name><surname>Hong</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name><name><surname>Shieh</surname><given-names>BH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Role of rhodopsin and arrestin phosphorylation in retinal degeneration of <italic>Drosophila</italic></article-title><source>The Journal of Neuroscience</source><volume>32</volume><fpage>10758</fpage><lpage>10766</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0565-12.2012</pub-id><pub-id pub-id-type="pmid">22855823</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname><given-names>B</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fast gapped-read alignment with Bowtie 2</article-title><source>Nature Methods</source><volume>9</volume><fpage>357</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id><pub-id pub-id-type="pmid">22388286</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>TJ</given-names></name><name><surname>Lee</surname><given-names>JW</given-names></name><name><surname>Haynes</surname><given-names>EM</given-names></name><name><surname>Eliceiri</surname><given-names>KW</given-names></name><name><surname>Halloran</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The Kinesin Adaptor Calsyntenin-1 Organizes Microtubule Polarity and Regulates Dynamics during Sensory Axon Arbor Development</article-title><source>Frontiers in Cellular Neuroscience</source><volume>11</volume><elocation-id>107</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2017.00107</pub-id><pub-id pub-id-type="pmid">28473757</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipina</surname><given-names>TV</given-names></name><name><surname>Prasad</surname><given-names>T</given-names></name><name><surname>Yokomaku</surname><given-names>D</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Connor</surname><given-names>SA</given-names></name><name><surname>Kawabe</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>YT</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Roder</surname><given-names>JC</given-names></name><name><surname>Craig</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cognitive Deficits in Calsyntenin-2-deficient Mice Associated with Reduced GABAergic Transmission</article-title><source>Neuropsychopharmacology</source><volume>41</volume><fpage>802</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1038/npp.2015.206</pub-id><pub-id pub-id-type="pmid">26171716</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lisman</surname><given-names>J</given-names></name><name><surname>Schulman</surname><given-names>H</given-names></name><name><surname>Cline</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The molecular basis of CaMKII function in synaptic and behavioural memory</article-title><source>Nature Reviews. Neuroscience</source><volume>3</volume><fpage>175</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1038/nrn753</pub-id><pub-id pub-id-type="pmid">11994750</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loreto</surname><given-names>A</given-names></name><name><surname>Hill</surname><given-names>CS</given-names></name><name><surname>Hewitt</surname><given-names>VL</given-names></name><name><surname>Orsomando</surname><given-names>G</given-names></name><name><surname>Angeletti</surname><given-names>C</given-names></name><name><surname>Gilley</surname><given-names>J</given-names></name><name><surname>Lucci</surname><given-names>C</given-names></name><name><surname>Sanchez-Martinez</surname><given-names>A</given-names></name><name><surname>Whitworth</surname><given-names>AJ</given-names></name><name><surname>Conforti</surname><given-names>L</given-names></name><name><surname>Dajas-Bailador</surname><given-names>F</given-names></name><name><surname>Coleman</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration</article-title><source>Neurobiology of Disease</source><volume>134</volume><elocation-id>104678</elocation-id><pub-id pub-id-type="doi">10.1016/j.nbd.2019.104678</pub-id><pub-id pub-id-type="pmid">31740269</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludwig</surname><given-names>A</given-names></name><name><surname>Blume</surname><given-names>J</given-names></name><name><surname>Diep</surname><given-names>T-M</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Mateos</surname><given-names>JM</given-names></name><name><surname>Leuthäuser</surname><given-names>K</given-names></name><name><surname>Steuble</surname><given-names>M</given-names></name><name><surname>Streit</surname><given-names>P</given-names></name><name><surname>Sonderegger</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Calsyntenins mediate TGN exit of APP in a kinesin-1-dependent manner</article-title><source>Traffic (Copenhagen, Denmark)</source><volume>10</volume><fpage>572</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0854.2009.00886.x</pub-id><pub-id pub-id-type="pmid">19192245</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Maier</surname><given-names>W</given-names></name><name><surname>Baumeiste</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><data-title>Mutation identification in model organism genomes using desktop PCs</data-title><source>Celegansde</source></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marambaud</surname><given-names>P</given-names></name><name><surname>Dreses-Werringloer</surname><given-names>U</given-names></name><name><surname>Vingtdeux</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Calcium signaling in neurodegeneration</article-title><source>Molecular Neurodegeneration</source><volume>4</volume><elocation-id>20</elocation-id><pub-id pub-id-type="doi">10.1186/1750-1326-4-20</pub-id><pub-id pub-id-type="pmid">19419557</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maximov</surname><given-names>A</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name><name><surname>Bezprozvanny</surname><given-names>I</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Association of neuronal calcium channels with modular adaptor proteins</article-title><source>The Journal of Biological Chemistry</source><volume>274</volume><fpage>24453</fpage><lpage>24456</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.35.24453</pub-id><pub-id pub-id-type="pmid">10455105</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maximov</surname><given-names>A</given-names></name><name><surname>Bezprozvanny</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Synaptic targeting of N-type calcium channels in hippocampal neurons</article-title><source>The Journal of Neuroscience</source><volume>22</volume><fpage>6939</fpage><lpage>6952</lpage><pub-id pub-id-type="pmid">12177192</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mello</surname><given-names>CC</given-names></name><name><surname>Kramer</surname><given-names>JM</given-names></name><name><surname>Stinchcomb</surname><given-names>D</given-names></name><name><surname>Ambros</surname><given-names>V</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Efficient gene transfer in <italic>C. elegans</italic>: extrachromosomal maintenance and integration of transforming sequences</article-title><source>The EMBO Journal</source><volume>10</volume><fpage>3959</fpage><lpage>3970</lpage><pub-id pub-id-type="doi">10.1002/j.1460-2075.1991.tb04966.x</pub-id><pub-id pub-id-type="pmid">1935914</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merrill</surname><given-names>MA</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Strack</surname><given-names>S</given-names></name><name><surname>Hell</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Activity-driven postsynaptic translocation of CaMKII</article-title><source>Trends in Pharmacological Sciences</source><volume>26</volume><fpage>645</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2005.10.003</pub-id><pub-id pub-id-type="pmid">16253351</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neukomm</surname><given-names>LJ</given-names></name><name><surname>Burdett</surname><given-names>TC</given-names></name><name><surname>Seeds</surname><given-names>AM</given-names></name><name><surname>Hampel</surname><given-names>S</given-names></name><name><surname>Coutinho-Budd</surname><given-names>JC</given-names></name><name><surname>Farley</surname><given-names>JE</given-names></name><name><surname>Wong</surname><given-names>J</given-names></name><name><surname>Karadeniz</surname><given-names>YB</given-names></name><name><surname>Osterloh</surname><given-names>JM</given-names></name><name><surname>Sheehan</surname><given-names>AE</given-names></name><name><surname>Freeman</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Axon Death Pathways Converge on Axundead to Promote Functional and Structural Axon Disassembly</article-title><source>Neuron</source><volume>95</volume><fpage>78</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.06.031</pub-id><pub-id pub-id-type="pmid">28683272</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nichols</surname><given-names>ALA</given-names></name><name><surname>Meelkop</surname><given-names>E</given-names></name><name><surname>Linton</surname><given-names>C</given-names></name><name><surname>Giordano-Santini</surname><given-names>R</given-names></name><name><surname>Sullivan</surname><given-names>RK</given-names></name><name><surname>Donato</surname><given-names>A</given-names></name><name><surname>Nolan</surname><given-names>C</given-names></name><name><surname>Hall</surname><given-names>DH</given-names></name><name><surname>Xue</surname><given-names>D</given-names></name><name><surname>Neumann</surname><given-names>B</given-names></name><name><surname>Hilliard</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The Apoptotic Engulfment Machinery Regulates Axonal Degeneration in <italic>C. elegans</italic> Neurons</article-title><source>Cell Reports</source><volume>14</volume><fpage>1673</fpage><lpage>1683</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.01.050</pub-id><pub-id pub-id-type="pmid">26876181</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nolan</surname><given-names>KM</given-names></name><name><surname>Sarafi-Reinach</surname><given-names>TR</given-names></name><name><surname>Horne</surname><given-names>JG</given-names></name><name><surname>Saffer</surname><given-names>AM</given-names></name><name><surname>Sengupta</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The DAF-7 TGF-beta signaling pathway regulates chemosensory receptor gene expression in <italic>C. elegans</italic></article-title><source>Genes &amp; Development</source><volume>16</volume><fpage>3061</fpage><lpage>3073</lpage><pub-id pub-id-type="doi">10.1101/gad.1027702</pub-id><pub-id pub-id-type="pmid">12464635</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohno</surname><given-names>H</given-names></name><name><surname>Kato</surname><given-names>S</given-names></name><name><surname>Naito</surname><given-names>Y</given-names></name><name><surname>Kunitomo</surname><given-names>H</given-names></name><name><surname>Tomioka</surname><given-names>M</given-names></name><name><surname>Iino</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Role of synaptic phosphatidylinositol 3-kinase in a behavioral learning response in <italic>C. elegans</italic></article-title><source>Science (New York, N.Y.)</source><volume>345</volume><fpage>313</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1126/science.1250709</pub-id><pub-id pub-id-type="pmid">25035490</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osterloh</surname><given-names>JM</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Rooney</surname><given-names>TM</given-names></name><name><surname>Fox</surname><given-names>AN</given-names></name><name><surname>Adalbert</surname><given-names>R</given-names></name><name><surname>Powell</surname><given-names>EH</given-names></name><name><surname>Sheehan</surname><given-names>AE</given-names></name><name><surname>Avery</surname><given-names>MA</given-names></name><name><surname>Hackett</surname><given-names>R</given-names></name><name><surname>Logan</surname><given-names>MA</given-names></name><name><surname>MacDonald</surname><given-names>JM</given-names></name><name><surname>Ziegenfuss</surname><given-names>JS</given-names></name><name><surname>Milde</surname><given-names>S</given-names></name><name><surname>Hou</surname><given-names>Y-J</given-names></name><name><surname>Nathan</surname><given-names>C</given-names></name><name><surname>Ding</surname><given-names>A</given-names></name><name><surname>Brown</surname><given-names>RH</given-names><suffix>Jr</suffix></name><name><surname>Conforti</surname><given-names>L</given-names></name><name><surname>Coleman</surname><given-names>M</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M</given-names></name><name><surname>Züchner</surname><given-names>S</given-names></name><name><surname>Freeman</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>dSarm/Sarm1 is required for activation of an injury-induced axon death pathway</article-title><source>Science (New York, N.Y.)</source><volume>337</volume><fpage>481</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1126/science.1223899</pub-id><pub-id pub-id-type="pmid">22678360</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otmakhov</surname><given-names>N</given-names></name><name><surname>Tao-Cheng</surname><given-names>JH</given-names></name><name><surname>Carpenter</surname><given-names>S</given-names></name><name><surname>Asrican</surname><given-names>B</given-names></name><name><surname>Dosemeci</surname><given-names>A</given-names></name><name><surname>Reese</surname><given-names>TS</given-names></name><name><surname>Lisman</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Persistent accumulation of calcium/calmodulin-dependent protein kinase II in dendritic spines after induction of NMDA receptor-dependent chemical long-term potentiation</article-title><source>The Journal of Neuroscience</source><volume>24</volume><fpage>9324</fpage><lpage>9331</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2350-04.2004</pub-id><pub-id pub-id-type="pmid">15496668</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagano</surname><given-names>DJ</given-names></name><name><surname>Kingston</surname><given-names>ER</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Tissue expression pattern of PMK-2 p38 MAPK is established by the miR-58 family in <italic>C. elegans</italic></article-title><source>PLOS Genetics</source><volume>11</volume><elocation-id>e1004997</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004997</pub-id><pub-id pub-id-type="pmid">25671546</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panneerselvam</surname><given-names>P</given-names></name><name><surname>Singh</surname><given-names>LP</given-names></name><name><surname>Ho</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Ding</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Targeting of pro-apoptotic TLR adaptor SARM to mitochondria: definition of the critical region and residues in the signal sequence</article-title><source>The Biochemical Journal</source><volume>442</volume><fpage>263</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1042/BJ20111653</pub-id><pub-id pub-id-type="pmid">22145856</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>OM</given-names></name><name><surname>Lewis</surname><given-names>EA</given-names></name><name><surname>Osterloh</surname><given-names>JM</given-names></name><name><surname>Weiss</surname><given-names>A</given-names></name><name><surname>Salameh</surname><given-names>JS</given-names></name><name><surname>Metterville</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>RH</given-names></name><name><surname>Freeman</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Loss of Sarm1 does not suppress motor neuron degeneration in the SOD1G93A mouse model of amyotrophic lateral sclerosis</article-title><source>Human Molecular Genetics</source><volume>27</volume><fpage>3761</fpage><lpage>3771</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddy260</pub-id><pub-id pub-id-type="pmid">30010873</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettem</surname><given-names>KL</given-names></name><name><surname>Yokomaku</surname><given-names>D</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Linhoff</surname><given-names>MW</given-names></name><name><surname>Prasad</surname><given-names>T</given-names></name><name><surname>Connor</surname><given-names>SA</given-names></name><name><surname>Siddiqui</surname><given-names>TJ</given-names></name><name><surname>Kawabe</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Rudenko</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>YT</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Craig</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The specific α-neurexin interactor calsyntenin-3 promotes excitatory and inhibitory synapse development</article-title><source>Neuron</source><volume>80</volume><fpage>113</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.07.016</pub-id><pub-id pub-id-type="pmid">24094106</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pickrell</surname><given-names>AM</given-names></name><name><surname>Youle</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson’s disease</article-title><source>Neuron</source><volume>85</volume><fpage>257</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.12.007</pub-id><pub-id pub-id-type="pmid">25611507</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponomareva</surname><given-names>OY</given-names></name><name><surname>Holmen</surname><given-names>IC</given-names></name><name><surname>Sperry</surname><given-names>AJ</given-names></name><name><surname>Eliceiri</surname><given-names>KW</given-names></name><name><surname>Halloran</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Calsyntenin-1 regulates axon branching and endosomal trafficking during sensory neuron development in vivo</article-title><source>The Journal of Neuroscience</source><volume>34</volume><fpage>9235</fpage><lpage>9248</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0561-14.2014</pub-id><pub-id pub-id-type="pmid">25009257</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preuschhof</surname><given-names>C</given-names></name><name><surname>Heekeren</surname><given-names>HR</given-names></name><name><surname>Li</surname><given-names>S-C</given-names></name><name><surname>Sander</surname><given-names>T</given-names></name><name><surname>Lindenberger</surname><given-names>U</given-names></name><name><surname>Bäckman</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>KIBRA and CLSTN2 polymorphisms exert interactive effects on human episodic memory</article-title><source>Neuropsychologia</source><volume>48</volume><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1016/j.neuropsychologia.2009.09.031</pub-id><pub-id pub-id-type="pmid">19804789</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rawson</surname><given-names>RL</given-names></name><name><surname>Yam</surname><given-names>L</given-names></name><name><surname>Weimer</surname><given-names>RM</given-names></name><name><surname>Bend</surname><given-names>EG</given-names></name><name><surname>Hartwieg</surname><given-names>E</given-names></name><name><surname>Horvitz</surname><given-names>HR</given-names></name><name><surname>Clark</surname><given-names>SG</given-names></name><name><surname>Jorgensen</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Axons degenerate in the absence of mitochondria in <italic>C. elegans</italic></article-title><source>Current Biology</source><volume>24</volume><fpage>760</fpage><lpage>765</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2014.02.025</pub-id><pub-id pub-id-type="pmid">24631238</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiner</surname><given-names>DJ</given-names></name><name><surname>Newton</surname><given-names>EM</given-names></name><name><surname>Tian</surname><given-names>H</given-names></name><name><surname>Thomas</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Diverse behavioural defects caused by mutations in <italic>Caenorhabditis elegans</italic> unc-43 CaM kinase II</article-title><source>Nature</source><volume>402</volume><fpage>199</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1038/46072</pub-id><pub-id pub-id-type="pmid">10647014</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>SX</given-names></name><name><surname>Craig</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Heterosynaptic molecular dynamics: locally induced propagating synaptic accumulation of CaM kinase II</article-title><source>Neuron</source><volume>61</volume><fpage>351</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2008.12.030</pub-id><pub-id pub-id-type="pmid">19217373</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagasti</surname><given-names>A</given-names></name><name><surname>Hisamoto</surname><given-names>N</given-names></name><name><surname>Hyodo</surname><given-names>J</given-names></name><name><surname>Tanaka-Hino</surname><given-names>M</given-names></name><name><surname>Matsumoto</surname><given-names>K</given-names></name><name><surname>Bargmann</surname><given-names>CI</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The CaMKII UNC-43 activates the MAPKKK NSY-1 to execute a lateral signaling decision required for asymmetric olfactory neuron fates</article-title><source>Cell</source><volume>105</volume><fpage>221</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(01)00313-0</pub-id><pub-id pub-id-type="pmid">11336672</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakamoto</surname><given-names>R</given-names></name><name><surname>Byrd</surname><given-names>DT</given-names></name><name><surname>Brown</surname><given-names>HM</given-names></name><name><surname>Hisamoto</surname><given-names>N</given-names></name><name><surname>Matsumoto</surname><given-names>K</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The <italic>Caenorhabditis elegans</italic> UNC-14 RUN domain protein binds to the kinesin-1 and UNC-16 complex and regulates synaptic vesicle localization</article-title><source>Molecular Biology of the Cell</source><volume>16</volume><fpage>483</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1091/mbc.e04-07-0553</pub-id><pub-id pub-id-type="pmid">15563606</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mitochondrial trafficking in neurons</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>5</volume><elocation-id>a011304</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a011304</pub-id><pub-id pub-id-type="pmid">23732472</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>K</given-names></name><name><surname>Meyer</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Dynamic control of CaMKII translocation and localization in hippocampal neurons by NMDA receptor stimulation</article-title><source>Science (New York, N.Y.)</source><volume>284</volume><fpage>162</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1126/science.284.5411.162</pub-id><pub-id pub-id-type="pmid">10102820</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sporny</surname><given-names>M</given-names></name><name><surname>Guez-Haddad</surname><given-names>J</given-names></name><name><surname>Lebendiker</surname><given-names>M</given-names></name><name><surname>Ulisse</surname><given-names>V</given-names></name><name><surname>Volf</surname><given-names>A</given-names></name><name><surname>Mim</surname><given-names>C</given-names></name><name><surname>Isupov</surname><given-names>MN</given-names></name><name><surname>Opatowsky</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Structural Evidence for an Octameric Ring Arrangement of SARM1</article-title><source>Journal of Molecular Biology</source><volume>431</volume><fpage>3591</fpage><lpage>3605</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2019.06.030</pub-id><pub-id pub-id-type="pmid">31278906</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ster</surname><given-names>J</given-names></name><name><surname>Steuble</surname><given-names>M</given-names></name><name><surname>Orlando</surname><given-names>C</given-names></name><name><surname>Diep</surname><given-names>TM</given-names></name><name><surname>Akhmedov</surname><given-names>A</given-names></name><name><surname>Raineteau</surname><given-names>O</given-names></name><name><surname>Pernet</surname><given-names>V</given-names></name><name><surname>Sonderegger</surname><given-names>P</given-names></name><name><surname>Gerber</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Calsyntenin-1 regulates targeting of dendritic NMDA receptors and dendritic spine maturation in CA1 hippocampal pyramidal cells during postnatal development</article-title><source>The Journal of Neuroscience</source><volume>34</volume><fpage>8716</fpage><lpage>8727</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0144-14.2014</pub-id><pub-id pub-id-type="pmid">24966372</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steuble</surname><given-names>M</given-names></name><name><surname>Diep</surname><given-names>T-M</given-names></name><name><surname>Schätzle</surname><given-names>P</given-names></name><name><surname>Ludwig</surname><given-names>A</given-names></name><name><surname>Tagaya</surname><given-names>M</given-names></name><name><surname>Kunz</surname><given-names>B</given-names></name><name><surname>Sonderegger</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Calsyntenin-1 shelters APP from proteolytic processing during anterograde axonal transport</article-title><source>Biology Open</source><volume>1</volume><fpage>761</fpage><lpage>774</lpage><pub-id pub-id-type="doi">10.1242/bio.20121578</pub-id><pub-id pub-id-type="pmid">23213470</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stowers</surname><given-names>RS</given-names></name><name><surname>Megeath</surname><given-names>LJ</given-names></name><name><surname>Górska-Andrzejak</surname><given-names>J</given-names></name><name><surname>Meinertzhagen</surname><given-names>IA</given-names></name><name><surname>Schwarz</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Axonal transport of mitochondria to synapses depends on milton, a novel <italic>Drosophila</italic> protein</article-title><source>Neuron</source><volume>36</volume><fpage>1063</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(02)01094-2</pub-id><pub-id pub-id-type="pmid">12495622</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Summers</surname><given-names>DW</given-names></name><name><surname>DiAntonio</surname><given-names>A</given-names></name><name><surname>Milbrandt</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mitochondrial Dysfunction Induces Sarm1-Dependent Cell Death in Sensory Neurons</article-title><source>Journal of Neuroscience</source><volume>34</volume><fpage>9338</fpage><lpage>9350</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0877-14.2014</pub-id><pub-id pub-id-type="pmid">25009267</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Summers</surname><given-names>DW</given-names></name><name><surname>Gibson</surname><given-names>DA</given-names></name><name><surname>DiAntonio</surname><given-names>A</given-names></name><name><surname>Milbrandt</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>SARM1-specific motifs in the TIR domain enable NAD+ loss and regulate injury-induced SARM1 activation</article-title><source>PNAS</source><volume>113</volume><fpage>E6271</fpage><lpage>E6280</lpage><pub-id pub-id-type="doi">10.1073/pnas.1601506113</pub-id><pub-id pub-id-type="pmid">27671644</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Summers</surname><given-names>DW</given-names></name><name><surname>Frey</surname><given-names>E</given-names></name><name><surname>Walker</surname><given-names>LJ</given-names></name><name><surname>Milbrandt</surname><given-names>J</given-names></name><name><surname>DiAntonio</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>DLK Activation Synergizes with Mitochondrial Dysfunction to Downregulate Axon Survival Factors and Promote SARM1-Dependent Axon Degeneration</article-title><source>Molecular Neurobiology</source><volume>57</volume><fpage>1146</fpage><lpage>1158</lpage><pub-id pub-id-type="doi">10.1007/s12035-019-01796-2</pub-id><pub-id pub-id-type="pmid">31696428</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sure</surname><given-names>GR</given-names></name><name><surname>Chatterjee</surname><given-names>A</given-names></name><name><surname>Mishra</surname><given-names>N</given-names></name><name><surname>Sabharwal</surname><given-names>V</given-names></name><name><surname>Devireddy</surname><given-names>S</given-names></name><name><surname>Awasthi</surname><given-names>A</given-names></name><name><surname>Mohan</surname><given-names>S</given-names></name><name><surname>Koushika</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>UNC-16/JIP3 and UNC-76/FEZ1 limit the density of mitochondria in <italic>C. elegans</italic> neurons by maintaining the balance of anterograde and retrograde mitochondrial transport</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>8938</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-27211-9</pub-id><pub-id pub-id-type="pmid">29895958</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takei</surname><given-names>N</given-names></name><name><surname>Sobu</surname><given-names>Y</given-names></name><name><surname>Kimura</surname><given-names>A</given-names></name><name><surname>Urano</surname><given-names>S</given-names></name><name><surname>Piao</surname><given-names>Y</given-names></name><name><surname>Araki</surname><given-names>Y</given-names></name><name><surname>Taru</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Hata</surname><given-names>S</given-names></name><name><surname>Nakaya</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cytoplasmic fragment of Alcadein α generated by regulated intramembrane proteolysis enhances amyloid β-protein precursor (APP) transport into the late secretory pathway and facilitates APP cleavage</article-title><source>The Journal of Biological Chemistry</source><volume>290</volume><fpage>987</fpage><lpage>995</lpage><pub-id pub-id-type="doi">10.1074/jbc.M114.599852</pub-id><pub-id pub-id-type="pmid">25406318</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>SR</given-names></name><name><surname>Santpere</surname><given-names>G</given-names></name><name><surname>Weinreb</surname><given-names>A</given-names></name><name><surname>Barrett</surname><given-names>A</given-names></name><name><surname>Reilly</surname><given-names>MB</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Varol</surname><given-names>E</given-names></name><name><surname>Oikonomou</surname><given-names>P</given-names></name><name><surname>Glenwinkel</surname><given-names>L</given-names></name><name><surname>McWhirter</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Molecular Topography of an Entire Nervous System</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.12.15.422897</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thapliyal</surname><given-names>S</given-names></name><name><surname>Vasudevan</surname><given-names>A</given-names></name><name><surname>Dong</surname><given-names>Y</given-names></name><name><surname>Bai</surname><given-names>J</given-names></name><name><surname>Koushika</surname><given-names>SP</given-names></name><name><surname>Babu</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The C-terminal of CASY-1/Calsyntenin regulates GABAergic synaptic transmission at the <italic>Caenorhabditis elegans</italic> neuromuscular junction</article-title><source>PLOS Genetics</source><volume>14</volume><elocation-id>e1007263</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007263</pub-id><pub-id pub-id-type="pmid">29529030</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomita</surname><given-names>S</given-names></name><name><surname>Ozaki</surname><given-names>T</given-names></name><name><surname>Taru</surname><given-names>H</given-names></name><name><surname>Oguchi</surname><given-names>S</given-names></name><name><surname>Takeda</surname><given-names>S</given-names></name><name><surname>Yagi</surname><given-names>Y</given-names></name><name><surname>Sakiyama</surname><given-names>S</given-names></name><name><surname>Kirino</surname><given-names>Y</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Interaction of a neuron-specific protein containing PDZ domains with Alzheimer’s amyloid precursor protein</article-title><source>The Journal of Biological Chemistry</source><volume>274</volume><fpage>2243</fpage><lpage>2254</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.4.2243</pub-id><pub-id pub-id-type="pmid">9890987</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turkiew</surname><given-names>E</given-names></name><name><surname>Falconer</surname><given-names>D</given-names></name><name><surname>Reed</surname><given-names>N</given-names></name><name><surname>Höke</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Deletion of Sarm1 gene is neuroprotective in two models of peripheral neuropathy</article-title><source>Journal of the Peripheral Nervous System</source><volume>22</volume><fpage>162</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1111/jns.12219</pub-id><pub-id pub-id-type="pmid">28485482</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uchida</surname><given-names>Y</given-names></name><name><surname>Gomi</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The role of calsyntenin-3 in dystrophic neurite formation in Alzheimer’s disease brain</article-title><source>Geriatrics &amp; Gerontology International</source><volume>16</volume><fpage>43</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1111/ggi.12737</pub-id><pub-id pub-id-type="pmid">27018282</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umemura</surname><given-names>T</given-names></name><name><surname>Rapp</surname><given-names>P</given-names></name><name><surname>Rongo</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The role of regulatory domain interactions in UNC-43 CaMKII localization and trafficking</article-title><source>Journal of Cell Science</source><volume>118</volume><fpage>3327</fpage><lpage>3338</lpage><pub-id pub-id-type="doi">10.1242/jcs.02457</pub-id><pub-id pub-id-type="pmid">16079277</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vagnoni</surname><given-names>A</given-names></name><name><surname>Perkinton</surname><given-names>MS</given-names></name><name><surname>Gray</surname><given-names>EH</given-names></name><name><surname>Francis</surname><given-names>PT</given-names></name><name><surname>Noble</surname><given-names>W</given-names></name><name><surname>Miller</surname><given-names>CCJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Calsyntenin-1 mediates axonal transport of the amyloid precursor protein and regulates A production</article-title><source>Human Molecular Genetics</source><volume>21</volume><fpage>2845</fpage><lpage>2854</lpage><pub-id pub-id-type="doi">10.1093/hmg/dds109</pub-id><pub-id pub-id-type="pmid">22434822</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vérièpe</surname><given-names>J</given-names></name><name><surname>Fossouo</surname><given-names>L</given-names></name><name><surname>Parker</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Neurodegeneration in <italic>C. elegans</italic> models of ALS requires TIR-1/Sarm1 immune pathway activation in neurons</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>7319</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms8319</pub-id><pub-id pub-id-type="pmid">26059317</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogt</surname><given-names>L</given-names></name><name><surname>Schrimpf</surname><given-names>SP</given-names></name><name><surname>Meskenaite</surname><given-names>V</given-names></name><name><surname>Frischknecht</surname><given-names>R</given-names></name><name><surname>Kinter</surname><given-names>J</given-names></name><name><surname>Leone</surname><given-names>DP</given-names></name><name><surname>Ziegler</surname><given-names>U</given-names></name><name><surname>Sonderegger</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Calsyntenin-1, a proteolytically processed postsynaptic membrane protein with a cytoplasmic calcium-binding domain</article-title><source>Molecular and Cellular Neurosciences</source><volume>17</volume><fpage>151</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1006/mcne.2000.0937</pub-id><pub-id pub-id-type="pmid">11161476</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>LJ</given-names></name><name><surname>Summers</surname><given-names>DW</given-names></name><name><surname>Sasaki</surname><given-names>Y</given-names></name><name><surname>Brace</surname><given-names>EJ</given-names></name><name><surname>Milbrandt</surname><given-names>J</given-names></name><name><surname>DiAntonio</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>MAPK signaling promotes axonal degeneration by speeding the turnover of the axonal maintenance factor NMNAT2</article-title><source>eLife</source><volume>6</volume><elocation-id>e22540</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.22540</pub-id><pub-id pub-id-type="pmid">28095293</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waterhouse</surname><given-names>AM</given-names></name><name><surname>Procter</surname><given-names>JB</given-names></name><name><surname>Martin</surname><given-names>DMA</given-names></name><name><surname>Clamp</surname><given-names>M</given-names></name><name><surname>Barton</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Jalview Version 2--a multiple sequence alignment editor and analysis workbench</article-title><source>Bioinformatics (Oxford, England)</source><volume>25</volume><fpage>1189</fpage><lpage>1191</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp033</pub-id><pub-id pub-id-type="pmid">19151095</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>West</surname><given-names>AE</given-names></name><name><surname>Chen</surname><given-names>WG</given-names></name><name><surname>Dalva</surname><given-names>MB</given-names></name><name><surname>Dolmetsch</surname><given-names>RE</given-names></name><name><surname>Kornhauser</surname><given-names>JM</given-names></name><name><surname>Shaywitz</surname><given-names>AJ</given-names></name><name><surname>Takasu</surname><given-names>MA</given-names></name><name><surname>Tao</surname><given-names>X</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Calcium regulation of neuronal gene expression</article-title><source>PNAS</source><volume>98</volume><fpage>11024</fpage><lpage>11031</lpage><pub-id pub-id-type="doi">10.1073/pnas.191352298</pub-id><pub-id pub-id-type="pmid">11572963</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolums</surname><given-names>BM</given-names></name><name><surname>McCray</surname><given-names>BA</given-names></name><name><surname>Sung</surname><given-names>H</given-names></name><name><surname>Tabuchi</surname><given-names>M</given-names></name><name><surname>Sullivan</surname><given-names>JM</given-names></name><name><surname>Ruppell</surname><given-names>KT</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Mamah</surname><given-names>C</given-names></name><name><surname>Aisenberg</surname><given-names>WH</given-names></name><name><surname>Saavedra-Rivera</surname><given-names>PC</given-names></name><name><surname>Larin</surname><given-names>BS</given-names></name><name><surname>Lau</surname><given-names>AR</given-names></name><name><surname>Robinson</surname><given-names>DN</given-names></name><name><surname>Xiang</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>MN</given-names></name><name><surname>Sumner</surname><given-names>CJ</given-names></name><name><surname>Lloyd</surname><given-names>TE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>TRPV4 disrupts mitochondrial transport and causes axonal degeneration via a CaMKII-dependent elevation of intracellular Ca2</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>2679</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-16411-5</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Chisholm</surname><given-names>AD</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The DLK-1 kinase promotes mRNA stability and local translation in <italic>C. elegans</italic> synapses and axon regeneration</article-title><source>Cell</source><volume>138</volume><fpage>1005</fpage><lpage>1018</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.06.023</pub-id><pub-id pub-id-type="pmid">19737525</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>E</given-names></name><name><surname>Schulman</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Structural examination of autoregulation of multifunctional calcium/calmodulin-dependent protein kinase II</article-title><source>The Journal of Biological Chemistry</source><volume>274</volume><fpage>26199</fpage><lpage>26208</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.37.26199</pub-id><pub-id pub-id-type="pmid">10473573</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Renier</surname><given-names>N</given-names></name><name><surname>Simon</surname><given-names>DJ</given-names></name><name><surname>Uryu</surname><given-names>K</given-names></name><name><surname>Park</surname><given-names>DS</given-names></name><name><surname>Greer</surname><given-names>PA</given-names></name><name><surname>Tournier</surname><given-names>C</given-names></name><name><surname>Davis</surname><given-names>RJ</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Pathological axonal death through a MAPK cascade that triggers a local energy deficit</article-title><source>Cell</source><volume>160</volume><fpage>161</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.11.053</pub-id><pub-id pub-id-type="pmid">25594179</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zalcman</surname><given-names>G</given-names></name><name><surname>Federman</surname><given-names>N</given-names></name><name><surname>Romano</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>CaMKII Isoforms in Learning and Memory: Localization and Function</article-title><source>Frontiers in Molecular Neuroscience</source><volume>11</volume><elocation-id>445</elocation-id><pub-id pub-id-type="doi">10.3389/fnmol.2018.00445</pub-id><pub-id pub-id-type="pmid">30564099</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>X</given-names></name><name><surname>Ye</surname><given-names>M</given-names></name><name><surname>Resch</surname><given-names>JM</given-names></name><name><surname>Jedrychowski</surname><given-names>MP</given-names></name><name><surname>Hu</surname><given-names>B</given-names></name><name><surname>Lowell</surname><given-names>BB</given-names></name><name><surname>Ginty</surname><given-names>DD</given-names></name><name><surname>Spiegelman</surname><given-names>BM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Innervation of thermogenic adipose tissue via a calsyntenin 3β-S100b axis</article-title><source>Nature</source><volume>569</volume><fpage>229</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1156-9</pub-id><pub-id pub-id-type="pmid">31043739</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Hsieh</surname><given-names>CH</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Feng</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Shen</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Metaxins are core components of mitochondrial transport adaptor complexes</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>83</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-20346-2</pub-id><pub-id pub-id-type="pmid">33397950</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Züchner</surname><given-names>S</given-names></name><name><surname>Mersiyanova</surname><given-names>IV</given-names></name><name><surname>Muglia</surname><given-names>M</given-names></name><name><surname>Bissar-Tadmouri</surname><given-names>N</given-names></name><name><surname>Rochelle</surname><given-names>J</given-names></name><name><surname>Dadali</surname><given-names>EL</given-names></name><name><surname>Zappia</surname><given-names>M</given-names></name><name><surname>Nelis</surname><given-names>E</given-names></name><name><surname>Patitucci</surname><given-names>A</given-names></name><name><surname>Senderek</surname><given-names>J</given-names></name><name><surname>Parman</surname><given-names>Y</given-names></name><name><surname>Evgrafov</surname><given-names>O</given-names></name><name><surname>Jonghe</surname><given-names>PD</given-names></name><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Tsuji</surname><given-names>S</given-names></name><name><surname>Pericak-Vance</surname><given-names>MA</given-names></name><name><surname>Quattrone</surname><given-names>A</given-names></name><name><surname>Battaloglu</surname><given-names>E</given-names></name><name><surname>Polyakov</surname><given-names>AV</given-names></name><name><surname>Timmerman</surname><given-names>V</given-names></name><name><surname>Schröder</surname><given-names>JM</given-names></name><name><surname>Vance</surname><given-names>JM</given-names></name><name><surname>Battologlu</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A</article-title><source>Nature Genetics</source><volume>36</volume><fpage>449</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1038/ng1341</pub-id><pub-id pub-id-type="pmid">15064763</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zündorf</surname><given-names>G</given-names></name><name><surname>Reiser</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection</article-title><source>Antioxidants &amp; Redox Signaling</source><volume>14</volume><fpage>1275</fpage><lpage>1288</lpage><pub-id pub-id-type="doi">10.1089/ars.2010.3359</pub-id><pub-id pub-id-type="pmid">20615073</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.73557.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Shen</surname><given-names>Kang</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Howard Hughes Medical Institute, Stanford University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>This work reports exciting findings that show that activation of CaMKII downstream of the L-type Ca channel protects axons from RIC-7-induced axon degeneration. The authors also report the surprising result that the worm SARM, TIR-1 together with NSY-1 and SEK-1, mediates this protection effect.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.73557.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Shen</surname><given-names>Kang</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Howard Hughes Medical Institute, Stanford University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Shen</surname><given-names>Kang</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Howard Hughes Medical Institute, Stanford University</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Freeman</surname><given-names>Marc</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/009avj582</institution-id><institution>Oregon Health and Science University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Activation of the CaMKII-Sarm1-ASK1 MAP kinase pathway protects against axon degeneration caused by loss of mitochondria&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including Kang Shen as Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Piali Sengupta as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Marc Freeman (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission. All reviewers agreed that this is a thorough genetic analyses of the mechanisms of a specific type of axonal degeneration induced by mitochondria defects. We all think that the results about the SARM/tir-1's potential protective function is unexpected and can be potentially interesting. The reviewers did raise a number technical questions as below. However, the only essential revision is to revise the text and abstract to make sure that you do not overstate the conclusions. Please make it clear that the mechanisms apply to this specific form of axon degeneration.</p><p>Essential revisions:</p><p>1) Please follow reviewer 3's suggestion to revise text.</p><p>2) Please consider using the suggestions made by all three reviewers in preparing your revised manuscript.</p><p><italic>Reviewer #1:</italic></p><p>Chen and colleagues made full advantage of the power of genetic to uncover novel pathways in axon degeneration and protection. They started with the ric-7 mutant which showed strong lack of mitochondria in <italic>C. elegans</italic> axons. They previously showed that ric-7 causes axonal degeneration. Using forward genetic screens, the discovered that mutations in CaMKII or casy-1 protects the axons from degenerating. Through extensive genetic analyses, they showed that the activation of CaMKII downstream of the L-type Ca channel protect axon from ric-7 induced axon degeneration. Surprisingly, the worm SARM, TIR-1 together with NSY-1 and SEK-1 mediates this protection effect. This is unexpected because SARM has been shown in both flies and mammals to promote axon degeneration.</p><p>The genetics experiments are of high quality. The suppression or desuppression phenotypes are very dramatic. The authors have also extensively used endogenously label proteins to study their localization, which avoid the commonly encountered overexpression problems. Overall, this is an exciting manuscript and deserves to be published in <italic>eLife</italic>.</p><p>Of course, because of the number of molecules involved in this pathway, there will be new things to be learned in the future. Much of my technical comments include some of the directions that I believe will be interesting. I don't see these comments as necessary to be addressed for this current manuscript except point No.1 and 2.</p><p>1. To what extent, does miro-1 miro-2 double mutant still have axonal mitochondria in PVQ axon? This will help us to understand to what extent mitochondria have to be lost in order to trigger axonal degeneration.</p><p>2. Since there are many phenotypes in kinesin 1 or klc-2 mutants, the changes of casy-1 distribution in the klc-2 is not the strongest argument for direct transport of casy-1 by kinesin motor complex. The conclusions should reflect this possibility. It would be interesting to look at casy-1 trafficking in the klc-2 mutant. I feel that &quot;demonstrate that <italic>C. elegans</italic> calsyntenin is anterogradely trafficked by kinesin, line 31&quot; is too strong.</p><p>3. Is there an explanation for why the trafficking parameters of casy-1 is altered in the ric-7 mutant?</p><p>4. How does LIN-10 affect ca<sup>2+</sup> channel localization? LIN-10, LIN-2 and LIN-7 forms a complex to localize EGF receptors. Are LIN-2 and LIN-7 involved in degeneration protection.</p><p>5. How does mitochondria distribution defect alter the Ca dynamics in the axon?</p><p><italic>Reviewer #2:</italic></p><p>7 years ago, the fact the suppressing the ability of mitochondria to traffic down axons leads to increased &quot;fragility&quot; and tendency to degenerate was established. The work presented here sought to understand why loss of mitochondria would do this. The authors used classical suppressor genetic screening to identify molecular elements necessary for this induced fragile state. The screen worked: the authors found several important new pieces of information building strong evidence for an &quot;anti-degenerative&quot; pathway. The findings are novel, robust and unexpected and they have identified several linked pieces. Given the interest in general in understanding the pathways of axon-degeneration, this view of 'anti-degeneration&quot; will likely be impactful on the field.</p><p>This is therefore an interesting and important paper. It describes many new facets of axon degeneration with the remarkable observation that Sarm can be prodegenerative when mitochondria are not present, and important and surprising twist. The story is nicely complimented by the connection to the CASY mutation, through likely activation of egl19 leading to activation of CamKII (unc43).</p><p>I have very few quibbles with this work</p><p>1) I think the authors should be more cautious in how they interpret the issue of unc-43 localization. All enzymes need to be localized to find their substrates. The fact that ric-7 leads to a restriction of un-43 to the cell body is interesting but the fact that moving some of it to the distal axon did not rescue the degeneration I don't think speaks very deeply to whether localization matters. The fact is we don't know where un-43 needs to be, and that forcing WT un-43 to the end of the axon does not rescue things is more or less a failed experiment. A more interesting experiment would be to see how specific localizations of WT versus active unc-43 impacts degeneration.</p><p>2) Related to the point above: perhaps having too much WT unc-43 in the cell body is the real problem and the active mutant simply does a better job of leaving the cell body.</p><p>The issues above serve as examples of why caution should be exercised in interpreting the localization experiments.</p><p>3) The EGL19 link is a potentially satisfying way to link up the unc43 hit with the CASY hit. A compelling experiment would be to use crisper/Cas9 to modify the channel conductance so that it could no longer serve as the potential source of Ca to activate unc43.</p><p><italic>Reviewer #3:</italic></p><p>The authors sought to understand how loss of ric-7, and in turn mitochondria from axons, leads to axon degeneration. In a forward genetic screen they identify CamkII and Casy, which led to their genetic analysis of CamkII/tir-1/NSY1 and cay/mint/kin in axon degeneration. The genetic analyses are excellent, clear and well done. Loss of either of these pathway appears to suppress ric-7-induced axon degeneration. In general, the authors claims are supported by their data, although I think they need to take care in extending their claims to other systems (see below). The potential impact of the work on the field is not entirely clear to me. The major surprise would be that tir-1 (SARM1 in mammals) plays a protective role in axon degeneration, which runs counter to all existing data. Curiously, worm tir-1 seems to lack the NADase activity required for axon degeneration in other systems (Horsefield et al., 2019, Science). In addition, to my knowledge there is no demonstrated role for tir-1 in axon degeneration in the worm, despite axons degenerating after axotomy. Is this signaling different in this system? As a model organism biologist i hesitate to say that, but in this case it is probably true. (It is also true that ric-7 does not seem to be present in flies, zebrafish or mice. So it is hard to glean additional information from the literature on it's role in other places.)</p><p>More generally, while the authors claim loss of mitochondria is what is driving axon degeneration in ric-7, it could also be many other (perhaps totally unrelated factors) that are inducing axon degeneration. They very strongly assert this is because mitochondria are gone, which may be true, but could be wrong.</p><p>Even if correct, what if tir-1/Sarm1 need mitochondria to drive axon degeneration, but in the context of mitochondrial loss, they are unable to execute degeneration? That would not be a protective role, it would be a mitochondrially-dependent pro-degenerative requirement. This has not been tested, they are relying solely on ric-7 mutations.</p><p>I don't have much to add. My main concerns would be on potential impact. I am not convinced yet that this applies to signaling in mammals, which would be the thrust of the novelty – that in some cases SARM1 is pro-survival. Whether or not that reduces impact to the point where <italic>eLife</italic> would not be interested, I don't know. It is a very nice study, but I'm just not sure how to think about the result.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.73557.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>[…]</p><p>Of course, because of the number of molecules involved in this pathway, there will be new things to be learned in the future. Much of my technical comments include some of the directions that I believe will be interesting. I don't see these comments as necessary to be addressed for this current manuscript except point No.1 and 2.</p><p>1. To what extent, does miro-1 miro-2 double mutant still have axonal mitochondria in PVQ axon? This will help us to understand to what extent mitochondria have to be lost in order to trigger axonal degeneration.</p></disp-quote><p>We labeled mitochondria in <italic>miro-1(tm1966); miro-2(tm2933)</italic> and <italic>miro-1(wy50180); mtx2(wy50266)</italic> double mutants and quantified mitochondria density in axons. We found that in <italic>miro-1(wy50180); mtx-2(wy50266)</italic> animals, mitochondria are completely absent from axons (Figure 1—figure supplement 1B) and axons degenerate (Figure 1—figure supplement 1A). In <italic>miro1(tm1966); miro-2(tm2933)</italic> animals, there is a slight trend of fewer axonal mitochondria but the density is not significantly reduced compared to the control (Figure 1—figure supplement 1B), which is similar to the previous findings in touch receptor neurons (Sure et al., 2018). Therefore, the results are not sufficient to address to what extent mitochondria have to be lost in order to trigger axonal degeneration. Nonetheless, according to the previous paper ((Rawson et al., 2014), see Figure 4A-4C), it seems that one single mitochondrion can provide substantial protection against axon degeneration after injury.</p><p>We also added new data showing that the suppressors, namely the active <italic>unc-43</italic> mutation and <italic>casy-1</italic> KO, also suppress degeneration in <italic>miro-1; mtx-2</italic> animals, indicating that these suppressors are not specific to the <italic>ric-7</italic> model (We included this new data in Figure 1—figure supplement 3 and updated the text).</p><disp-quote content-type="editor-comment"><p>2. Since there are many phenotypes in kinesin 1 or klc-2 mutants, the changes of casy-1 distribution in the klc-2 is not the strongest argument for direct transport of casy-1 by kinesin motor complex. The conclusions should reflect this possibility. It would be interesting to look at casy-1 trafficking in the klc-2 mutant. I feel that &quot;demonstrate that C. elegans calsyntenin is anterogradely trafficked by kinesin, line 31&quot; is too strong.</p></disp-quote><p>We thank the reviewer for this critique. All the trafficking experiments were done with overexpression, and consistent with the endogenous data in Figure 4D, overexpressed CASY-1C in <italic>klc-2</italic> mutants also accumulate strongly in PVQ cell bodies (See <xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>). As a consequence, CASY-1C abundance in PVQ axons are much lower compared to WT controls. The weak signals in axons make it very difficult for trafficking analyses. Therefore, we did not directly compare trafficking between control and <italic>klc-2</italic> mutants, we have revised the section titled “Anterograde traffic of Calsyntenin/CASY-1 by kinesin promotes axon degeneration” in results and the section titled “A calsyntenin/Mint/kinesin complex controls CaMKII activity and degeneration” in discussion to make sure we don’t overstate the conclusion. Nevertheless, we would like to highlight that there is a rich body of literature suggesting that calsyntenin is transported by the kinesin motor. First, the direct interaction between mouse calsyntenin and KLC-1(the mouse homolog of the worm KLC-2) was confirmed using in vitro binding assays of purified proteins (Araki et al., 2007; Konecna et al., 2006). Second, the anterograde trafficking of calsyntenin vesicles is reduced when KLC-1 is knocked down in cultured mouse neurons (Araki et al., 2007). Moreover, the two tryptophan (W) residues in the two kinesin-binding sites that are essential for KLC binding are conserved in <italic>C. elegans</italic> CASY-1. Importantly, the interaction between <italic>C. elegans</italic> CASY-1 and KLC-2 requires the two tryptophan residues (Ohno et al., 2014). In our study, we found that the casy-1 WW/AA mutant transgene no longer promotes degeneration, presumably because it can no longer bind KLC-2 (Figure 4A). Similarly, degeneration is suppressed in the <italic>klc-2</italic> mutant (Figure 4B). Therefore, our data is consistent with the model that CASY-1 binds to KLC and is transported by kinesin motors.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><caption><title>Overexpressed CASY-1C accumulates on punctated structures in PVQ cell bodies and is at very low level in axons in <italic>klc-2(km11)</italic> mutants.</title><p>Same imaging conditions and contrasts. Scale bar = 10 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73557-sa2-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>3. Is there an explanation for why the trafficking parameters of casy-1 is altered in the ric-7 mutant?</p></disp-quote><p>We are also very intrigued by this observation, but we are not sure what the cause is. It may be related to the lack of mitochondria and thus reduced ATP production.</p><disp-quote content-type="editor-comment"><p>4. How does LIN-10 affect ca<sup>2+</sup> channel localization? LIN-10, LIN-2 and LIN-7 forms a complex to localize EGF receptors. Are LIN-2 and LIN-7 involved in degeneration protection.</p></disp-quote><p>We thank the reviewer for these suggestions.</p><p>For the LIN-2/7/10 complex: We tested the <italic>lin-2 lof</italic> allele <italic>e1309</italic> and it does not suppress PVQ axon degeneration in <italic>ric-7(n2657)</italic>. Therefore, we do not think the LIN-2/7/10 complex (or EGF receptors) are involved. We included this new data in Figure 5—figure supplement 2 and updated the texts. There is substantial published data indicating that LIN-10 has functions independent of this complex (Glodowski et al., 2005; Rongo et al., 1998).</p><p>For how loss of lin-10 affects calcium channel localization: This is a great question, but the bottom line is that we were not able to get results that we are very confident in. We labeled endogenous EGL-19 with the split-GFP approach and visualized it in PVQ. However, the endogenous EGL-19 signals were very weak and we had to use high laser intensity, high exposure and binning, which increased the background and reduced the resolution. <xref ref-type="fig" rid="sa2fig2">Author response image 2</xref> is our best examples with decent EGL-19 signals. In the PVQ cell body, there seem to be more accumulated EGL-19 puncta in <italic>lin-10 (n1853)</italic> mutants. However, we do not know where exactly this EGL-19 is located, e.g. cell membrane vs some kind of endosomes or golgi-derived vesicles. In the distal axon, EGL-19 signals are very weak and are often barely detectable. Similar to controls, we did observe EGL-19 puncta in <italic>lin-10</italic> mutants, but we were unable to make a satisfactory quantitation. Further, because the head neurons are co-labelled by the sra-6 promoter, we lose single axon resolution of PVQ after it enters the nerve ring-which is presumably the synapse and calcium channel-dense region. Thus, we do not have a definitive answer of how LIN-10 affects VGCC localization in either the cell body or the distal axon, although if pushed we would favor an effect in the cell body. Further optimization of the labeling method and an expanded investigation of VGCC components will be helpful in the future to address this question. Nonetheless, in light of the role of LIN-10 in sorting and recycling of membrane receptors (Gauthier and Rocheleau, 2021; Glodowski et al., 2005; Rongo et al., 1998; Zhang et al., 2012), we think the idea that CASY-1/LIN-10 regulates VGCC localization is an interesting possibility and discussed how it may regulate the CaMKII activity in the manuscript (See the section titled L-type calcium channels link the calsyntenin/Mint/KLC-2 trafficking complex to CaMKII activity and axon protection in Discussion)</p><fig id="sa2fig2" position="float"><label>Author response image 2.</label><caption><title>Endogenous EGL-19 in PVQ is visualized by the NATF approach.</title><p>For the distal axon, the z projections are focused either on the axon before it joins the nerve ring or the nerve ring itself. White lines indicate the distal part of the PVQ axon or the axon bundles in the nerve ring. Asterisks indicate head neurons. Scale bar = 10 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73557-sa2-fig2-v1.tif"/></fig><p>In addition, although we could not resolve the question of EGL-19 localization, we do include new data showing that the p38 MAPK PMK-3 and the transcription factor CEBP-1 function downstream of the CaMKII-MAPK pathway to protect against axon degeneration (Figure 2G, Figure 5E and Figure 5F). Since CEBP-1 is a transcription factor, it likely acts in the nucleus to suppress degeneration. We updated the cartoon in Figure 6F to reflect this and revised the title, abstract and text accordingly.</p><disp-quote content-type="editor-comment"><p>5. How does mitochondria distribution defect alter the Ca dynamics in the axon?</p></disp-quote><p>We thank the reviewer for this comment. In a pilot experiment, we tried to measure steady-state calcium levels in PVQ axons using GCaMP signals normalized to a chemical dye. However, we did not have conclusive results due to variation and background noise from surrounding tissues. We have not examined short-term calcium dynamics, i.e. in response to stimulation. Therefore, we do not currently have good evidence for how mitochondria affect Ca dynamics in axons. But we agree this is very interesting future direction.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>[…]</p><p>I have very few quibbles with this work</p><p>1) I think the authors should be more cautious in how they interpret the issue of unc-43 localization. All enzymes need to be localized to find their substrates. The fact that ric-7 leads to a restriction of un-43 to the cell body is interesting but the fact that moving some of it to the distal axon did not rescue the degeneration I don't think speaks very deeply to whether localization matters. The fact is we don't know where un-43 needs to be, and that forcing WT un-43 to the end of the axon does not rescue things is more or less a failed experiment. A more interesting experiment would be to see how specific localizations of WT versus active unc-43 impacts degeneration.</p></disp-quote><p>We thank the reviewer for the constructive critique. We agree that the relocalization experiment is not definitive enough. We decided to take it out of the manuscript and no longer make the conclusion that activity matters more than localization. We think that in order to conclude whether localization matters and where CaMKII functions, it requires us to localize WT/active CaMKII into different compartments with high accuracy, e.g. to the soma exclusively or axon exclusively. For example, restricting all WT CaMKII to the soma and test if degeneration can be induced in WT controls will tell us whether it is the loss of CaMKII in the distal axon that causes degeneration. Similarly, restricting constitutively-active CaMKII to the soma and testing if degeneration can be suppressed in <italic>ric-7</italic> will tell us whether active CaMKII can suppress degeneration even if it is away from the degeneration site. However, we do not know a very good tool to achieve this compartmentalization. Even if there is such a tool, it will still face the uncertainty of finding and binding CaMKII substrates. Therefore, we decided not to pursue this route.</p><disp-quote content-type="editor-comment"><p>2) Related to the point above: perhaps having too much WT unc-43 in the cell body is the real problem and the active mutant simply does a better job of leaving the cell body.</p><p>The issues above serve as examples of why caution should be exercised in interpreting the localization experiments.</p></disp-quote><p>We agree that caution should be taken and the relocalization experiment has been taken out. Nevertheless, we do not think having too much WT UNC-43 in the soma specifically causes degeneration. First, we did not observe increased UNC-43 levels in <italic>ric-7</italic> animals (Figure 2D-2E). Second, the relocalization experiment, though not definitive, does suggest that simply removing UNC-43 from the soma does not suppress degeneration.</p><disp-quote content-type="editor-comment"><p>3) The EGL19 link is a potentially satisfying way to link up the unc43 hit with the CASY hit. A compelling experiment would be to use crisper/Cas9 to modify the channel conductance so that it could no longer serve as the potential source of Ca to activate unc43.</p></disp-quote><p>We thank the reviewer for the suggestion. The <italic>egl-19 n582</italic> allele that we used in the study is a reduction of function mutation in the voltage-sensing S4 segment of the channel. It has been shown to reduce calcium conductance in <italic>C. elegans</italic> (Jospin et al., 2002). Specifically, this mutation causes slower activation kinetics of the channel, smaller ca<sup>2+</sup> entry and increased threshold for ca<sup>2+</sup> transients. We have not used CRISPR/Cas9 to make more mutations in the channel pore to modify channel conductance as it would presumably require techniques such as electrophysiology to confirm that they work. We think our genetic epistasis data supports the model that ca<sup>2+</sup> entry through EGL-19 activates UNC-43.</p><disp-quote content-type="editor-comment"><p>Reviewer #3:</p><p>The authors sought to understand how loss of ric-7, and in turn mitochondria from axons, leads to axon degeneration. In a forward genetic screen they identify CamkII and Casy, which led to their genetic analysis of CamkII/tir-1/NSY1 and cay/mint/kin in axon degeneration. The genetic analyses are excellent, clear and well done. Loss of either of these pathway appears to suppress ric-7-induced axon degeneration. In general, the authors claims are supported by their data, although I think they need to take care in extending their claims to other systems (see below). The potential impact of the work on the field is not entirely clear to me. The major surprise would be that tir-1 (SARM1 in mammals) plays a protective role in axon degeneration, which runs counter to all existing data. Curiously, worm tir-1 seems to lack the NADase activity required for axon degeneration in other systems (Horsefield et al., 2019, Science). In addition, to my knowledge there is no demonstrated role for tir-1 in axon degeneration in the worm, despite axons degenerating after axotomy. Is this signaling different in this system? As a model organism biologist i hesitate to say that, but in this case it is probably true. (It is also true that ric-7 does not seem to be present in flies, zebrafish or mice. So it is hard to glean additional information from the literature on it's role in other places.)</p><p>More generally, while the authors claim loss of mitochondria is what is driving axon degeneration in ric-7, it could also be many other (perhaps totally unrelated factors) that are inducing axon degeneration. They very strongly assert this is because mitochondria are gone, which may be true, but could be wrong.</p><p>Even if correct, what if tir-1/Sarm1 need mitochondria to drive axon degeneration, but in the context of mitochondrial loss, they are unable to execute degeneration? That would not be a protective role, it would be a mitochondrially-dependent pro-degenerative requirement. This has not been tested, they are relying solely on ric-7 mutations.</p></disp-quote><p>We thank the reviewer for the insightful discussion and comments.</p><p>We made sure we have a concise review of the domains and functions of fly, mammalian Sarm1 and <italic>C. elegans</italic> TIR-1 in the Discussion section under the title “The surprising neuroprotective role of the Sarm1/TIR-1-ASK1/NSY-1 MAPK pathway” where we also discussed their similarities and differences. It is worth noting that worm TIR-1 does seem to have some NADase activity although it requires both the SAM domain and the TIR domain and has a lower activity than the human or the fly counterparts (Horsefield et al., 2019). Furthermore, induced dimerization of worm TIR-1 does lead to cell death and consumption of NAD<sup>+</sup>, which again is less efficient than the human counterpart (Summers et al., 2016). Despite its NADase activity, we also reviewed several lines of evidence in the discussion which suggest that the NADase activity of CeTIR-1 is not an essential factor to trigger degeneration in worms. Consistent with this hypothesis, we overexpressed worm NMNATs in <italic>ric-7</italic> animals and found that they do not suppress degeneration (We included this new data in Figure 2—figure supplement 2 and updated the text). This does raise the possibility that the CeTIR-1 is involved in different or additional signaling pathways. We revised this part of the discussion to better reflect the above points.</p><p>Nevertheless, we do want to highlight that all the other genes that we identified such as CaMKII and the MAPK pathway are also highly conserved and that we are examining their role in this specific degeneration model induced by the loss of mitochondria. It is possible that CeTIR-1 is versatile, and in this context exhibits a protective role through the CaMKII-MAPK branch of the signaling pathway. Our new data show that the p38 MAPK PMK-3 and the transcription factor CEBP-1 mediate the protection downstream of TIR-1, which is different from what Sarm1 does (NAD<sup>+</sup> consumption) in axons. Moreover, a recent exciting paper demonstrated that active CaMKII protects against cell death in retinal ganglion cells in a variety of degeneration models in mice (Guo et al., 2021). Therefore, we agree that discrepancies exit and modified the discussion to call for more caution in extending the results, but we also think our findings will be helpful to the field.</p><p>In terms of the driving force of axon degeneration in <italic>ric-7</italic> mutants, we have a couple of experiments demonstrating that it is the loss of mitochondria. First, we observed no axonal mitochondria in <italic>ric-7</italic> as the reviewer has mentioned. Second, we examined other mitochondria trafficking mutants including <italic>unc-116</italic> and <italic>miro-1; mtx-2</italic> animals in which mitochondria are also absent and found axons degenerate similarly (Figure 2C and Figure 1—figure supplement 1A), which indicates that degeneration is not caused by some unknown defects of the <italic>ric-7</italic> mutation. Importantly, the suppressors, namely the active <italic>unc-43</italic> mutation and <italic>casy-1</italic> KO, also suppress degeneration in <italic>miro-1; mtx-2</italic> animals, suggesting that they are not specific to the <italic>ric-7</italic> model (We included this new data in Figure 1—figure supplement 3 and updated the text). Third, we were able to suppress degeneration by pulling mitochondria from the cell body back into the axon (Figure 1—figure supplement 1C-1D). Therefore, our observations support the model that degeneration is caused by the lack of mitochondria.</p><p>The mitochondrially-dependent pro-degenerative requirement of TIR-1 is a good alternative hypothesis for the observation that knocking out <italic>tir-1</italic> does not suppress axon degeneration in <italic>ric-7</italic> (Figure 2J). We tested this by crossing out the <italic>ric-7</italic> mutation and examining if overexpressing full-length tir-1 in WT animals induces axon degeneration. However, in a total of 45 animals, not a single truncated or degenerating axon was observed. Moreover, we think that the observation that overexpressing TIR-1 suppresses degeneration in <italic>ric-7</italic> suggests that it has a protective role at least in the absence of mitochondria (Figure 2H)-otherwise, we would have observed nothing instead of suppression.</p><p>Reference</p><p>Araki, Y., Kawano, T., Taru, H., Saito, Y., Wada, S., Miyamoto, K., Kobayashi, H., Ishikawa, H.O., Ohsugi, Y., Yamamoto, T.<italic>, et al.</italic> (2007). The novel cargo Alcadein induces vesicle association of kinesin-1 motor components and activates axonal transport. EMBO J <italic>26</italic>, 1475-1486.</p><p>Gauthier, K.D., and Rocheleau, C.E. (2021). LIN-10 can promote LET-23 EGFR signaling and trafficking independently of LIN-2 and LIN-7. Mol Biol Cell <italic>32</italic>, 788-799.</p><p>Glodowski, D.R., Wright, T., Martinowich, K., Chang, H.C., Beach, D., and Rongo, C. (2005). Distinct LIN10 domains are required for its neuronal function, its epithelial function, and its synaptic localization. Mol Biol Cell <italic>16</italic>, 1417-1426.</p><p>Guo, X., Zhou, J., Starr, C., Mohns, E.J., Li, Y., Chen, E.P., Yoon, Y., Kellner, C.P., Tanaka, K., Wang, H.<italic>, et al.</italic> (2021). Preservation of vision after CaMKII-mediated protection of retinal ganglion cells. Cell <italic>184</italic>, 4299-4314 e4212.</p><p>Horsefield, S., Burdett, H., Zhang, X., Manik, M.K., Shi, Y., Chen, J., Qi, T., Gilley, J., Lai, J.S., Rank, M.X.<italic>, et al.</italic> (2019). NAD(+) cleavage activity by animal and plant TIR domains in cell death pathways. Science <italic>365</italic>, 793-799.</p><p>Jospin, M., Jacquemond, V., Mariol, M.C., Segalat, L., and Allard, B. (2002). The L-type voltagedependent ca<sup>2+</sup> channel EGL-19 controls body wall muscle function in <italic>Caenorhabditis elegans</italic>. J Cell Biol <italic>159</italic>, 337-348.</p><p>Konecna, A., Frischknecht, R., Kinter, J., Ludwig, A., Steuble, M., Meskenaite, V., Indermuhle, M., Engel, M., Cen, C., Mateos, J.M.<italic>, et al.</italic> (2006). Calsyntenin-1 docks vesicular cargo to kinesin-1. Mol Biol Cell <italic>17</italic>, 3651-3663.</p><p>Ohno, H., Kato, S., Naito, Y., Kunitomo, H., Tomioka, M., and Iino, Y. (2014). Role of synaptic phosphatidylinositol 3-kinase in a behavioral learning response in <italic>C. elegans</italic>. Science <italic>345</italic>, 313-317. Rawson, R.L., Yam, L., Weimer, R.M., Bend, E.G., Hartwieg, E., Horvitz, H.R., Clark, S.G., and Jorgensen, E.M. (2014). Axons degenerate in the absence of mitochondria in <italic>C. elegans</italic>. Curr Biol <italic>24</italic>, 760-765. Rongo, C., Whitfield, C.W., Rodal, A., Kim, S.K., and Kaplan, J.M. (1998). LIN-10 is a shared component of the polarized protein localization pathways in neurons and epithelia. Cell <italic>94</italic>, 751-759.</p><p>Summers, D.W., Gibson, D.A., DiAntonio, A., and Milbrandt, J. (2016). SARM1-specific motifs in the TIR domain enable NAD<sup>+</sup> loss and regulate injury-induced SARM1 activation. Proc Natl Acad Sci U S A <italic>113</italic>, E6271-E6280.</p><p>Sure, G.R., Chatterjee, A., Mishra, N., Sabharwal, V., Devireddy, S., Awasthi, A., Mohan, S., and Koushika, S.P. (2018). UNC-16/JIP3 and UNC-76/FEZ1 limit the density of mitochondria in <italic>C. elegans</italic> neurons by maintaining the balance of anterograde and retrograde mitochondrial transport. Sci Rep <italic>8</italic>, 8938. Zhang, D., Isack, N.R., Glodowski, D.R., Liu, J., Chen, C.C., Xu, X.Z., Grant, B.D., and Rongo, C. (2012). RAB-</p><p>6.2 and the retromer regulate glutamate receptor recycling through a retrograde pathway. J Cell Biol <italic>196</italic>, 85-101.</p></body></sub-article></article>